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Parts of this dissertation are based on submitted manuscripts for publication or on peer-review 
research articles.  
 
The publications are based on work carried out between January 2015 and July 2018 for this 
dissertation. Sections based on publications are marked at the beginning of each section. The 
text of these sections may be largely identical to the publications, but has been supplemented 
in parts by further information as well as illustrations.   
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You may never know what results come of your actions, but if you do 
nothing, there will be no results. (Mahatma Gandhi)  
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Abstract 
The enzyme family of ω-transaminases (ω-TA) catalyzes a stereoselective transfer of an amino 
group from an amino donor to an acceptor molecule (with ketone/aldehyde function). ω-TA are 
of great interest for many pharmaceutical processes and synthesis strategies, as they enable the 
production of enantiomerically pure amino-drugs.  
This thesis, which is part of the Molecular Interaction Engineering (MIE) project funded by the 
German Federal Ministry of Education and Research, deals with enzyme production and 
modification using the synthesis of β-amino acids and their degradation by microorganisms as 
examples. Therefore, the focus of this work was set on the transamination of β-keto acids/esters, 
the necessary enzyme engineering, as well as the characterization and cataloguing of the 
ω-transaminase family. The primary goal was to demonstrate the synthesis of the chiral cancer 
drug component paclitaxel (Taxol), β-phenylalanine(ester), mediated by ω-transaminases. 
In summary, the following points could be achieved in this thesis:  
o The β-phenylalanine converting Variovorax paradoxus ω-TA gene was codon 
optimized for expression in E. coli BL21, purified by fast protein liquid chromatography 
(FPLC) using Ni-NTA columns and thermostabilized by in silico guided site directed 
mutagenesis. 
o The ω-transaminase engineering database (oTAED) was developed as a helpful starting 
point for protein engineering and discovery of ω-TA. 
o Functional amino acid positions in the V. paradoxus ω-TA were mutated and the effects 
on activity were investigated. 
o The protein stability of ω-TA from V. paradoxus was improved by targeted mutagenesis 
(single mutation) while maintaining the enzymatic activity. 
o The difficulties in the synthesis of β-phenylalanine (β-PA)  by a lipase-ω-TA reaction 
cascade were demonstrated. Alternative synthesis methods were proposed and at least 
one established.  
o Therefore two ω-TA for the synthesis of (R)- and (S)-β-phenylalanine ethyl ester were 
identified by screening an ω-TA library. 
o The ω-TA 3FCR_4M showed potential for up-scaling by a factor of 200 for the 
synthesis of (S)-β-phenylalanine ethyl ester (200 mL - 30 mM product concentration). 
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o The degradation of β-phenylalanine by two bacteria was analyzed in detail under 
controlled conditions. Additionally for the first time the simultaneous degradation of 
both enantiomers was shown for one bacterium.   
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Chapter 1 introduces the importance of α- and β-amino acids and presents the various synthesis 
processes (chemical and enzymatic). The mode of action of the enzymatic catalyst is also 
described in detail. In addition, it is discussed how enzymes can be specifically modified by 
simulation methods in order to modify important properties such as substrate selectivity or 
protein stability. 
This also presupposes that the enzyme family(s) are systematically catalogued and 
characterized in order to predict and underline properties such as enantioselectivity, substrate 
selectivity and to adapt reaction conditions. Therefore, a publicly available transaminase 
database was created which is described in Chapter 3. In this chapter, the evolutionary 
conserved amino acid positions within the two ω-TA families (fold type I and type IV) are 
shown and their functions are analyzed. It could also be shown that by standardizing the amino 
acid positions (standard numbering), the properties of certain amino acid positions can be 
compared and transferred between different ω-TA. As an example, a mutation study conducted 
at a particular ω-TA can be transferred to a second poorly characterized ω-TA (within the same 
family). In order to demonstrate the standardization of amino acid positions, data from the 
literature were compared with each other, with the result that different mutation studies (at 
different ω-TA) had actually mutated and investigated the same standard amino acid positions. 
This illustrates the need for standard numbering of amino acid positions within an enzyme 
family, in particular with regard to ω-TA engineering, since the large and extensive search for 
engineering sites within the long peptide chain of enzymes is no longer necessary. 
Within the ω-TA family of (S)-selective enzymes, a relatively large group of β-PA converting 
transaminases was determined within the database. This group also includes ω-TA from V. 
paradoxus which show high activity towards this substrate. Therefore, chapter 4 deals with the 
characterization, enzyme production and the targeted improvement of the protein stability of 
ω-TA from V. paradoxus. This particular ω-TA allows the conversion of β-PA under mild 
reaction conditions in a buffered aqueous reaction system. This enzyme should be modified for 
further processing by specific mutations within the protein sequence in such a manner that the 
protein stability and long-term activity of the enzyme will be increased. This was achieved 
using the FoldX protein stabilization algorithm and potentially energy-stabilizing mutations 
were identified and tested. The amino acid changes predicted on this basis were introduced into 
the gene of ω-TA by mutagenesis PCR. The activities of the resulting ω-TA variants were 
investigated and the resulting stabilization was analyzed using the protein melting point. The 
starting point of protein melting was shifted by approx. 4°C for the best variant. This increase 
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in thermostability allows maintaining the enzymatic activity over a longer period of time. 
Furthermore, this improvement can be used as a basis for further enzyme mutation experiments, 
as mutations often lead to a reduction in protein stability.  
Based on the systematic analysis of mainly the (S) and (R)-selective ω-TA family, Chapter 5 
discusses the enzymatic synthesis of β-phenylalanine ethyl ester from the substrate ethyl 3-oxo 
phenylpropanoate (β-keto ester) using mutant and natural ω-TA. It was therefore shown for the 
first time that ω-TA are able to convert this category of aromatic substrate. For this reason, 
mutation experiments were carried out for the ω-TA from V. paradoxus, as it converts the 
product, β-phenylalanine, with a high turnover rate. The amino acid positions of the ω-TA, 
which should have an influence on substrate selectivity, were determined and mutated by 
methods developed in Chapter 3. At all, the wild type enzyme showed no activity towards the 
β-keto ester substrate. Mainly amino acid residues within the enzyme were altered which should 
have an influence on the substrate binding, namely: R41, Y76, Y159 and R398. R41, for 
example, is an important arginine residue that binds the negatively charged carboxyl group of 
β-phenylalanine via its positive charge. This residue was replaced because the substrate of 
interest does not have a free carboxyl group, but an ester functionality. However, no activity 
against ethyl 3-oxo-phenylpropanoate could be detected for most variants. Only the variant 
R41K-R398K could be regarded as active in qualitative terms, but the activity was too low to 
allow a quantitative statement about the activity. Since no clearly active variant with a 
quantifiable turnover was found, an ω-TA library of the Bornscheuer working group 
(University of Greifswald) was screened. For this purpose, a chromophoric screening test was 
used which allows a quick selection between non-active and active transaminases. At least two 
transaminases with activity were detected in this screening, one (R)-selective, the other (S)-
selective. These two transaminases are no longer wild type enzymes, but contain several 
mutations. The (R)-selective enzyme was determined as the transaminase ATA117, which was 
created for the synthesis of sitagpliptin by Savile et al.. The (S)-selective ω-TA is an enzyme 
which was engineered by the Bornscheuer research group for the conversion of large aromatic 
ketones. The (S)-selective reaction was used in a preparative approach with an (S)-selective 
enzyme to demonstrate that the detected ω-TA also enables up-scaling. In this context, a 
preparative purification method using automated column chromatography was also established.  
In contrast to the enzyme conversion, however, little is generally known about the degradation 
of β-amino acids by microorganisms. Therefore, chapter 6 deals with the characterization of 
β-PA degradation by β-Proteobacteria Paraburkholderia PsJN and BS115. BS115 is a strain 
isolated from potting soil enriched with soy-peptone. Type strain PsJN, on the other hand, has 
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originally been isolated from plants and is closely involved with the nitrogen cycle in soil. The 
aim was to discover new, as yet uncharacterized ω-TA and maybe additional enzymes and to 
investigate the microbial resolution of the racemate as an alternative to an enzymatic resolution. 
This degradation process was investigated under controlled conditions in a 2.5L bioreactor and 
the temporal degradation and biomass formation was investigated. It could be shown that 
racemic β-PA is degraded stereoselectively by PsJN. During this process, (S)-β-PA was 
completely degraded while the (R)-enantiomer was completely retained in the fermentation 
medium. In contrast, the strain BS115 showed that (R)-β-PA was also degraded at a late stage 
of fermentation. However, it could be ruled out that the degradation process of (R)-β-PA took 
place via a ω-TA, so presumably the activity of an additional enzyme has been detected. The 
results showed that genome sequencing of the BS115 strain is probably required to more 
accurately characterize the monitored (R)-β-phenylalanine degradation.       
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Zusammenfassung 
Diese Arbeit erörtert die Enzyme-Familie der ω-Transaminasen (ω-TA), die eine 
stereoselektive Übertragung einer Stickstoffgruppe von einem Amino-Donor auf ein 
Akzeptor-Molekül (mit Keton/Aldehyd-Funktion) katalysieren. ω-Transaminasen sind von 
großem Interesse für viele pharmazeutische Prozesse und Synthese-Strategien, da selbige es 
ermöglichen, stickstoffhaltige Wirkstoffe enantiomerenrein zu produzieren.  
Die Dissertation, angefertigt im Rahmen des vom Bundesministerium für Bildung und 
Forschung geförderten Projektes Molecular Interaction Engineering (MIE), beschäftigte sich 
hierbei mit der Enzymherstellung und Modifikation am Beispiel der Synthese von 
β-Aminosäuren sowie dem Abbau selbiger durch Mikroorganismen. Im Fokus dieser Arbeit 
stand daher die Transaminierung von β-Ketosäuren/estern, das dafür notwendige Enzym 
Engineering, sowie die Charakterisierung und Katalogisierung der ω-Transaminase-Familie.  
Das primäre Ziel war hierbei die Synthese des chiralen Paclitaxel-Bestandteils, β-
Phenylalanine(ester), durch ω-Transaminasen demonstrieren. 
Zusammenfassend konnten in dieser Thesis folgende Punkte erreicht werden:  
o Die Proteinproduktion und Reinigung der ω-TA aus Variovorax  paradoxus konnte 
durch Codon-Optimierung sowie Fast protein liquid chromatography (FPLC) mittels 
Ni-NTA-Säulen verbessert werden und die Langzeitstabilität konnte erhöht werden  
o Außerdem konnte eine ω-Transaminase-Engineering-Datenbank (oTAED) als 
hilfreiche Basis für das Transaminase-Engineering etabliert werden 
o Funktionelle Aminosäurepositionen in der V. paradoxus ω-TA wurden mutiert und die 
Auswirkungen auf die Aktivität untersucht 
o Durch gezielte Mutagenese konnte die Proteinstabilität der ω-TA aus V. paradoxus 
unter gleichzeitigem Erhalt der Aktivität verbessert werden. 
o Es konnten die Schwierigkeiten bei der Synthese von β-Phenylalanin (β-PA) durch eine 
Lipase-ω-TA Kaskadenreaktion erörtert und gezeigt werden. Hierbei wurden alternative 
Syntheseweg vorgeschlagen und analysiert 
o Es wurden zwei ω-TA für die Synthese von (R)- sowie (S)-β-PA-Ethylester identifiziert 
durch Screening einer ω-TA Bibliothek 
o Eine ω-TA (namentlich 3FCR_4M) zeigte Potenzial für eine Maßstabsvergrößerung um 
den Faktor 200 für die Synthese des (S)-β-PA-Ethylester (200 mL - 30 mM 
Produktkonzentration). 
Zusammenfassung 
IX 
 
o Der Abbau von β-PA durch zwei Bakterien konnte unter kontrollierten Bedingungen 
genauer analysiert werden. Dabei wurde erstmals der simultane Abbau beider 
Enantiomere einer β-Aminosäure durch ein Bakterium gezeigt, wobei neben der 
Transaminierung noch ein weiterer, bislang unbekannter Abbaumechanismus erfolgt.   
 
Kapitel 1 führt in die Bedeutung von α- sowie β-Aminosäuren ein und stellt die verschiedenen 
Syntheseverfahren (chemisch u. enzymatisch) vor. Es wird zudem die Wirkungsweise des 
enzymatischen Katalysators im Detail beschrieben. Außerdem wird darauf eingegangen, wie 
durch Simulationsverfahren Enzyme gezielt modifiziert werden können, um wichtige 
Eigenschaften wie Substratselektivität oder Proteinstabilität modifizieren zu können.  
Dies setzt aber auch voraus, dass die Enzyme-Familie(n) systematisch katalogisiert und 
charakterisiert sind um Eigenschaften wie Enantioselektivität, Substratselektivität und 
Reaktionsbedingungen eingrenzen und vorhersagen zu können. Daher wurde in Kapitel 3 eine 
öffentlich verfügbare Transaminase Datenbank erstellt und beschrieben. In dieser Thesis 
konnten evolutiv konservierte Aminosäurepositionen innerhalb der zwei ω-TA-Familien (Fold 
type I und type IV) aufgezeigt und deren Funktion analysiert werden. Dabei konnte auch gezeigt 
werden, dass durch Standardisierung der Aminosäurepositionen die Eigenschaften bestimmter 
Aminosäurepositionen zwischen verschiedenen ω-TA verglichen und übertragen werden 
können. Beispielsweise kann eine Mutationsstudie, durchgeführt an einer bestimmten ω-TA, 
auf eine zweite noch wenig charakterisierte ω-TA (innerhalb der Familie) übertragen werden. 
Zur Demonstration der Standardisierung von Aminosäurepositionen wurden hierfür Daten aus 
der Literatur untereinander verglichen, mit dem Ergebnis, dass verschiedene Mutationsstudien 
(an verschiedenen ω-TA) im Endeffekt die gleichen Standard Aminosäurepositionen mutiert 
und untersucht hatten. Dies verdeutlicht die Notwendigkeit einer einheitlichen Nummerierung 
der Aminosäurepositionen innerhalb einer Enzymfamilie, insbesondere im Hinblick auf 
ω-Transaminase-Engineering, da die große und umfangreiche Suche nach Engineering-Stellen 
innerhalb der langen Peptidkette der Enzyme entfällt. 
Innerhalb der ω-TA Familie der (S)-selektiven Enzyme, wurde so auch eine relativ große 
Gruppe an β-PA umsetzenden Transaminasen bestimmt. Zu dieser Gruppe gehört unter 
anderem auch die ω-TA aus V. paradoxus, die hohe Aktivitäten gegenüber diesem Substrat 
aufzeigt. Daher beschäftigt sich Kapitel 4 mit der Charakterisierung, der Enzymherstellung und 
der gezielten Verbesserung der Proteinstabilität der ω-Transaminase aus dem Mikroorganismus 
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V. paradoxus. Diese besondere ω-TA erlaubt die Umsetzung von β-PA unter milden 
Reaktionsbedingungen in einem gepufferten wässrigen Reaktionssystem. Dieses Enzym sollte 
für das weitere Vorgehen durch gezielte Mutationen innerhalb der Proteinsequenz so 
modifiziert werden, dass die Proteinstabilität und Langzeitaktivität des Enzyms verbessert 
werden sollte. Hierfür wurde der Proteinstabilisierungs-Algorithmus FoldX angewandt und 
potentiell energiestabiliserende Mutationen hervorgesagt und getestet. Die auf dieser Basis 
vorhergesagten Aminosäureveränderungen wurden durch Mutagenese-PCR in das Gen der 
ω-TA eingeführt. Die erhaltenen ω-TA Varianten wurden auf ihre Aktivität hin untersucht und 
die erhaltene Stabilisierung anhand von Proteinschmelzkurven analysiert. Hierbei zeigte sich, 
dass der Startpunkt der Proteinentfaltung, dem Schmelzen, um ca. 4°C verschoben werden 
konnte. Diese Erhöhung der Thermostabilität erlaubt, über einen längeren Zeitraum die 
Aktivität des Enzyms in der Reaktionslösung zu erhalten. Des Weiteren kann diese 
Verbesserung als Grundlage für weitere Enzym-Mutationsexperimente verwendet werden, da 
oftmals Mutationen zu einer Absenkung der Proteinstabilität führen.    
Auf Grundlage der systematischen Analyse der (S)-selektiven ω-TA Familie, behandelt 
Kapitel 5 die enzymatische Synthese von β-Phenylalaninethylester aus dem Substrat 
Ethyl-3-oxo-phenylpropanoat (β-Ketoester) mit Hilfe von mutierten und natürlichen 
ω-Transaminasen. Es wurde erstmalig gezeigt, dass ω-TA in der Lage sind diese aromatische 
Substratkategorie umzusetzen. Bis zu diesem Zeitpunkt waren andere Transaminasen mit 
Aktivität gegenüber dem nicht chiralen β-Ketoester nicht bekannt. Es wurden daher zunächst 
Mutationsexperimente an der ω-Transaminase aus V. paradoxus durchgeführt, da selbige das 
Produkt mit hoher Aktivität umsetzt. Die Aminosäurepositionen der ω-TA, welche einen 
Einfluss auf die Substratselektivität haben sollten, wurden durch in die Kapitel 3 erarbeiteten 
Methoden bestimmt und mutiert. Das ursprüngliche Enzym zeigte hierbei keine Aktivität 
gegenüber dem β-Ketoester. Es wurden vor allem Aminosäure-Reste innerhalb des Enzyms 
verändert die einen Einfluss auf die Substratbindung haben sollten, namentlich: R41, Y76, 
Y159 sowie R398. R41 ist beispielsweise ein wichtiger Arginin-Rest der über seine positive 
Ladung die Bindung der negativ geladenen Carboxylgruppe des β-PA ermöglicht. Dieser Rest 
wurde ausgetauscht, da das Substrat keine freie Carboxylgruppe besitzt, sondern eine 
ungeladene Ester-Funktionalität. Es konnte jedoch für keine Variante eine Aktivität gegenüber 
Ethyl 3-oxo-phenylpropanoat nachgewiesen werden. Lediglich die Variante R41K-R398K 
konnte qualitativ als aktiv betrachtet werden, jedoch war die Aktivität zu gering um eine 
quantitative Aussage über die Aktivität treffen zu können. Da keine eindeutig aktive Variante 
gefunden wurde, die einen quantifizierbaren Umsatz aufwies, wurde eine ω-Transaminase 
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Bibliothek der Arbeitsgruppe Bornscheuer (Universität Greifswald) in einem Screening 
untersucht. Hierfür wurde ein farbgebender Screening-Test verwendet, der eine schnelle 
Selektion zwischen nicht aktiven und aktiven Transaminasen erlaubt. Es konnten in diesem 
Screening zwei Transaminasen mit Aktivität gefunden werden, eine (R)-selektiv, die andere 
(S)-selektiv. Beide Transaminasen sind keine natürlichen Enzyme mehr, sondern enthalten 
mehrere Mutationen. Das (R)-selektive Enzym war hierbei die Transaminase ATA117, die für 
die Synthese von Sitagpliptin von Savile et al. mutiert worden war. Die (S)-selektive TA ist ein 
Enzym, welches von der Forschungsgruppe Bornscheuer mutiert worden war für den Umsatz 
von großen aromatischen Ketonen. Die (S)-selektive Reaktion wurde in einem präparativen 
Ansatz mit einer (S)-selektive TA gezeigt, um das Potential der ω-TA für ein Up-scaling zu 
untersuchen. In diesem Zusammenhang wurde auch eine präparative Reinigungsmethode 
mittels automatisier Säulenchromatographie etabliert. 
Im Gegensatz zur enzymatischen Umsetzung ist jedoch wenig über den Abbau von 
β-Aminosäuren durch Mikroorganismen im Allgemeinen bekannt. Daher beschäftigt sich 
Kapitel 6 mit der Charakterisierung des β-Phenylalanin Abbaus durch die β-Proteobakterien 
Paraburkholderia PsJN und BS115. BS115 ist ein Isolat, welches in Vorarbeiten aus 
Blumenerde isoliert wurde, die mit Sojapepton angereichert wurde. Der gut untersuchte 
Typenstamm PsJN dagegen wurde ursprünglich von Pflanzen isoliert und ist eng in den 
Stickstoffkreislauf im Boden involviert. Ziel war es zum einen, neue, noch nicht charakterisierte 
ω-TA sowie möglicherweise weitere Enzyme zu entdecken, zum anderen die mikrobielle 
Resolution des Racemats als eine Alternative zu einer enzymatischen Resolution zu 
untersuchen. Dieser Abbauprozess wurde unter kontrollierten Bedingungen in einem 2.5 L 
Bioreaktor untersucht und der zeitliche Abbau, sowie die Biomassebildung untersucht. Es 
konnte gezeigt werden, dass racemisches β-PA stereoselektiv durch PsJN abgebaut wird. 
Hierbei wurde vollständig (S)-β-PA abgebaut und das (R)-Enantiomer blieb hingegen 
vollständig im Fermentationsmedium erhalten. Der Stamm BS115 dagegen zeigte, dass zu 
einem späten Zeitpunkt der Fermentation auch (R)-β-Phenylalanin abgebaut wurde. Es konnte 
jedoch ausgeschlossen werden, dass der  Abbauprozess des (R)- β-Phenylalanin über eine ω-TA 
erfolgte; folglich wurde hier die Aktivität eines bislang nicht beschriebenen Enzyms entdeckt. 
Die Ergebnisse zeigten, dass wahrscheinlich eine Genom-Sequenzierung des Stamms BS115 
erforderlich ist, um den beobachteten (R)-β-PA Abbau genauer charakterisieren zu können. 
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Introduction 
 
The following parts reflect the technical background with regard to the experimental section of 
this thesis. The aim of this thesis is the systematic analysis of the function of ω-TA as well as 
enzyme engineering under the objective of the synthesis of β-amino acids. In subsection 1.1. 
the target molecules of this thesis are introduced, with focus on β-phenylalanine. In 1.2., ω-TA 
and reaction mechanism as well as applications are introduced1.3 focuses on synthesis 
strategies to produce chiral β-amino acids. Therefore, chemical as well as enzymatic synthesis 
approaches are presented. In subsection 1.4 an introduction in protein engineering with focus 
on protein stability is given.  
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1.1) Amino acids as important chemicals and building blocks  
 
Beside the (de)oxyribo-nucleic acids as molecules for saving information and as blue script for 
building biological systems, amino acids are the most important biofunctional carbon 
compounds on earth. The life we know is inconceivable without amino acids: Even the simplest 
biological systems need amino acids to build functional proteins. Furthermore amino acids are 
even found in extraterrestrial matter (e.g. meteoritic dust/rocks) and it is possible that meteors 
delivered these molecules to the earth [1,2]. This proves that amino acids can be found 
everywhere and have played a role since the beginning of the earth. 
The importance of amino acids is visualized by the high demand for amino acids by world 
economy. The scale ranges at millions of tons, particular for food and feed industry, but also 
for precursors for the production of pharmaceuticals like antibiotics, sweeteners, peptide-drugs, 
polymers but also as agrochemicals [3–5]. The dominant group with the largest focus is 
L-α-amino acids. As building blocks for proteins, these molecules are omnipresent in nature, 
but some (micro)organisms need external L-α-amino acids, which cannot be produced by their 
own metabolism. These amino acids are known as essential amino acids and therefor a 
multibillion $ market exists. One of the most prominent examples for chemically produced 
amino acids is methionine (as a racemate), which is fed in large scale to chickens to reduce the 
necessary amounts of feed [6]. Methionine is produced on a scale of 0.85 million tons per a [7]. 
As a side effect, it might be even beneficial for the immune response of chickens [8].  
Beside methionine, the most prominent proteinogenic L-α-amino acids are L-threonine, L-lysine 
and L-tryptophan for feed industry. Moreover L-glutamate is an important flavor enhancer. 
These amino acids are mainly produced by fermentation processes with sugar as carbon source 
[8]. However, α-amino acids are not only used in the food and feed industry.  L-Arginine, for 
example, shows manifold effects from improvement of wound healing, support of muscle 
growth to increased release of hormones. [9]. Although chemical synthesis routes like the 
Strecker-synthesis are known since 1850, later developed enzymatic and microbial processes 
became important for chiral processes [10]. The world-wide market for amino acids is 8 billion 
$ and the two bestselling amino acids are L-glutamate/L-lysine with 3.3 and 2.2 million tons per 
year (Table 1). This underpins the importance of fermentative and enzymatic methods towards 
the world economy. The most prominent example for bioprocesses is the L-glutamate 
production using Corynebacterium glutamicum [7].   
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Table 1 Overview of world production of L-α-amino acids on the basis of fermentation or enzyme 
processes according to Sanchez et al.[7]. 
 market volume 
[$] 
Scale 
[thousand 
tons] 
Fermentation 
titer [g/L] 
L -glutamate 1.5 billion 3300  150  
L -lysine-HCl 1.5 billion 2200 170 
L -threonine  0.270 billion 30 132 
L -arginine 0.150 billion 1.5 96 
L -tryptophan 0.150 billion 14.0 60  
L -tyrosine 0.05 billion 0.200 55 
L –phenylalanine 1.0 billion 30 57 
 
However, also non-α-amino acids gained attention as important building blocks for 
pharmaceuticals, artificial and protease resistant peptides and as antibiotics. The research and 
development is also focused on these special amino acids as well as important amines, which 
are synthesized using enzymes or microorganisms.  
1.1.2) Role of β-amino acids as compounds active agents and as part of compounds  
 
One of these special group of amino acids are β-amino acids, which are part of functional 
biomolecules. They are labeled with “β”, because the amine group is positioned at the second 
carbon atom from the carboxylic group within the molecule (see also Figure 1.1). A general 
introduction to the naming and description of β-amino acids was given by Seebach et al., 
Juaristi et al. and Dold et al. [11–13]. These special amino acids can be utilized as single 
compounds for the design of bioactive ligands and other biomaterials. A particularly important 
example are antifungal β-amino acids, which are inhibiting the protein synthesis and cell growth 
e.g. of the yeast Candida albicans [14]. Further examples for bioactive β-amino derivatives are 
cispentacin (10), BAY 10-8888 (12), tilidin (3), oxetin (11), icofugipen (1) and oryzoxymicin 
(6). They are acting as antifungal, antibacterial or as analgetic compounds [15]. Furthermore 
the β-amino acid-azanindoles show potential as inhibitor against influenza polymerase (4) [16]. 
This molecule class has a promising function for the treatment of both seasonal and pandemic 
influenza. In addition, the β-amino acid ester-phosphodiamide compound is known as antiviral 
drug and acts as inhibitor for the reverse transcriptase of HI-virus (12)[17]. It can be concluded 
Introduction 
4 
that β-amino acids have great potential as active ingredients parts in respect to improved 
protease resistance and properties compared to α-amino acid containing active ingredients. 
Moreover, β-amino acids can be utilized for the production of self-assembling nanomaterials 
and for bioactive β-peptides [18].  
β-peptides as promising drugs 
Artificial β-amino-acid containing peptides form more stable secondary structures than known 
for proteinogenic amino acids [11]. Furthermore, single β-amino acids can protect peptides 
towards degradation by proteases, because evolution adapted proteases for peptides and 
proteins consisting of standard L-α-amino acids. Small protein-like chains, which are composed 
of β-amino acids, are also called peptidomimetics, because they mimic the shape and function 
of natural peptides. For example antimicrobial peptides must be protected against protease 
degradation, otherwise they will be decomposed in biological systems very fast. Therefore 
cyclic β-amino acids or β-amino acids as peptide building blocks are able for efficient protease 
protection [15].  
One example for peptidomimectis is a derivative of morphiceptin (8) which contains β² and β³i 
amino acids and acts as opioid drug  [19]. These β² and β3 peptidomimetics act as 
antinociceptive and antidiarrheal drugs and lower the sensation of pain [19]. As oligopeptide-
modified poly(β-amino acid ester)s they can be utilized as inductors for osteogenesis to 
reprogram dental pluripotent-cells to stem cell like states ii [20]. In addition peptides of β/γ- 
amino acids show antimicrobial effects, especially against the pathogenic bacteria 
Pseudomonas aeruginosa and Staphylococcus aureus [21]. Another example is the β-PA  
containing pseudopeptide andrimid (13), which acts as inhibitor of the bacterial fatty acid 
biosynthesis. More precisely andrimid inhibits the bacterial acetyl-CoA carboxylase [22]. This 
biomolecule was originally isolated from the plant hopper Nilaparvata lugens [23].  
β-amino acids as functional building blocks 
Furthermore cyclic β-amino acids are important precursors of β-lactam antibiotics (2) (Scheme 
1). Cyclic peptides which are containing β-amino acids are able to act as antiproliferative and 
cytotoxic agents, like known for jasplakinolid from the marine sponge Jaspis johnstoni (5) [24]. 
β-amino acids can be utilized for the production of biodegradable polymers, suitable as drug 
                                                 
i β3 means the amino acid residue is next to the amino group within a peptide. Conversely, β2 means that the amino 
acid residue is directly adjacent to the carboxyl group [11].    
ii The authors refer to β-amino acid esters which have been extended with a peptide terminus as oligopeptide-
modified poly (β-amino acid ester)s.    
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delivery systems e.g  as complex former for polynucleotide drugs [25]. Those drugs can be 
applied as intracellular delivery system for treatment of brain cancer [26]. Beside peptides and 
polymers, β-amino compounds exist also in lipopeptides like described for YM-170320, 
topostatin and fusaristain [27–29]. For example YM-170320 (7) acts as antimicrobial 
substances by inhibiting the ergosterol biosynthesis in fungi [27,30]. Furthermore, the two very 
similar substances, 12 and 10, also act as fungicides by inhibiting the protein synthesis [31]. 
 
 
β-Phenylalanine as building block of the anti-cancer drug paclitaxel 
The most prominent example of β-amino acid containing biomolecule is the complex natural 
compound Paclitaxel with thirteen stereo centers (PT, 14).  This diterpenoid agent was 
discovered in Taxus plants (yew trees), especially in the pacific Taxus brevifolia and acts as 
medical substance against ovarian cancer. The demand on PT is currently increasing due to the 
expanding application possibilities. Over the years PT was tested for different kinds of cancer, 
e.g. brain tumor types and it was considered as one of the most important anticancer drug with 
a market volume of over 1 billion $ per year [32,33]. Moreover, also further applications like 
treatment of heart restenosis are conceivable. PT can be used in stents to avoid restenosis, which 
increased the interests in PT further [34,35]. Beside the original natural compound some 
derivatives are found or created like Docetaxel [32]. A disadvantage of PT is the marginal 
availability of the complex natural compound. Only 0.01 to 0.04 % dry weight are accumulated 
in a yew tree, mainly in the bark [32]. To overcome these limitations, alternatives are 
investigated and applied like transgenic plant cell lines of Taxus sp. [36]. Precursor molecules 
can also be isolated from the Taxus baccata (European yew), Taxus wallchiana (Himalaya yew) 
and from the needles of the Taxus brevifolia. These complex natural product precursors are 
10-decatylbaccatin III and docetaxel [32,37–39]. Despite the importance of the synthesis of 
larger amounts of PT, some enzyme conversion steps in metabolic pathways are still unknown 
or uncharacterized [35]. 
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Figure 1.1 Examples of β-amino acid containing functional biomolecules or precursors for 
pharmaceuticals. The basic structure of the β-amino acid is highlighted in yellow.  
Recently, Walker et al. demonstrated in a proof of concept an enzyme cascade starting with 
baccatin III (15) and β-phenylalanine (β-PA, 16) for the synthesis of N-(2-furoyl)paclitaxel 
using four different enzymes (Figure 1.2). They demonstrated clearly that this reaction cascade 
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might by a promising strategy compared to existing processes, because baccatin III can be 
isolated in four times excess compared to paclitaxel from Taxus cell cultivations [35,40,41]. 
 
Figure 1.2 Enzymatic synthesis of 17 from 15 and 16. Baccatin III is isolated as a paclitaxel precursor 
from yew species. 16 can be varied in the α and/β-carbon position. The natural product from Taxus 
brevifolia carries a hydroxyl group in α-position and an aryl-residue in β-position. Note that this can 
also change the nomenclature from (R) to (S) and vice versa. 
However, not only complex β-amino acids containing natural products show effects, also small 
non-cyclic β-amino acid drugs exist like Imagabalin (9). Imagabalin is active ingredient against 
general anxiety disorder and is actually tested in clinical studies by the company Pfizer [42]. 
This β-amino acid drug is at the same time an example for the chiral synthesis of 
pharmaceuticals using ω-Transaminase (ω-TA) [43], which is discussed later in chapter 1.3.  
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1.2) Enzymatic and chemical strategies for the synthesis of β-amino 
acids 
 
The extraordinary relevance of non-canonical amino acids like β-amino acids, shown in 
chapter 1.1, underlines the requirement for chiral synthesis strategies with focus on highly 
optically pure β-amino acids, with regard to yields and atom efficiencyiii. This thesis focuses on 
β-phenylalanine (ester) as an example for β-amino acid synthesis using transaminases. 
Therefore in this chapter possibilities for β-amino acid syntheses are shown and in figure 1.3 
three main strategies are presented.  
Firstly, the complete transition metal based synthesis according to the reported strategy is 
presented. Secondly a chemo-enzymatic strategy using the advantages of classical chemistry 
and kinetic resolution by lipases are shown. Thirdly, an exhaustive enzymatic synthesis using 
ω-TA and other enzymes in cascade approaches is prestend in figure 1.4. For example the 
chemical reduction of asymmetric enamide is performed under overpressure (5-25 bar). The 
hydrogenation using oximes is conducted using chiral ruthenium catalysts and dichloromethane 
or methanol as solvent. The enantioselective ruthenium catalyst is built by large chiral 
phosphorus ligands, enabling the performance of enantioselective reactions. For that reason a 
broad spectrum exists of mono- or bi-dentate chiral ligands to synthesize differently configured 
products. Furthermore for enantioselective reductive amination a variety of different catalysts 
exist. Most strategies depend on high pressure and complex chiral ligand-metal complexes. An 
example is the chiral reductive amination of aromates using high pressure (69 bar) and an 
iridium or iron ligand [44]. 
The chemical strategy for enantioselective synthesis of β-PA requires usually an (axial) chiral 
ligand molecules (e.g. BINAP (2,2’-bis(diphenylphosphino)-1,1’-binaphthyl) which 
coordinates a metal atom and reduces ketones to amines. Matsumura et al. demonstrated in a 
patent the synthesis of β-amino acid derivatives using ruthenium-dm-BINAPiv as catalyst. The 
reaction was performed at 80 °C and under overpressure using hydrogen gas (3 MPa) resulting 
in diverse product yields between 7.5 % and 94 % with enantiomeric excesses between 35.8 
and 93 %ee. For example the ethyl ester of (S)-β-PA  was produced with a yield of 29 % and 
an enantiomeric purity of 94 %ee, but also the (R)-enantiomer can also be produced in this way     
                                                 
iii Atom efficiency is defined as ratio between molecular mass of product(s) to the molecular mass off all substrates.  
iv Until now, BINAP is one of the few ligands of industrial importance. [203] 
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[45] . Starting with unsaturated molecules, like enamines, a rhodium/ruthenium-ligand complex 
can catalyze the hydrogenation of the asymmetric substrate in an enantioselective order. At the 
same time the catalyst itself has to be highly optically pure, otherwise no or low enantiomeric 
excesses will be obtained.  
Figure 1.3 Chemical and chemo-enzymatic strategies for producing chiral (S) or (R)-β-PA. a) Chemical 
strategies using chiral ligands for enantioselective synthesis can be used for production of (S) and for 
(R)- β-PA. The amination of ethyl benzoylacetate is e.g. performed with chiral Ru(OCOCH3)2(R)-dm-
binap under pressure (3 MPa) and heat [45]. b) Evonik-Degussa process using acetophenone as substrate 
and lipase catalyzed chiral resolution for production of (S)-β-PA.   
Therefore the ligands are produced in enantioselective manner using chiral catalysts like 
esterases or lipases, which do not reduce the complexity for the complete synthesis concept 
[46]. Against this background, it is not surprising that Evonik-Degussa proposed a non-
enantioselective process for the synthesis of rac-β-phenylalanine-propylester without chiral-
ligand chemistry. The produced racemate is then in a second step enantioselectively hydrolyzed 
using an enantioselective lipase in MTBE. The disadvantage of this process is the theoretical 
maximal yield of 50 % (caused by kinetic resolution), because initially only the racemate is 
produced as intermediate (figure 1.3 (b)). In addition the efficiency of the esterification of the 
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rac-β-PA was not reported by the authors and might also reduce the yield of this strategy [47]. 
Usually, any additional reaction step reduces the practical yield and thus increases the costs.  
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Challenges of ω-TA catalyzed synthesis of β-PA 
However, ω-TA catalyzed synthesis strategies are a promising alternative, but they have not yet 
been thoroughly investigated for the production of β-amino acids. Although ω-TA as 
sustainable catalysts for chiral syntheses can enable one-step or two-step synthesis reactions 
(Figure 1.4), but unfortunately only few ω-TA are reported to be β-PA converting enzymes so 
far (a general overview of transaminases can be found in chapter 1.3).  
 
Figure 1.4 Different approaches of ω-transaminase catalyzed synthesis of β-PA. a) Chiral resolution of 
β-PA. b) Nitrilase and lipase-cascade reaction. c) Synthesis using β-keto ester as stable substrate.  
The first ω-amino acid (non-α-amino acid) conversions were shown mainly for β-alanine and 
γ-aminobutyrate, which are naturally occurring amino acids [48–50]. In contrast, Yun et al. 
described in 2004 an ω-TA with an new substrat preference using Alcaligenes denitrificans 
Y2k-2, showing potential for synthesis of non-aromatic β-amino acids [51]. Three years later 
Kim et al. demonstrated that an ω-TA from Mesorhizobium sp. shows activity towards 
(S)-β-phenylalanine. Additionally they demonstrated that a lipase- ω-TA cascade reaction can 
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be utilized for synthesis of (S)-β-PA from β-keto ester substrates. After hydrolysis of the β-keto 
ester substrate (ethyl benzoylacetate) the instable β-keto acid is built, and finally converted by 
the ω-TA to the stable product β-PA. As amino donor the authors utilized 3-aminobutyric acid 
(β-amino acid) as reagent to shift the reaction equilibrium towards (S)-β-PA, because the 
corresponding co-product, acetoacetic acid, decarboxylates like all β-keto acids towards CO2 
and to a smaller ketone (acetone). The yield after 24 h was only 20 % but resulted in a optically 
pure product (> 99 % ee) [52]. 
Afterwards this ω-TA was fully examined by Wybenga et al. and the 3D structure of the enzyme 
was resolved. They demonstrated clearly that this enzyme is specific for binding α- and β-amino 
acids in the substrate binding pocket. Furthermore, it was shown that β-amino acids bind in a 
different manner than α-keto acceptor molecules at the substrate binding pocket. It was shown 
that (S)- as well as (R)-β-amino acids are converted depending on their conformation and 
constitution [53]. The same research group reported one year later a second ω-TA from 
V. paradoxus also with high activity towards (S)-β-PA [54]. After eight years the first report 
was given confirming that a cascade reaction from β-keto esters to β-amino acid is possible for 
synthesis of (S)-β-PA using a newly characterized ω-TA from Polaromonas sp. JS666. They 
achieved high yields by using whole cell-mixture with recombinant E. coli BL21 in 
combination with high concentrations of the amino donor 1-phenylethylamine (PEA, 150 mM). 
The concentration of lipase was adapted to 36 mg mL-1 in combination with 20 mg mL-1 of 
whole cell catalysts containing the (S)-selective ω-TA. In this highly concentrated protein-cell 
debris suspension they achieved yields between 26 and 99 % of product after 24 h [55]. In 2016, 
in a similar study with an ω-TA from Sphaerobacter thermophilus, they reported a maximum 
product concentration of 44 % of β-PA. This time they used a purified ω-TA at a concentration 
level of 2.5 mg mL-1 (pure protein) and lowered the lipase concentration to 20 mg mL-1. In a 
third study Mathew et al. exchanged the lipase towards a nitrilase (using again Polaromonas 
ω-TA). The nitrilase was used as whole-cell catalyst in a suspension with dry cell mass 
concentrations of 30 mg mL-1 in combination with 20 mg mL-1 of ω-TA resulting in a yield of 
72 % for (S)-β-PA [56]. In 2018, Zhang et al. showed that the reaction cascade of a nitrilase 
and an ω-TA could even be optimized by a two-phase system and large amounts (in total >40 
mg mL-1 ) of lyophilized enzymes (see Chapter 5.1.1) [57]. Therefore, they utilized β-alanine 
as amino donor. These reports suggest that the reaction cascade is supported by high 
concentrations of protein or cell-extracts and surprisingly not inhibited by the resulting 
acetophenone, which was reported earlier by Shik et al. [58]. Additionally it has also been 
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reported that the ω-TA reaction rate is lowered in presence of high amino-donor concentrations 
of PEA [59].  
 
Challenge of β-keto acid reactions 
In view of the reported enzyme cascade reactions, the free β-keto acid is produced in all cases. 
However, the intermediate disintegrates very fast in aqueous solutions. The decarboxylation 
reaction required for this is promoted by a circular transition state (Figure 1.5) [60]. 
 
Figure 1.5 Postulated decarboxylation mechanism of β-keto acids in water according to Bach et al.and 
Hanson [60–62].  
The elimination of CO2 is supported by migrating hydrogen from β-keto oxygen to carboxyl 
oxygen, which leads to a cleavage of the C-C bond between carboxylic group and α-carbon 
atom. The decarboxylation is less favored, when the pH is physiological and additionally 
coulombic interactions might stabilize the β-keto acid [61]. The resulting carbonic acid can 
easily evaporate as carbon dioxide at standard pressure conditions. Therefore to avoid an 
instable β-keto acid in solution, a protected β-keto ester which cannot decarboxylate should be 
more beneficial. Also the reported high protein and cell concentrations of cascade reactions 
seem to be easily scalable to larger volumes (up to 50 g of cell dry weight per liter).  
Avoiding free β-keto acids 
Therefore it seems reasonable to utilize protected β-keto acid substrates to avoid large enzyme 
and cell concentrations. However, one of the obstacles is the low availability of ω-TA with 
reported activity towards β-keto ester substrates. The only enzyme with activity towards 
aliphatic β-keto esters was reported by Midelfort et al. using an engineered ω-TA from 
V. fluvialis. The ω-TA-variant was able to convert (R)-ethyl 5-methyl 3-oxooctanoate at high 
concentrations using PEA as amino donor. The enzyme concentration was reduced to 
74 µg mL-1 leading in a total yield of 28% of β-amino ester product. The resulting β-amino ester 
product can easily be hydrolyzed using a lipase or sodium hydroxide to gain the resulting 
β-amino acid [63]. For that reason one focus of this thesis was to engineer the β-PA converting 
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ω-TA from V. paradoxus for conversion of β-keto ester substrates avoiding free and instable β-
keto acids, reported later in this work (chapter 5). A desired side effect is the easy extraction of 
aromatic keto-esters from the reaction medium with water immisciblev solvents like ethyl 
acetate. However, it is essential to understand the function of ω-TA in order to enable efficient 
synthesis reactions. Therefore, the next chapter presents an overview of the reaction mechanism 
and applications of ω-TA. In addition, an overview of the protein-sequence-function relation is 
presented in chapter 3.  
                                                 
v Immiscible means in this context that two liquids cannot be mixed together in all ratios. 
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1.3) Mechanism, function and applications of ω-Transaminases  
The basic functionality of transaminases is of particular importance for understanding the 
synthesis strategies of possible applications and for the protein engineering.  
1.3.1) The discovery and description of transaminases  
Transaminases are well described enzymes for the metabolism of L-amino acids and were 
indirectly described by Needham et al. in the year 1930 during the investigation of muscle cell 
metabolism [64]. After several observations that muscle cells can perform transamination 
reactions, Braunstein, Cohen and Kritzmann showed that transaminases are the catalyst of 
interest [65–67]. At the beginning the German term for the reaction was used, Umaminierung, 
which was later translated to the name transaminase (Enzyme Class 2.6.1.X) according to the 
French and English designations [64]. These early results in enzyme research demonstrated 
clearly that a so called transaminase needs an amino acceptor, which was ketoglutaric acid, 
sulfopyruvic acid or oxaloacetic acid. Furthermore a second molecule is involved in the 
reaction, which is acting as amino donor. These kind of amino donors were discovered to be 
always an α-amino acid like cysteine, alanine, aspartate and glutamate [64]. Furthermore it was 
demonstrated that this class of enzymes is enantioselective towards L-amino acids and that the 
reaction is fully reversible [65–67]. Thereby the principle of transamination reactions was 
established. Braunstein suggested, that this enzyme familiy also requires a cofactorvi, which is 
known today as pyridoxal-5-phosphate (PLP) and commonly known in the active form as 
vitamin B6 [65]. The importance of transaminases is due to the fact that these enzymes are 
essential for amino acid metabolism. Several decades later Taylor et al. described transaminases 
as promising catalyst for biosynthesis according to a lack of expensive cofactor regeneration 
systems, rapid reaction rates and due to the relative low substrate specify [68]. This is at the 
same time a shift in transaminase research from fundamental research in the field of 
biochemistry and metabolism towards applied researches in the field of biocatalysis. 
The results of transaminase research are culminating in one of the largest enzyme engineering 
projects for industrial applications, Sitagliptin synthesis using a transaminase [69]. The 
engineered enzyme is known as a (R)-selective ω-TA, which means that the biocatalyst is not 
limited to α-amino acid substrates (Figure 1.6). The group of transaminases which are 
accepting amine molecules and are not limited towards α-amino acids are generally not 
                                                 
vi In the biochemical context, a cofactor is understood as a non-protein molecule that participates in the reaction 
(e.g. vitamins/metal ions). 
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consistently named, but all are classified preferably with the Greek letter ω as a prefix (see also 
Chapter 3.4) [70,71]. The naming convention for ω derives from the possibility to convert 
ω-amino acids and was expanded to a common naming convention for utilizing ω- as term for 
every substrate, which is not an α-amino acid [72]. 
 
Figure 1.6 Reaction scheme of α and ω-TAs. The substrate of ω-TAs can vary between molecules with 
carboxylic group and without carboxylic group. α-TAs are only able to convert α-amino acids. In 
contrast to α-TAs the distance between carboxylic group and amino group (or acceptor position) is 
undefined. Moreover a carboxylic group can be completely absent. R = residue (R3-6) : -H, -CH3, -
COOH, -phenyl, -CH2R, etc.)      
Preferably ω-TA accept primary and secondary amino-groups, but the substrate can vary in 
structure, e.g. the amino donor can be n-butylamine, cadaverine (a C5-chain diamine), bulky 
bicyclic amines and many other molecule classes which are containing an amino group [73–
76]. Naturally, ω- and α-TA are involved in the metabolism of amino acids, alkaloids, 
polyamines and amino sugars and therefore perform various transamination tasks (Reviewed 
by Slabu et al. 2017)[77].  
The classification and differentiation of ω-transaminases 
However, within the family of ω-TA, these enzymes are very specific to one group or subclass 
of substrates according to functionality and molecule size. For that reason it seems to be 
reasonable to sort the enzymes into groups according to their substrate preferences. Steffen-
Münsberg et al. reviewed databases with putative enzymes and characterized ω-TA and PLP-
dependent enzymes with high similarity. They demonstrated the large diversity of ω-TA within 
the structural Fold type I. Fold type I ω-TA and closely-related enzymes can be grouped and 
named after their substrate preference, similarity, or due to their reaction mechanism. The major 
groups are labeled as: ornithine-TA, ω-amino acid:pyruvate, ω-TA with unusual acceptor 
spectrum (e.g. β-PA), glutamate-1-semialdehyde transaminases, decarboxylation dependent 
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TA and two other groups, which have a different reaction mechanism (e.g. racemase and 
epimerase functions) but have a high sequence identity. Furthermore also a group of 
uncharacterized enzymes is named in this review, which also includes amino-sugar 
transaminases [78].  
The close relations between enzyme classes within vitamin B6 dependent enzymes are 
demonstrated at the example of two phosphorlyases, which are included according to their 
similarity to class III transaminase family, but surprisingly show no transaminase activity. Both 
enzymes, characterized by Veiga da Cunha et al, showed in experiments lyase activity towards 
o-phosphoethanolamine and 5-phosphohydroxy-L-lysine. It turned out, that only four key 
amino acids at the active site seem to be important for the change from a transaminase towards 
a lyase and vice versa [78,79]. This example should also be understood as an indication that the 
name of the uncharacterized proteins in the family of vitamin B6 dependent enzymes is not 
necessarily descriptive for predicting enzyme function in protein databases. In databases these 
names are registered mainly according towards protein-sequence similarity and not necessarily 
according to protein-function.  
Protein fold type as a distinguishing feature  
Beside the nomenclature of transaminases, also the mentioned protein fold type of PLP-
dependent enzymes can help to divide the group of ω-TA in two categories, one known as Fold 
type I and mostly (S)-selective and one known as Fold type IV and (R)-selective. A total of five 
different folding types exist within the family of PLP-dependent enzymes and therefore allows 
the structural classification of the same [80]. In general the group members of Fold type IV are 
smaller than Fold type I ω-TA, but both groups belong to the superfamily of pyridoxal-5-
phosphate dependent enzymes, which includes beside transaminases also the enzyme classes of 
oxidoreductases, hydrolases, lyases and isomerases. Within this large enzyme family over 2700 
known proteins are known [81].  
Surprisingly, the functional closely related α-TA do not belong only to one fold type (Fold type 
I), as known for (S)-selective ω-TA, but are also partly member of Fold type IV. α-TA are 
strictly limited to α-amino acids as donor and accept only α-keto acids like pyruvate. Within 
the group of Fold type IV-enzymes they are specially known as branched-chain α-TA with 
activity to large aliphatic amino acids like L-leucin [82,83] . In contrast ω-TA show a broad 
amino donor substrate spectrum from α- to ω-amino acids, amino alcohols, amines and in 
general amino-group consisting molecules.  
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However, the pool of different ω-TA is growing constantly and still a general naming 
convention for transaminases is missing. To give the family of ω-transaminase a certain order, 
a database was created and the relationship of transaminases in-depth analyzed (Chapter 3).   
1.3.2) Transaminase mechanism 
In addition to classification and naming, the function of the transaminases is of interest, 
especially for targeted protein engineering a profound understanding is required. The 
mechanism of PLP-mediated transaminase reactions were investigated in detail by Kirsch et al. 
in 1984, proposed on the basis of the spatial structure, at the example of an aspartate 
aminotransferase from chicken heart mitochondria [84]. In addition, the energy profile of the 
reaction was calculated and the necessary steps to create a model were characterized. [206]. 
The mechanism was refined by density functional theory calculations and by visualization of  
 
Figure 1.7 Proposed transamination cycle of two half-reactions at the example of β-phenylalanine and 
α-ketoglutaric acid according to Slabu et al., Manta et al. and Dajnowicz et al. [77,204,205]. Active site 
lysine is highlighted blue. Proton transfer according to Djanowicz et al.. Not every intermediate state is 
shown in this figure.   
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the hydrogen atoms involved by neutron crystalography [204,205].The studies uncovered 
clearly the importance of pyridoxal-5-phosphate for the reaction mechanism and furthermore 
functional amino acid residues of transaminase were pointed out like the catalytically-active 
lysine residue in the active site (Figure 1.7). The general reaction mechanism is closely related 
to other members of vitamin-B6-enzyme family, e.g. ornithine decarboxylases, tryptophan 
synthases, amino acid racemases, lysine 2,3 aminomutases and more. In particular for all 
defined transaminase classes from I to VI the proposed reaction mechanism is valid [85]. The 
proposed reaction mechanism is shown using the V. paradoxus ω-TA as example for β-PA 
conversion. The detailed reaction mechanism comprises at least 17 steps and has been 
simplified in Figure 1.7 [204]. The three-dimensional representation is illustrated in Figure 
1.8. Therein the most prominent amino acid residues for active site engineering are highlighted, 
which are involved in binding the cofactor PLP or the cofactor-substrate complex (external 
aldimine) at the active site.  
The reaction mechanism of transaminases is known to be a ping-pong bi-bi mechanism due to 
the cyclic reaction pathway using two substrates and one cofactor which is recycled after two 
half reactions [86]. However, this also means that the reaction equilibrium between products 
and substrates is usually balanced in equal parts.  
 
Figure 1.8 Active site of the dimeric V. paradoxus ω-TA as an example to describe the location of 
cofactor-substrate complex in ω-TAs. The prominent amino acid for binding PLP is the tyrosine 159 
residue. The catalytic lysine residue 267 is located under the cofactor-substrate complex (Structure PDB-
ID 4AOA). The figure was created with Chimera 1.1[87]. 
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The transamination reaction cycle starts with bound or unbound pyridoxal-5-phosphate (PLP, 
7 or 1 ) which forms a covalent bond with the catalytic lysine residue (see also [77,86,88, 
204,205, 206]). If PLP is bound, the cycle starts with the hydrolysis of PLP to break the imine 
bond between the lysine residue and cofactor (2). In presence of the substrate (e.g. 
β-phenylalanine), a reaction of carbon-aldehyde (cofactor) with the amino substrate group 
follows and a Schiff base intermediate is formed (like lysine-PLP aldimine). This molecule is 
by contrast described as external aldimine (3) (because no covalent bond exists anymore 
towards the enzyme). After deprotonating the external aldimine, a transition state is constituted 
known as quinonoid-carbanion intermediate. This intermediate is stabilized by resonance 
structures [77,88]. Afterwards the imine bond between substrate and cofactor is built (ketamine) 
and by addition of water the ketamine is hydrolyzed (4). Consequently the desaminated 3-oxo-
3-phenylpropanoic acid (keto product) is released. The corresponding 3-oxo-3-
phenylpropanoic acid decays on the basis of decarboxylation mechanism and therefore shifts 
the reaction equilibrium towards amination of the acceptor substrate, which is described as 
common mechanism for β-keto acids [60]. From decarboxylation experiments with aspartate 
and ninhydrin it is known that the formed intermediate, a β-keto acid, decarboxylates very fast 
[89] (see also Figure 1.5). In the second part of the reaction mechanism, the aminated PLP, 
pyridoxamine phosphate (PMP), reacts with the α-keto acid acceptor (or other acceptor 
molecules like aldehydes, β-keto acids etc.), which can be α-ketoglutaric acid and others (e.g. 
pyruvate). Analog to deamination process of β-PA the acceptor molecule gets aminated by PMP 
(5) and L-glutamate is released from the enzyme. Afterwards the reaction cycle can start again.  
 
Special significance of PLP as catalytic cofactor 
The cofactor PLP per se is an interesting and reactive molecule, which reduces the activation 
energy (Ea) of reactions. It is presumed that enzymes stabilize multiple transition states during 
the transamination reaction of PLP-substrate intermediates. Furthermore PLP changes the 
amino-group properties of the substrate and lowers the acidity of it. For example the 
intermediate PLP-glycine iminium ion shows a pKa-value of 6 (pKa (carboxyl) glycine 2.34). 
The cofactor substrate intermediate thus changes the protonation behaviour of the substrate 
molecules in the enzyme. Furthermore the phosphate-group of PLP seems to be important for 
transition state stabilization and for binding at the enzymatic substrate binding pocket [88,90]. 
The formed imine bond between the aldehyde group of the cofactor PLP and the ε-amine of the 
catalytically active lysine residue is also called internal aldimine (E-PLP, intermediary 
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product). This state of bound PLP seems to be also relevant with regard to the stability of the 
ω-TAs [91]. This also explains why the reactive vitamin B6 has proven to be an important 
molecule in different enzyme classes.   
As mentioned before, the cofactor is usually bound by several amino acids at the active site and 
particularly the phosphate-group of PLP/PMP is coordinated by a so called binding cup [92]. 
The aldehyde-group of PLP allows a covalent binding with the described active site lysine. In 
contrast to PLP, the active site’s lysine seems not really to participate during the reaction, but 
it promotes the deprotonation of substrate and of cofactor-substrate intermediates and is located 
on the opposite to the PLP-coordinating tyrosine residue [92,93].  
 
 
PLP enzyme binding as an indicator of enzyme stability and concentration 
After release of the product, PLP gets covalently bound again by the active site lysine residue 
and most of the time it seems to be located at the active site. According to Cassimjee et al. the 
cofactor can even be used for quantification of active ω-TA due to an increase in light 
adsorption, when a PLP-enzyme bond is build. This interaction can also be utilized as an 
alternative for enzyme quantification compared to protein assays like Bradford or BCA-assay 
and to consider if the protein is functional anymore [91].   
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1.3.3) Industrial applications of ω-transaminases 
 
On this account the PLP-depended ω-TA provide the opportunity for chiral synthesis of amines 
and are an alternative to metal-ligand based chiral chemistry. In contrast to the already 
presented synthesis possibility of β-amino acids, the application possibilities of transaminases 
go much further (Chapter 1.2). Additionally these enzymes complement the toolbox of 
synthesis opportunities and can be utilized for kinetic resolution or for asymmetric synthesis 
approaches [94]. A prerequisite for industrial usability is the availability of transaminases and 
their technical formulation. In addition, it must be shown for which reactions transaminases can 
be used reasonably. 
At this time technical ω-TA formulations are already available which can be used for semi-
industrial applications in miniaturized fixed-bed reactors. Therefore an application was 
demonstrated by Bajić et al. with immobilized ω-TA in so called LentiKats®-encapsulations 
(Poly vinvyl alcohol hydrogel capsules) showing a long-term activity of at least 21 days at 
continuous operation at RT [95]. ω-TA-LentiKats® were also tested at larger scale (18 L), 
showing a conversion rate of up to 85 % [96]. Furthermore ω-TA immobilization was shown 
on magnetic-poly vinyl alcohol beads in small scale, which are easy removable from liquid 
phases [97]. In addition to the enzyme formulation itself, the reaction applications of ω-TA are 
widely diversified from kinetic resolutions to asymmetric synthesis. However, the position of 
the chemical equilibrium is fundamentally important for all synthesis.    
1.3.3.1) Reaction equilibrium 
For this reason the greatest challenge of transamination reactions is to shift the reaction 
equilibrium towards products to reach higher space-time yields and to overcome substrate as 
well as product inhibition. The most prominent approach to push the equilibrium is the 
pyruvate(co-product)-removal system using glucose-dehydrogenase, lactate dehydrogenase 
(LDH) and L-alanine as amino donor. After deamination of L-alanine the corresponding 
pyruvate is reduced by lactate dehydrogenase to form lactic acid. This one step reaction already 
shifts dramatically the equilibrium [59,98](Figure 1.9). To inhibit the back reaction, from lactic 
acid to pyruvate, the expensive cofactor reduced nicotinamide adenine dinucleotide (NADH) 
can be regenerated by GDH using high amounts of D-glucose as driving power, whereas the 
complex cofactor can be recycled [99]. Alternatively, a pyruvate decarboxylase can be utilized 
to degrade pyruvate to CO2 and acetic acid [100]. Such a co-product removing system is in 
focus of research, because most of ω-TA are able to convert the α-amino acid L/D-alanine, 
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which is a generally good accepted amino donor for all TA. Beside alanine, also 
phenylethylamine (PEA) gained attention as commonly accepted amino donor for ω-TA [58]. 
The corresponding co-product acetophenone (using PEA) shows an equilibrium constant Keq 
of 10-3 M, this demonstrates that PEA is suitable for some amination reactions. However, a 
clear disadvantage is the enzyme inhibition of the ω-TA by high acetophenone concentrations 
[58]. Furthermore, the smallest amino donor with useful properties for transamination reactions 
is isopropylamine (IPA), because it converts during a reaction to acetone. The co-product 
acetone can then evaporate easily from the reaction mixture (e.g. under reduced pressure). For 
example the engineered ATA117-transaminase was adapted for accepting IPA as amino donor 
to produce Sitagliptin in a large scale process [69,98]. IPA and PEA are two good examples for 
shifting the reaction equilibrium by their corresponding product properties. This contrasts with 
the amino donor alanine, which requires like mentioned a coproduct removal system. Beside 
those three widespread amino donors, o-xylylenediamine (OXD) seem to be a promising 
substrate, because it polymerizes and precipitates after deamination [101]. The beneficial side 
effects are the possibility to perform large screenings with ω-TA with OXD and the second 
benefit is the irreversible polymerization, which pushes the reaction equilibrium towards 
products. Therefore the equilibrium displacement techniques are highly important for ω-TA 
approaches, this topic was summarized in-depth by Guo et al., Dold et al., and Tufvesson et al 
[76,102,103]. In figure 1.9 an overview of the most prominent equilibrium displacement 
techniques is given. Donor1 symbolizes the changeable amino donor and acceptor2 representing 
the resulting co-product of Donor1. In this reaction scheme donor2 defines the product.  
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Figure 1.9 Equilibrium of prominent displacement techniques. The co-product is either removed by 
enzymatic reactions/metabolization (1) or continues to react autocatalytically (2,4). In addition, the co-
product can either be removed by physical processes (5) (e.g. using under-pressure) or it shows a low 
reactivity (3) and thus prevents the back reaction [76,102,103].  
In addition to the mentioned possibilities for pyruvate removal using LDH and PDC, an 
alternative is also amination using an amino acid dehydrogenase and ammonia, which was 
demonstrated by Truppo et al. [99]. Furthermore, also the properties of living cells can be 
utilized for equilibrium shifting, according to the ongoing metabolism of microorganism. For 
that reason, the resulting pyruvate can also be removed by an innate metabolic pathway of 
E. coli. The microorganism contains and expresses at the same time the transaminase of interest 
[104]. The latest application for shifting the equilibrium are aliphatic diamine(s), like 
putrescine, which automatically cyclize after deamination. This approach was also reported for 
1,5 diketones, which undergo a spontaneous cyclization to form piperidine rings. The strategy 
was e.g. reported by Simon et al. using different lyophilized E. coli cells containing ω-TA, but 
this approach is limited in respect to the substrate(s), diketones, or to the products which are 
able to cyclize by itself [105].  
In general every technique has its challenge, like low substrate acceptance by the most of 
transaminases (e.g. using putrescine), high substrate and enzyme costs, high substrate 
concentrations of the amino donor (e.g. IPA or L-alanine), low availability of enzymes or 
uncommercial substrates. Furthermore, the co-product properties might lead to interference. 
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For example, the deaminated co-product of OXD results in interfering precipitates caused by 
auto-polymerization. In general, many equilibrium shift-strategies are imaginable, but the costs 
and the atom economy will be pivotal for the economic efficiency of industrial processes.  
In addition to the efficiency of the catalyst, the synthesis strategy is also decisive. 
Transaminases can be used in two synthesis strategies, one is called kinetic resolution, the other 
as asymmetric synthesis.   
 
1.3.3.2) (Dynamic) Kinetic resolution 
Kinetic resolution (KR) syntheses are advantageous to produce chiral products, when synthesis 
of a racemic educt is simple and inexpensive in relationship to the value of the chiral product. 
The kinetic resolution is then performed with an enantioselective (bio)catalyst to gain optically 
pure product.  
An example of industrial scale KR was demonstrated for the synthesis of a chiral β-amino acid 
by Evonik-Degussa. Firstly the rac-amino acid is produced using a robust chemical process, 
afterwards the amino acid is esterified and then an enantioselective lipase separation process is 
applied to separate co-product and product. The racemate of β-PA is produced from 
benzaldehyde, succinic acid and nitroso-carboxylic acid. The intermediate product is then in a 
second step esterified with propanol and in a third reaction step hydrolyzed using an 
enantioselective lipase in a two-phase system consisting of water and MTBE (methyl-tert-
butylether) to gain (S)-β-PA (see also Figure 1.10). The left (R)-enantiomer, which retained as 
ester, can be easily separated and hydrolyzed to the corresponding β-amino acid [47]. A general 
disadvantage of this strategy is the low atom efficiency, particular when only one enantiomer 
is demanded, because the theoretical yield is maximal 50 %. Nevertheless, also strategies were 
applied using ω-TA as enzymes for kinetic resolution processes, although ω-TA are more 
expensive and often less available than other enantioselective catalysts like the widespread 
lipases.  
For increasing the yield, dynamic kinetic resolution (DRK) serves as approach to increase the 
yields, using a suitable racemase, chemically racemization or spontaneous racemization [77]. 
For example, analogs of PLP can be utilized for racemization, which was demonstrated on the 
example of L-alanine [88,106]. Most prominent examples for DKR using ω-TA are the 
synthesis of precursors for the synthesis of (S)-Ivabradine, Vernakalant and for PEA. For 
example Vernakalant is an antiarrhythmic drug for the treatment of atrial fibrillation in heart 
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[107]. Vernakalent is expected to have a market volume of $ 1.1 billion in 2018 [108]. A second 
example is the drug (S)-Ivabradine, which is also a pharmaceutical for treatment of the heart 
disease like angina pectoris and sinus tachycardia [109,110].  
The DKR to gain chiral Ivabradine and Vernakalant is reasonable, because the substrate can be 
synthesized as a racemate. Therefore, ω-TA is suitable for the enantioselective transfer of the 
amino group. Both examples utilize engineered transaminases, which are commercial enzymes 
from Codexis. Furthermore, the synthesis of a precursor of (R)-3-phenyl-GABA can be 
performed as DKR using a (R)-selective transaminase [111]. The substrate, 4-oxo-3-
phenylbutyric acid ethyl ester, racemizes spontaneously and on this account the ω-TA can 
convert up to 92 % of the total substrate amount. In the most of other cases, a spontaneous 
racemization does not happen.  
 
Figure 1.10 Overview of kinetic resolution-reaction examples using ω-TA or microorganism. 
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Moreover, also fermentation processes can be utilized for enantio-separation. The example for 
chiral resolution to gain optically pure (S)-β-PA using living cells, might not be ω-TA mediated, 
because the degradation pathway in Arthrobacter sp. AKU 638 is still unknown. However, it is 
presented in Figure 1.10 as complement for KR of β-PA.  
Besides the possibilities mentioned there are many approaches how a (D)KR can be carried out. 
The applications spread over fermentation-processes, whole-cell catalysis and enzyme 
reactions for chiral resolution of even small amines like 1-phenylethylamine (PEA). Mano et 
al. showed in growth studies with bacteria, that it is possible to produce chiral β-PA from 
racemate using two different microorganisms [112]. In chapter 6, an example of a fermentative 
KR for β-PA is therefore shown. An example for whole-cell catalysis was shown by Weber et 
al.. Saccharomyces cerevisiae was used for chiral separation of PEA to produce the (R)-
enantiomer and to refill the co-substrate concentration by metabolism of S. cerevisiae [113]. 
An example for the utilization of whole-cell catalysis in E. coli was also given by Yun et al. for 
KR of sec-butylamine using overexpressed Vibrio fluvialis ω-TA. To shift the chemical 
equilibrium the pressure was reduced and the substrate concentration level was increased to 
400 mM [114].  
The research efforts with focus on KR also resulted in a sophisticated understanding of the 
equilibrium of ω-TA reactions, which is very important for realization of industrial ω-TA 
approaches [58]. In contrast to (D)KR, the amination of asymmetric substrates is not favored 
by thermodynamics, which leads to an unfavorable equilibrium with respect to product 
formation [114]. Other approaches of optical resolution are crystallization or chromatographic 
separation [115,116]. However, it is economically desired to produce a chiral and 
enantiomerically pure molecule than to form a racemate in the first place. 
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1.3.3.3) Asymmetric synthesis strategies  
In general, the enzyme catalyzed asymmetric synthesisvii strategies have to compete with 
enantioselective chemical processes. The most prominent chemical strategies are metal-
catalyzed using imine- or enamine-reduction approaches. High pressure and the requirement 
for chiral ligands are disadvantageous for sustainable synthesis of amines. Furthermore, also 
strategies for removal of the metal catalyst have to be performed. The removal of metals from 
the reaction is very elaborate, especially when the products are considered for medical and food 
purposes. Moreover, starting from the ketone as asymmetric substrate, a strict chemical 
synthesis route requires at least a three-step reaction. Therefore enzymes seem to be ideal 
catalyst for amination of asymmetric ketones and a wide range of enzymes were investigated 
in respect of their ability to produce chiral amines, though not all strategies are asymmetric 
approaches. In figure 1.11 a selection of chiral β-amino acid producing enzymes is given.  
Biocatalytic strategies for enantioselective synthesis 
Beside the mentioned ω-TA-catalyzed synthesis, only the engineered β-amino acid 
dehydrogenase and the engineered β-amino acid lyase convert asymmetric substrates to form 
chiral amino acids [117,118]. Most of the other strategies use chiral substrates, which are 
enantio-pure or racemic. For that reason the use of racemic substrates results in kinetic 
resolution reactions. However, also dynamic kinetic resolution is possible to produce optically 
pure products. An example is the utilization of the hydantoine-racemase in combination with a 
hydantoinase and a carbamoylase, but so far this has been realized on industrial scale only for 
α-amino acids [119]. Recently the enzymatic hydrolysis of dihydropyrimidine precursor for β-
amino acid synthesis was demonstrated [120,121]. However, the realization of the whole 
enzymatic cascade is still missing.  
The opportunities to use β-amino acid dehydrogenases are very limited due to the low 
availability of these enzymes. Until now, no wild type enzyme is described with activity 
towards β-keto acid(ester) substrates. Zhang et al. engineered for that reason a NAD(P)H 
dependent β-amino acid dehydrogenase from a former L-erythro-3,5-diaminohexanoate 
dehydrogenase. The β-keto acid conversion was demonstrated in a reaction cascade system 
consisting of nitrilase or lipase starting with a β-keto nitrile or β-keto ester substrate. It was 
described that the activity of the engineered enzyme was very low and only in the scale of mU 
per mg of enzyme. The cascade reactions achieved yields of 12 % and 22 %, respectively [117]. 
                                                 
vii The asymmetric synthesis is considered to be reactions that create a new stereocenter and do not produce a 
racemate. 
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The before mentioned lipase-strategy is also displayed for the resolution of racemic β-amino 
acid substrates. An alternative to those enzymes, is the utilization of an engineered β-amino 
acid lyase. This was shown for an engineered aspartase, which achieved higher activities (0.1 U 
per mg), but until now only the conversion of the small 3-aminobutyrate was reported [118].  
 
Figure 1.11 Overview of different (hypothetical) enantioselective synthesis strategies towards β-amino 
acid preparation. The synthesis of β-phenylalanine using hydantoniase and carbamoylase is not 
demonstrated in a cascade reaction until now. Figure modified, corrected and adapted from Zhang et 
al.[56,117,118,121–126].  
In addition also a natural ammonia lyase –EncP- was characterized by Weise et al. towards 
activity for different arylacrylates, but the natural enzyme shows only low selectivity. However 
they achieved higher enantioselectivity after enzyme engineering of EncP was performed, but 
only for some arylacrylates-substrates [127]. In addition also the level of knowledge about 
β-amino acid converting lyases and aminomutases is relatively low compared to other well 
characterized enzymes and only little is known for the rest of enzymatic conversion strategies. 
So far ω-TA are the most promising enzymes for the synthesis of chiral amines and in particular 
for the synthesis of β-amino acids. In conclusion ω-TA are displaying many advantages 
compared to other enzyme-classes, with expection for lipases, because they are enantioselective 
and well describedIn fact ω-TA are cofactor dependent, but the cofactor is recycled by every 
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second half reaction and ω -TA enable 100% conversion of asymmetric substrates into chiral 
products, unlike lipases (see Figure 1.7). Furthermore ω-TA shortcut the synthesis of chiral 
amines compared to chemically synthesis strategies. For these reasons, ω-TA are the enzymes 
of choice for enantioselective synthesis. 
 
1.3.3.4) Applied enantioselective synthesis of amines  
ω-TA also compete with chemical synthesis strategies. Therefore examples of prominent 
applications of ω-TA towards asymmetric synthesis are displayed in Figure 1.12. The most 
prominent examples, which replaced a purely chemical synthesis strategy, was demonstrated 
by Codexis and Merck using the engineered ω-TA ATA117 (11rd). This engineered enzyme is 
ideal for the amination of bulky-substrates. The best known example is the synthesis of the 
antidiabetic drug Sitagliptin, which is the flagship in respect of chiral amine synthesis and was 
discussed by a large variety of publications [69,128–132]. After engineering of the enzyme, the 
substrate concentration could be drastically increased to 250 g L-1 and the solvent content of 
DMSO was increased simultaneously to 50 % (v/v). The engineered enzyme showed 
furthermore an increased long-term stability in respect of higher temperatures up to 50°C. This 
example shows that an enzymatic process can be more economical and ecological than a pure 
chemical process [133]. At all, the enzymatic process showed an increase in productivity of 
53 % and at the same time the amount of waste was reduced by more than 19 %. The decisive 
factor was that the process can be carried out at standard pressure, because the transition metal 
catalyst was replaced by the enzyme [134]. The final chemo-enzymatic process generated sales 
of $ 6 billion and is therefore also a beacon project for applied biocatalysis [135]. In addition, 
Besifloxacin, AZD 1480 and MK-6096 are further examples of the use of ω-TA on larger scales 
for production of chiral pharmaceutics and for production of building blocks for antibiotic 
synthesis  [136–138]. Further pharmaceutical relevant enzymatic synthesis, which are shown 
to be feasible at larger amounts are those of (S)-Ivabradine and Vernakalant.   
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Figure 1.12 Concept and examples for using ω-TA for high valuable drug synthesis. Concept of chiral 
amine synthesis according to [44,47,78]. References for synthesizes: Sitagliptin [139], Imagabalin [43], 
Suvorexant [140,141], norephedrine [142]. 
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A second example for asymmetric reactions of bulky ketone substrates is the synthesis of the 
orexin inhibitor Suvorexant. Suvorexant is used as drug for the treatment of insomnia (sleep 
disorder) since 2015 in USA and Japan. After transamination the Suvorexant precursor 
undergoes a spontaneous cyclization to the final product. In a study of Schwentner et al. PEA 
was utilized as amino donor with positive effects on the reaction equilibrium. Using the 
engineered and (R)-selective ATA11711rd, they were able to reduce the number of necessary 
reaction steps from five to one compared to the chemical synthesis strategy [140]. Moreover 
the mentioned synthesis of Imagabalin is a further example for ω-TA engineering towards 
enzymatic processes for the production of chiral amino-drugs. Imagabalin is a phase III drug 
for the treatment of generalized anxiety disorder and the only example for a Fold type I 
engineered ω-TA using β-keto esters as substrate [43]. Until now the final technical application 
has not yet been published or shown. However, the smart synthesis strategy avoid the instable 
β-keto acids for the synthesis of β-amino acids, but until now the engineered ω-TA from Vibrio 
fluvialis displays relative low activity to β-keto esters. On the threshold of technical 
applicability, the research group of D. Rother demonstrated also the utility of ω-TAs for the 
synthesis of drugs at the example of (R) and (S)-norephedrineviii synthesis using ω-TAs from 
Aspergillus terreus (Fold type IV) and Chromobacterium violaceum (Fold type I). The 
synthesis was performed in a simple one-pot reaction starting from non-chiral substrates [142].  
In general, all applications are based on small amino donor molecules, such as IPA, using 
DMSO as a co-solvent to increase the solubility of substrates with low water solubility. The 
illustrated examples of drug synthesis using natural and engineered ω-TA clearly demonstrate 
the relevance of these family of enzymes for the synthesis of chiral amines. Furthermore it is 
shown that ω-TA can be utilized for industrial scale processes. On this account the focus of this 
work was set on the analyzation of ω-TA and furthermore the ability of chiral β-PA synthesis 
was investigated. 
 
  
                                                 
viii Norephedrine is an amphetamine and it is used as an appetite suppressant and decongestant. 
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1.4) Protein engineering 
Although function and protein structure are interdependent, the relationship between both is 
only understood superficially [143]. In theory, the primary sequence of the polyamide chain 
contains every information, which is necessary for the three dimensional folding which forms 
finally a structure in a minimized free energy (ΔG) state [144]. However, for theoretical 
calculations simplifications of reality are made, so for example the process of simultaneous 
translation and pre-folding is usually not considered in predictions. Whereas protein-complexes 
are built by independently folded monomeric units, which are interacting mainly via their 
surfaces with each other [145]. Since the direct prediction of protein structure and function is 
not feasible, many calculation methods have been established which derive functions from 
existing data and compare sequences in order to obtain functional information about 
uncharacterized proteins. A variety of such tools for sequence-function relationships were 
summarized by Widmann et al.[146]. However, in principle the procedure can be divided into 
three categories, depending on whether the protein structure is present, whether a target design 
is to be created or whether random mutations should bring the desired effects through controlled 
evolution (Figure 1.13). 
 
Figure 1.13 Strategy overview for enzyme engineering. For the purpose of changing the enzymatic 
properties, different approaches can be chosen and combined, depending on whether structure and 
experimental information are available or not (see also Table 2). For example, random mutagenesis in 
the context of directed evolution can help to overcome missing structure and functional knowledge. 
However, all approaches can be combined with each other to obtain an adapted enzyme.       
Introduction 
34 
In general, many variants of an enzyme still need to be investigated in-situ, because the 
prediction accuracy is too low, even though protein-function predictions currently improving. 
The de novo design of enzymes might be possible in future to create proteins with desired 
functions, although the number of possibility for a hypothetical protein with 300 amino acids 
is enormously large (20300). The idea to create enzymes with desired activities by avoiding large 
scale libraries, would increase the attractiveness of biocatalysis [147]. 
 
1.4.1) The challenge of function prediction 
Until now it is not possible to predict the structure accurately, but the knowledge about the 
correlation is necessary to predict the function of large biomolecules like enzymes [148–151]. 
Once the protein structure is dissolved, the properties of proteins can be determined with the 
help of various prediction tools. These and other in-silico strategies can help to engineer 
enzymes, which is an option to directed evolution experiments. The possibilities to mine 
enzyme information by calculations can guide enzyme designs, also known as “Rational Protein 
design” (RPD). RPD requires also protein structures, which are gained by X-ray crystallography 
or NMR to uncover the position of atoms within the polypeptide chain. The most of all protein 
structures are collected on the RCSB protein data bank [152]. Structure data are necessary for 
the majority of in silico tools, like for sophisticated MD-simulations and e.g. for the prediction 
of artificial disulfide bonds within a polypeptide chain. A summary of protein engineering tools 
are listed in table 1.2.  
The displayed tools underline the diversification of predicition tools, however the majority 
needs protein structures as starting point. In addition, the protein structure can also be predicted, 
mainly using homology models for calculation. Examples for structure-prediction algorithms 
are CABS-fold, DCA or SHAPREN, which can be utilized to predict the structure of a protein 
from the amino acid sequence [153,154] . Such calculation approaches are described as de novo 
modeling. Therefore, exemplary target parameters of protein engineering are the 
thermostability or substrate selectivity of an enzyme. The creation of artificial disulfide bridge 
bonds is also a engineering goal for increasing protein stability by improving the intermolecular 
forces (covalent bond(s)) within the polypeptide chain [155]. One example is the Disulfide by 
Design 2.0 algorithm. 
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Table 1.2 Examples for protein function and engineering tools.  
Tool Function Structure based Reference 
Auto-mute  Prediction of protein stability 
due to mutation effects 
Yes [156] 
CABS-fold Prediction of protein structure No [153] 
CheShift Graphic validation of protein 
structures  
Yes [157] 
Direct coupling analysis 
(DCA) 
Genomic sequence 
information for prediction of 
protein structures 
No [158] 
Disulfide by Design 2.0 Disulfide bridge engineering Yes [155] 
EGAD Empirical parameter free 
prediction for protein design  
No ( only natural counterparts are 
necessary) 
[159] 
Fireprot Prediction of protein stability 
due to multiple mutation 
effects 
Yes [160] 
FoldX Prediction of protein stability 
due to mutation effects 
Yes [161] 
HotSpot Wizward Prediction of hot spots for 
protein engineering 
Yes [162] 
IPRO Iterative protein redesign ( 
ligand binding)  
No (parental structure needed) [163] 
I-TASSER Prediction of structure and 
function 
No [149] 
MAP Directed protein evolution – 
tool 
Not necessary [164] 
PoPMuSiC Estimation of protein stability  Yes [165] 
PROTDES Optimization protein folding Yes [166] 
Rosetta Online Server  Molecular modeling-ligand 
binding 
Yes [167] 
RosettaDesign Design of new protein 
structures  
Yes [168] 
SHARPEN Protein structure prediction No (parental structure needed) [154] 
STAR Machine learning algorithm 
for design of novel proteins 
No [169] 
WHAT IF Modeling of proteins  Yes [170] 
 
Independent of the optimization target, also supporting tools can be utilized to short cut 
mutagenesis experiments. An example is the mutagenesis assistant program (MAP), which 
helps to identify promising engineering sites. Engineering sites are often not evolutionary 
conserved, which means that these amino acids can be exchanged in a protein without losing 
the function and stability of the protein. Amino acid positions with increased variability can be 
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identified as allowed engineering mutation sites and can therefore be useful to reduce the size 
of protein mutagenesis libraries [164]. A sophisticated prediction tool for this is HotSpot 
Wizard which combines evolutionary and structural information and simultaneously compares 
homologous protein sequences. Ultimately, this allows the quick exclusion of amino acid 
positions that should be preserved. The received small scale libraries contain less protein 
variants than necessary for classical directed evolution experiments [137].  
Protein motion– molecular dynamic- simulations  
However, not all predictions can be made on a pure protein sequence basis using static protein-
structure data. Molecular dynamic (MD) simulations can also be used as a tool for the 
investigation of time-resolved structures of proteins, which can be the starting point for further 
calculations (e.g. prediction stability or contract probability of residues). In contrast, a static 
structure is only a snapshot of protein-folding on an energy minimum, this gives no indication 
of how a protein behaves over a longer period of time. Furthermore, also the entire protein 
molecule is in motion due to Brownian motion and thus in interaction with surrounding 
molecules (e.g. solvent molecules or other proteins) [171,172].  
For example molecular dynamic simulations try to mimic the movement of the proteins in 
solution using theoretical force fields, which are causing movements of structural parts of 
proteins. This kind of simulations can be performed for prediction of protein folding and 
unfolding with regard to stability. However, the predictive power is limited by the short 
simulation time, which is mainly limited by the high computational effort. In contrast the time 
scale in which a protein folds can extend over very long periods of time and it also differs 
between proteins by a factor of one million [173]. For that reason, a trajectory is recorded 
normally for periods of ns to ms for gaining time-resolved coordination of amino acid residues 
within the protein, but therefore the simulation do not cover slow protein folding events. 
Basis of MD simulations 
In order to predict the mobility of the protein, a force-field is applied to the atoms of the 
structural model, which is based on equations of classical physical mechanics [174]. The 
mechanical forces are calculated according to empirical potential energy functions like adapted 
Larange’s or Newton’s equations, which help to calculate unfolding or folding events 
[173,175]. Using the example of the Newton’s equation, which bases on the standard equation 
(force is mass multiplied with movement in x,y,z coordination) the movements are predicted in 
a Cartesian coordinate system. The motion is described as differential ri , which is the vector of 
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an atom or amino acid residue within the protein.Therefore, mi is the mass of this atom or amino 
acid residue. According to this basic equation, i is the number of atom-vectors of the molecule 
[175]. 
mir̈i = 𝐹𝑖         𝑤𝑖𝑡ℎ ?̈?𝑖 = 𝑑2𝑟𝑖𝑑𝑡2  
The so called molecular dynamic simulation is then the time resolved movement of each atom 
within the model. To gain trajectories (time resolved structures) the basic equations have to be 
integrated, which can be solved by numerical solutions. The evaluation of such motion profiles 
can be finally used to analyze the stability of a protein structure (shown in Chapter 4). 
 
 
1.4.1) Thermostabilization using in silico tools  
 
The thermostability of proteins depends on their environment and on intrinsic forces like bonds 
and interactions, but also the entropy is an essential part of stability (Figure 1.14). After 
expression of a polypeptide chain (e.g. an enzyme), the chain gets folded by it-self or will be 
folded by other proteins, like chaperons and rests afterwards in a local energy minimum (stable 
state) [176,177]. In aqueous solutions, the folded protein is permanently in balance between 
folding and unfolding-states. In denaturated state (partially folded states or folding 
intermediates) the protein-residues are disordered and the function of the protein gets lost. After 
complete unfolding, the protein is forming amorphous aggregates. This protein folding state is 
generally equal to an irreversibly inactivated protein, which loses all functions and in most of 
the cases a reverse folding is impossible [177,178].   
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Figure 1.14 Chemo-physical forces contributing to protein stability. a) The sum of the stabilizing 
energies forms a local/global energy minimum (folded state) [178]. When a protein unfolds, it changes 
to a new energy minimum. If further denaturation occurs, the protein can be irreversibly inactivated and 
reaches again a new stable energy minimum. b) Influences on protein stability. (Hypotheic protein 
structure was visualized using Chimera 1.1)  
According to the equation in figure 1.14, the first term is described as thermodynamic stability 
with the constant of unfolding (kunfold). From this hypothetic unfolded state the protein can be 
undergo a transition to an inactivated state to form aggregates. The resistance to get inactivated 
is described as kinetic stability. Factors that support unfolding and denaturation of enzymes are 
e.g. heat, solvent-stress, ion concentrations or pH-value. The solvent (aqueous or organic) is 
directly responsible for protein stability and moreover the concentration of ions (salts) can be 
important in respect of stability [179,180]. Enzymes are naturally adapted to aqueous solutions, 
but some of them are also active and stable in organic solutions. An important parameter for 
the stability of enzymes in organic solvents is the water activity (aw), since water molecules are 
elementarily important for the protein structure. The water molecules are indispensable for the 
structure of proteins, because they are tightly bound by the protein and build a shell around the 
protein, which maintains the functional structure in an organic solvent [94]. Moreover also the 
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pH-value has a large influence on the protein surface charge, which is important for the 
solubility, stability and for the intermolecular interactions of a protein. In general, proteins show 
the highest stability at their isoelectric point. Depending on the pH value, proteins are either 
protonated or deprotonated, therefore the charge of the protein also changes. Furthermore the 
force of repulsion (between two charged molecules/proteins) is increased [181]. In contrast to 
the surface, the protein core is mostly hydrophobic and stabilizes the polypeptide chain by the 
hydrophobic effect and other forces. This means that hydrophobic amino acid residues move 
away from the water and thus stabilize the folded state by formation of a hydrophobic core. The 
temperature of the protein containing system is very important towards the stability of the 
enzyme, if the temperature is increased, the energy of the protein increases and results in faster 
and stronger motions of protein parts (kinetic energy is increased). If these molecular kinetic 
energy is strong enough to expose the hydrophobic core, it will be interacting with solvent 
molecules and the refolding of the protein will become unlikely. The unlikely refolding is 
caused by the interactions of the protein backbone with water molecules (or solvent molecules) 
and thus prevents the formation of secondary structural elements such as helices, coils and 
sheets [181]. The main forces leading to the formation of a rigid enzyme are hydrogen bridge 
formation and the hydrophobic effect. However, hydrophobic effect seems to be the most 
important factor for stability [182–184]. By contrast within the protein-chain only 36 % of the 
stabilizing bonds are side-chain interactions, the majority are backbone interactions, which are 
decisive for stability [145].  
Moreover, the entropy of the protein is important in regards to the stability. For example glycine 
residue show the highest entropy of all amino acid residues, because the degree of freedom 
(movement) is higher than for all other standard α-amino acids. In contrast, a proline residue 
shows the least entropy value, because the degree of freely selectable conformation states is 
lower than for all other α-amino acids [185]. Also electrostatic interactions (coulombic energy) 
between positive and negative charged amino acid residues are important for the stability and 
can act in distances of even more than 4 Å up to 6 Å ( e.g. between L-glutamate and L-arginine-
residues) [181,186]. Although Van-der-Waals interaction energies are quite low, the sum of all 
interactions contributes also to protein stability [187,188]. Furthermore the interactions with 
solvent molecules by Van-der-Waals forces can also stabilize proteins [187,188]. This kind of 
interactions can be a target for engineering experiments to increase the stability of enzymes. 
Therefore in-silico approaches like the mentioned force field algorithm FoldX are applied by 
exchanging amino acid residues, which is presented in detail in chapter 4. Besides the 
theoretical calculation of protein stability, this can also be determined experimentally by 
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determination of the physical melting point of proteins using circular dichroism spectra or 
thermal shift assays [189,190].  
1.4.1.1) Protein melting point 
The protein melting point (Tm) can be utilized as measure for stability, which can be detected 
using laboratory equipment like qPCR-devices. The Tm is the temperature at which the amount 
of folded and unfolded protein is equal. Moreover, the free energy change ΔG is 0 at Tm. If the 
stability of a protein changes, its Tm will also shift, as it describes the temperature at which the 
protein unfolding rate is highest. Therefore,  the melting point can be also described as a 
function of variation of enthalpy (ΔH) between folded/unfolded state and as function of heat 
capacity (Cp) of the protein (known as Gibbs-Helmholtz equation) [191]. ∆𝐺(𝑇) = ∆𝐻𝑚 (1 − 𝑇𝑇𝑚) − ∆𝐶𝑝[ (𝑇𝑚 − 𝑇) + 𝑇 ln ( 𝑇𝑇𝑚)] 
To determine the Tm value, the isolated protein is heated at a constant rate in a solution with a 
protein dye, such as SYPRO orange, and the shift in fluorescence intensity is recorded e.g. with 
a real-time PCR cycler [192]. The increase in fluorescence intensity is due to the fact that the 
fluorescence dye can interact with amino acid residues from the mostly hydrophobic protein 
core, when it gets exposed to the solvent. The fluorescence intensity of SYPRO orange is 
strongly quenched in presence of water [192]. In contrast, the increased number of dye-protein 
complex number results in drastic increase of fluorescence enhancement (increase of the 
fluorescence quantum yield) of up to ~500 fold [193]. After complete denaturation, the 
fluorescence intensity decreases again because the now emerging protein aggregates have a 
smaller solvent exposed surface area than the unfolded proteins. The function of denaturation 
can be described as a sigmoidal curve [194](Figure 1.15). 
When the fluorescence intensity curve is plotted against the time, the inflection point marks the 
Tm at that equilibrium state, where the amount of unfolded and folded protein is equal [192]. 
The Tm is calculated by fitting the fluorescence intensity against temperature under variation of 
parameters of a sigmoidal function. When the parameterized function is used, the turning point 
(highest slope) of this function represents the Tm of the protein.  
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Figure 1.15 Determination of the protein melting point using thermal shift assay with protein 
fluorescence dye (Protein is symbolized by a black β-sheet). Not shown is the decrease of relative 
fluorescence intensity (RFU) after complete denaturation of the protein. The decrease is caused by 
protein aggregation, which reduces the protein surface again (with increasing temperature and increasing 
incubation time).  
In addition to SYPRO orange, also the fluorescence dyes dapoxyl sulfonic acid or anilino-8-
naphthalene sulfonate can be utilized [192]. The present thesis describes protein engineering 
applications to increase the Tm. Therefore two main approaches were performed and discussed 
within this thesis. As first approach for improvement of thermostability was the FoldX guided 
site directed mutagenesis chosen. As an alternative the disulfide bridge engineering was 
evaluated.   
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1.4.1.2) Disulfide bridge engineering 
Disulfide bridges are covalent bonds, which are important for stabilization of the protein 
structure and therefore also the enzyme function. Proteins with disulfide bonds can be more 
resistant against destructive forces e.g. during industrial processes or in respect to proteolytic 
degradation [195–197]. Examples of proteins with natural disulfide bridges of particular 
importance for commercial applications are the protein products Insulin, Pectinase, Pepsin, 
Papain and lytic polysaccharide monooxygenases which are containing at least three disulfide 
bridges [195,198]. Moreover, disulfide bonds are quite beneficial for stability, because the bond 
between the sulfur atoms of cysteine(s) is a strong covalent bond and allows therefore the 
fixation of structural protein domains. Disulfide bonds are highly energy stabilizing and reduce 
the content of free energy between 10 kJ mol-1 and up to 21.7 kJ mol-1 [199,200]. To introduce 
artificial disulfide bonds, Wijma et al. created a disulfide-engineering algorithm, called DDD. 
This algorithm uses MD-simulations to gain conformational information about the protein 
backbone movement and analyses the distances between possible disulfide bond positions. The 
cut-off value for the maximal distance between cysteine-residues was defined to be maximal 
7 Å. To avoid disulfide bonds between direct neighbors (at possible disulfide sites) a minimal 
distance was set of 15 amino acid positions in the primary sequence. The remaining engineering 
sites were analyzed by conformational simulations to define the position of the introduced 
cysteine residue according to the dihedrals angles of the selected residues. In addition to the 
MD simulation itself, additional energy calculations are carried out to be able to measure the 
change in stability and therefore to select predicted variants. According to those tools they 
reduced the number of engineering sites from 28 possible engineering sites to only 17. For these 
sites they performed site directed mutagenesis to introduce cysteine residues. Of those 17 
engineering sites, 10 were stabilizing and showed a stability improvement of 4 to 15°C 
according to the protein-melting point (Tm) [199].  This study demonstrated clearly that 
artificial disulfide bonds can drastically improve the protein stability. In earlier studies the T4-
lysozyme was the subject of disulfide bridge engineering even without any MD-simulations. 
Improvements of up to 11°C (ΔTm) for single disulfide bridges were achieved [201]. However, 
even higher stability changes were reported for multiple disulfide bridges: In T4-lysozyme a 
ΔTm of + 23.4°C was achieved by Matsumura et al.[202] . In contrast, it was also demonstrated 
that not every disulfide bond results in a stabilized protein. There exist also examples, which 
are reporting a decrease of protein stability [200]. Furthermore, MD-simulations and energy 
calculations are helpful to increase the success rate by site directed mutagenesis experiments. 
These artificial disulfide bonds can also be combined with stabilizing point mutants to create 
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enzyme variants with even higher thermostability. Wijma et al. demonstrated this at the 
example of thermostability improvement of a limone-1,2-expoxide hydrolase, which showed a 
ΔTm improvement of 35°C. The enzyme activity of the wild-type enzyme was slightly higher 
than that of the mutants at 50°C, but at 60°C the mutants showed four times the total enzymatic 
activity of the wild-type (at 50°C), while the wild-type variant even lost its activity [199]. 
 
1.4.2) Outlook of enzyme engineering 
In summary, the applicability of enzymes for industrial purposes is a multidimensional 
challenge. On the one hand, the cost-efficiency of an enzymatic process depends significantly 
on the long-term activity and reusability of the enzyme. A possible strategy is therefore to 
stabilize enzymes against external influences by targeted mutagenesis (This problem is 
discussed in Chapter 4). On the other hand, the targeted design of enzymes for specific 
synthesis approaches is primarily a problem based on the knowledge content of an enzyme 
family. For this reason, targeted protein mutation processes require a broad knowledge base 
(database) that enables the transfer of knowledge from literature to the target enzyme. This can 
be achieved in the form of protein engineering databases described in Chapter 3 for ω-TA. 
Finally, such predictions have to be evaluated by experiments on the enzyme in order to finally 
obtain a biocatalyst with the desired properties. This is described exemplary in more detail in 
Chapter 5. However, if such approaches do not lead to the desired success, a change in the 
synthesis strategy or search for new enzymes becomes necessary to solve the problem, which 
is exemplified in Chapter 6. Modern non-random-based enzyme engineering covers all these 
levels to ultimately obtain the desired enzyme. 
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2) Research proposal 
The synthesis of chiral amines is of particular interest, as 40% of all pharmaceuticals contain a 
stereocenter with an amine substituent in their structure [1]. In addition, amino acids as a special 
class of amines are of particular interest for food and feed industry, but also for the production 
of pharmaceuticals. The standard procedure for producing most α-amino acids is microbial 
fermentation. In contrast the pharmaceutically relevant chiral β-amino acids cannot be produced 
by fermentation, so various chemical, biocatalytical and chemo-enzymatical synthesis solutions 
are currently being investigated. Common enzymatic synthesis strategies bear limitations such 
as low solubility of substrates, instability of cascade reaction intermediates (e.g. β-keto acid) or 
the necessity of high enzyme concentrations. The enzyme family of ω-transaminases (ω-TA) is 
able to synthesize chiral amines and to convert β-amino acids such as β-phenylalanine (β-PA) 
and has therefore been selected as a promising group of biocatalysts. ω-TA can convert the 
corresponding β-keto acid into β-PA, but so far no variants have been found to convert more 
stable aromatic β-keto esters into corresponding β-PA-esters. Therefore, first the diversity of 
ω-TA was analyzed and subsequently a β-PA converting ω-TA was characterized as the starting 
point for enzyme engineering. Hence, this work focused on ω-TA as an alternative towards 
transition metal catalyzed and organocatalytic methods.  
The main aims of this study are (see also Figure 2.1): 
 The constitution of a database for ω-TA engineering in regard to literature and the 
investigation of  its usability (Chapter 3) 
 The improvement of (process)-stability of a selected ω-TA using an algorithm for 
prediction of free energy changes within the polypeptide chain (Chapter 4) 
 Analysis of engineering sites within the ω-TA of the β-proteobacterium Variovorax 
paradoxus regarding β-phenylalanine ester synthesis (Chapter 5.1) 
 Development of an alternative synthesis strategy for the synthesis of β-phenylalanine 
ester using engineered ω-TA from a protein library (Chapter 5.2) 
 Characterization of microbial degradation and chiral resolution of rac-β-
phenylalanine by Paraburkholderia PsJN in a bioreactor system (Chapter 6) 
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Figure 2.1 Strategy for the ω-TA catalyzed synthesis of β-phenylalanine (esters). (R= H, CH3-, 
CH3CH2-). Enzyme structure was visualized using Chimera 1.1. The bioreactor drawing was designed 
using Fusion 360 (Autodesk).  
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The following chapter briefly explains the diversity of ω-TA and how to sort them into public 
databases like the presented oTAED database. This database collects (S)- and (R)-selective 
ω-TA and divides them into two superfamilies consisting of Fold type I and Fold type IV 
proteins. Furthermore the application of the standard-numbering tool is presented towards 
comparative design and engineering of ω-TA.  
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3.1) Introduction 
3.1.1) Definition and function of transaminases  
 
The ubiquity of amino groups in natural products leads to a great diversity of different 
transaminases (TA, E.C. 2.6.1) [1]. Because the structure of the donor and the acceptor might 
differ and because the reaction is reversible, the enzymes accept two different amines as amino 
donors, which is known as dual substrate recognition [2]. As a further consequence of the 
reversibility of the transamination, subsequent reaction steps or product separation are required 
in biosynthetic applications [3]. Other members of the family of PLP-dependent enzymes 
include lyases, oxidoreductases, and hydrolases [4]. Because TA differ by their amine donor 
and acceptor scope, substrate specificity was used to assign TA to two major families. 
α-transaminases (α-TA) catalyze transfer of the amino group exclusively to a carbonyl group 
in α-position to a carboxyl group (see also chapter 1). ω-TA lack the selectivity towards α-keto 
substrates and have a wide spectrum of acceptor/donor molecules, e.g. α-alanine, 1-
phenylethylamine, putrescine and other amines. α-TA are involved in amino acid biosynthesis, 
which makes them interesting enzymes for the production of D- or L-amino acids. Their 
limitation to α-carbonyl substrates is a disadvantage for broader application of these enzymes 
[5–7].  
Applications of ω-transaminases 
In contrast, ω-TA lack the dependence on a carboxyl group in the acceptor substrate and are 
therefore promising enzymes for the synthesis of a broad range of optically pure amines [15–
22], such as the pharmaceuticals imagabalin and sitagliptin [23,24], rivastigmine, α‐
aminosteroids, mexiletine, cathine, and 3-amino-8-aza-bicyclo[3.2.1]oct-8-yl-phenyl-
methanone [14,25–28] (see also chapter 1). However, considerable enzyme engineering efforts 
were needed to adapt enzymes to the desired substrates. In amino acid synthesis, a special focus 
lies on the synthesis of optically pure β-amino acids like β-PA which can be produced using 
lipase - ω-TA cascade reactions or racemic resolution reactions using Fold type I-(S)-selective 
ω-TA [21,29]. Non-standard amino acids might be applied in synthetic peptides or for the 
synthesis of the antitumor drug paclitaxel [29–31]. 
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Box 3.1 The nomenclature of ω-TA is not consistent within literature, therefore further information are 
summarized within this information box. Examples are from citations [8–14]. 
Like mentioned before for asymmetric synthesis, the reaction equilibrium is pushed towards 
the desired product by removing the co-product or by high concentrations of the amine donor 
or alternatively by regenerating of the co-substrate. Beside the reaction equilibrium, solvent 
stability of ω-TA is an important factor. Many relevant substrates exhibit low solubility in 
aqueous solvents. While the co-solvent DMSO is compatible with ω-TA, only few ω-TA are 
known to be active in organic solvents such as tert-butyl ether [24,32]. The most widely used 
ω-TA are from the microorganisms Vibrio fluvialis, Chromobacterium violaceum and 
Arthrobacter citreus [33]. The most famous amine product, sitagliptin, which is produced using 
ω-TA, reached in 2016 a revenue of 6 billion dollar [34]. Further applications are presented in 
the reviews of Guo et al., Slabu et al. and Dold et al.[33,35,36].  
This proves the importance for technical applications of transaminases, but there are still 
enzyme based limitations. To overcome the limitations of unmodified wild type ω-TA, 
screening, data mining, and enzyme engineering are promising strategies to develop enzymes 
with higher stability, broader substrate specificity and increased selectivity. While literature 
mining is an obvious starting point for most engineering projects, its success is limited by the 
lack of naming conventions and standard residue numbering of ω-TA, which makes it difficult 
to compare mutagenesis studies or to analyze important sequence motifs in different ω-TA 
groups. 
Definitions
ω-Transaminases (ω-TA) belong to the enzyme class E.C. 2.6.1.X. Within this class also α-transaminases
are present. For example ω-TA can be found in class 2.6.1.18 - group of β-alanine-pyruvate transaminases-.
Other nomenclatures of ω-TA are: transaminase, amine transaminase, ω-aminotransferase, α,ω-
diamine transaminase, β-transaminase and other misleading terms in protein databases. The group of (S)-
selective ω-TA can be also found within the PLP-dependent-enzyme classification system as class III
transaminase family. In contrast, (R)-selective ω-TA are often associated with the D-alanine transaminase
family.
Fold type
Furthermore ω-TA are be defined according to mainly two different Fold types of PLP-dependent enzymes.
Most of the (S)-selective ω-TA are present within Fold type I, together with aspartate aminotransferases,
aromatic acid aminotransferases and etc.. In contrast (R)-selective ω-TA are member of Fold type IV,
together with D-amino acid aminotransferases (DATA), branched chain amino acid transferases (BCAT) and
aminodeoxychorismate lyases (ADCL). b
.
Concept of standard numbering
According to relocate amino acid residues in different ω-TAs a standard numbering was defined for Fold
type I and Fold type IV. The standard numbering refers to a respective reference protein, the amino acid
positions are then transferred to other protein sequences by alignment. If not stated otherwise, the standard
positions are reported within this chapter.
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Enzyme engineering of ω-transaminases   
The substrate binding sites of ω-TA consist of the large O- and the small P-pocket [22], also 
called A and B pocket, respectively [37]. Promising mutation sites of ω-TA were reviewed 
recently [35]. In recent years, the aim of engineering efforts is obtaining enzymes with high 
activity towards bulky substrates lacking a carboxyl group [38]. In the case of Vibrio fluvialis 
ω-TA, the activity of the enzyme towards β-keto-methylester was substantially increased by 
only eight point mutations [23]. The most beneficial single mutation was W57F (located in the 
P-pocket). Palvidis et al. could increase activity of an (S)-selective ω-transaminase from 
Ruegeria sp. TM1040 (3FCR) by a factor of 8,900 [38]. The best variant was created by 
introducing only four mutations, Y59W, Y89F, Y152F and T231A. 
 
The challenge of classification 
Three classification schemes for TA based on biochemical function, sequence, or structure have 
been proposed. The functional classification divided the protein sequences into α-TA and ω-
TA [23]. The sequence classification assigned TA to five different aminotransferase classes  
based on sequence similarity [8,39–42] or alternatively six Pfam groups based on profile hidden 
Markov models [43–45]. Evolutionary analysis led to a phylogenic tree with α-TA in Pfam 
group I and ω-TA in Pfam group III [15,46]. Based on structure, PLP-dependent enzymes have 
been divided into five different fold types [42,47], with α- and ω- TA found in Fold types I and 
IV [42,47–49]. Fold type I (S)-selective ω-TA have an α-β-α-structure pattern. In contrast, Fold 
type IV (R)-selective ω-TA consisting of two domains, a two-layer ω-sandwich and an α-β-
barrel pattern. TA of both Fold types form at least homodimers, and the active sites are located 
at the homodimer interface. Because both α- and ω-TA are found in each of the two Fold types, 
regioselectivity is not strictly linked to global protein structure. The substrate binding sites of 
Fold types I and IV are mirror images with the catalytic lysine located at the si- and re-face of 
PLP, respectively, resulting in the observed enantiocomplementarity of the two folds [8,50] 
with Fold type I (S)-selective ω-TA converting (S)-amines and (S)-amino acids, whereas Fold 
type IV (R)-selective ω-TA converting (R)-amines and (R)-amino acids as well as branched-
chain L-amino acids [49].  
The three classification schemes are used in parallel. TA are named by their stereo-preference 
((R)/(S)-selective), their substrate specificity, their regioselectivity (α/ω-TA), or their Pfam 
group (aminotransferase class), resulting in enzyme names such as: ω-aminotransferase, 
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(S)-selective aminotransferase, aromatic amino acid TA, γ-aminobutyrate TA, ω-amino 
acid:pyruvate TAs and class III aminotransferase [23,51–55]. A public online database on ω-TA 
will be a helpful tool, connecting information about mutation sites, structure data and substrate 
scope, thus allowing researchers the mining of uncharacterized ω-TA for the desired enzyme 
functions and predicting interesting mutation sites.  The first public database for ω-TA 
screening was the B6-database for the description and classification of vitamin B6 dependent 
enzymes [4]. Höhne et al. and Pavlidis et al. demonstrated data mining as a successful strategy 
for in silico screening of (R)-selective TA accepting bulky substrates [14,49,56]. In contrast 
Calvelage et al. reported a systematic analysis of ω-TA (amine transaminases) according to 
reported reaction data and selected important selectivity and activity indicators. However, this 
analysis was limited to a small fraction (~500) of ω-TA and only to amine substrates [57]. To 
support enzyme engineering and to facilitate navigation and annotation, we established a 
publicly available database on ω-TA which includes sequence information and structural data. 
Additionally, standard numbering schemes for both Fold types were established to identify 
equivalent positions in homologous proteins and to compare the effects of corresponding 
mutations in different proteins.  
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3.2) Methods 
 
Setup and clustering of the ω-Transaminase Engineering Database (oTAED) 
The sequences of nine representative ω-transaminases (ω-TA) were used as query sequences 
against the NCBI non-redundant protein database with an E-value threshold of 10-10 (table 3.2) 
[58]. The setup of the oTAED and the clustering of the sequences was performed within the 
BioCatNet database system [59]. A sequence identity threshold of 98% was applied to assign 
sequences to proteins and a threshold of 40% sequence similarity was used to form homologous 
families. If the majority of sequence entries from a homologous family showed sequence 
lengths longer than 350 amino acids, the homologous family was assigned completely to the 
Fold type I superfamily. Consequently, homologous families were assigned to the Fold type IV 
superfamily, if most of their sequences were shorter than 350 amino acids. 
All sequences within a superfamily that could not be assigned to a homologous family were 
collected in a separate group. Sequences shorter than 200 and longer than 550 amino acids were 
discarded. If available, crystal structures from the PDB repository were assigned to the 
sequence entries. Multiple sequence alignments and phylogenetic trees were generated using 
Clustal Omega [60] and can be downloaded from a WWW-accessible user interface. The 
oTAED is online available. 
 
Standard numbering schemes 
Standard numbering schemes were established for the two superfamilies Fold type I and Fold 
type IV as described previously [61]. For the respective superfamily, reference structures 
containing the cofactor PLP and covering the most abundant homologous families were selected 
(Table 3.1). For Fold type IV, a structural alignment of six reference structures was created 
using STAMP [62]. For Fold type I, fourteen characterized ω-TA were selected. The N-terminal 
region (positions 1 to 64 of PDB entry 2YKU), which was not resolved completely in all 
reference structures, was discarded to improve the robustness of the alignment. The multiple 
sequence alignment of the Fold type I reference sequences from Clustal Omega was refined 
manually, guided by structural superimposition [60]. From the manually optimized alignments 
of Fold type I and IV reference structures, profile hidden Markov models were created by 
HMMER (version 3) [63]. By aligning all sequences to their respective sequence profile, 
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position numbers were transferred to Fold type I sequences from PDB entry 2YKU (ω-TA from 
Mesorhizobium sp. LUK) and to Fold type IV sequences from PDB entry 4CE5 (ω-TA from 
Aspergillus terreus). 
Table 3.1 Reference structures for the standard numbering schemes of ω-transaminase 
superfamilies Fold Type I and Fold Type IV. 
Fold Type I 
PDB entry 
Fold Type I 
Source 
Fold Type IV 
PDB entry 
Fold Type IV 
Source  
1DTY Escherichia coli 3WWH Arthrobacter sp. KNK168  
1SZS Escherichia coli 4CE5 Aspergillus terreus 
2OAT Homo sapiens 4CHI Aspergillus fumigatus 
2YKU Mesorhizobium sp. LUK 4CMD Nectria haematococca 
2ZSL Aeropyrum pernix 5E25 Geoglobus acetivorans 
3A8U Pseudomonas putida 5K3W Curtobacterium pusillum 
3DOD Bacillus subtilis   
3FCR Ruegeria sp. TM1040    
3I5T Rhodobacter sphaeroides   
4AOA Variovorax paradoxus   
4E3R Homo sapiens   
4JEW Salmonella enterica    
4UOX Escherichia coli   
4YSN Lactobacillus buchneri   
 
 
Conservation analysis 
The two standard numbering schemes for Fold type I and Fold type IV sequences were used 
separately to analyze the amino acid composition of both superfamilies. A position was 
considered to be conserved in a superfamily, if a single amino acid was present in more than 
70% of all sequences. 
Sequence networks 
Sequence networks were generated for distances between pairs of homologous sequences. To 
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identity using the algorithm of USEARCH [64]. Pairwise global sequence alignments were 
calculated using the implementation of the Needleman-Wunsch algorithm in the EMBOSS 
software suite [65]. Sequence networks were created by using a cutoff of 50% pairwise 
sequence similarity, and the resulting networks were visualized by Cytoscape version 3.4.0 
using the Prefuse force-directed layout algorithm with respect to the edge weights. 
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3.3) Results 
 
3.3.1) The ω-Transaminase Engineering Database (oTAED) 
The ω-Transaminase Engineering Database (oTAED) consists of two superfamilies, Fold types 
I and IV. The database was created using query sequences of different characterized ω-TA of 
Fold type I and IV (Table 3.2). The ω-TA sequences were assigned to the two superfamilies by 
sequence length. The oTAED includes 67,210 proteins (114,655 sequences) which were 
separated into 169 homologous families (HFams) based on global sequence similarity. 
Table 3.2 Query sequences for the initial BLAST search to set up the ω-Transaminase Engineering 
Database (oTAED). Annotation according to UniProt nomenclature.  
UniProt ID Annotation Fold type  Source organism Reference 
H8WR05 Beta-Phenylalanine 
Aminotransferase 
I Variovorax paradoxus [22] 
Q0C8G1 AT-OmegaTA IV Aspergillus terreus [8] 
A1TDP1 Multispecies: 
Aminotransferase IV  
IV Mycobacterium 
vanbaalenii 
[66] 
A1DD33 Aminotransferase, Class IV, 
Putative 
IV Aspergillus fischeri [66] 
F2XBU9 Pyruvate transaminase I Vibrio fluvialis [67] 
A0A1B4YGI6 Beta – Alanine Pyruvate 
Transaminase 
I Mesorhizobium loti [51] 
P28269  Omega Amino Acid: Pyruvate 
Aminotransferase 
I Pseudomonas putida [68] 
D5VI64 Aspartate Aminotransferase 
Family Protein 
I Caulobacter segnis 
 
[69] 
Q9I700 Aspartate Aminotransferase 
Family Protein 
I Pseudomonas 
aeruginosa 
[10] 
 
The database oTAED was published using the biocatnet-database platform from Pleiss’s 
research group [59]. The tool allows researchers to identify putative ω-TA and to characterize 
ω-TA of interest using a standard numbering scheme for easy transfer of engineering sites 
between ω-TA of one Fold type. Fold type I proteins have an average length of 432 amino acids, 
whereas Fold type IV proteins have an average length of 297 amino acids (Figure 3.1). Nearly 
31% of Fold type IV proteins have a length of 290 amino acids (at a bin-size of 10). The largest 
group of Fold type I proteins are 430 amino acids in length. Very short sequences of up to 220 
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amino acids occur for Fold type I, but do not have a large overall share of the size distribution. 
In the case these short-chain Fold type I enzymes are not only fragments. However, such short 
enzymes would be very interesting because shorter proteins showing less synthetic costs for the 
expression host and might be also evolutionary more conserved than proteins with larger 
lengths [70]. Fold type IV proteins with a very long length of over 500 amino acids also occur, 
even if their absolute number is relatively small (>40). However no proteins with lengths shorter 
than 270 amino acids are present within the family of Fold type IV proteins. An example for a 
short Fold type I protein sequence is the ornithine aminotransferase from Trichinella spiralis 
with an amino acid length of only 256 residues. However, some of those short gene bank entries 
might be only protein fragments, like the 220 long protein sequence (ID 1330537) of the 
succinylornithine transaminase from Yersinia pseudotuberculosis (real protein size 414, 
UniProt ID Q66B21). Therefore, very small protein lengths might indicate also protein 
fragments, which can be found within protein databases and therefore also in oTAED.  
Besides the classification into HFams (homologous families), the standard numbering was also 
a goal of this work. For the standard numbering an ω-TA sequence was utilized as reference 
and an alignment was performed using a setup of 15 Fold type I ω-TA and 6 Fold type IV ω-
TA structures. Therefore too similar structures were excluded, because high sequence- and 
structural-identities are useless in respect of creating a consensus sequence. In the following 
the database results of Fold type I and type IV are analyzed.  
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Figure 3.1 Protein length of Fold type I (a) and IV (b) (Caution logarithmic Y-axis scaling). Fold type 
IV sequences peaking in a length of 290 amino acids (~31% of all sequences). Fold type I proteins are 
generally larger and showing a global maximum at 430 amino acids (~21% of all sequences). The bin 
size was set to 10 using the total sequence FASTA-file from oTAED 1.0.1. The histogram was analyzed 
using Microsoft-Excel.   
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Characterization of Fold type I 
The Fold type I superfamily consists of 101,738 protein sequences (89% of the oTAED entries), 
which were assigned to 124 homologous families. Most of the putative Fold type I (S)-selective 
ω-TA belong to one large homologous family (HFam 239) comprising 99,559 sequences (98% 
of all Fold type I sequences) and 164 structures. The discrepancy of sequence amount in regard 
to the amount of structures prevents the direct functional analysis of most of the sequences. 
However also experimentally characterized sequences can be found within the database, some 
of them even in combination with the protein structure.  
The Fold type I family contains the previously characterized (S)-selective ω-TA from 
Mesorhizobium sp. LUK and V. paradoxus (PDB entries 4AO4 and 4AOA), which are active 
towards aromatic β-amino acids and were reported before in chapter 1 [11,22]. Their host 
organisms are soil bacteria living in symbiosis with plants for fixation of nitrogen from plant 
material [71,72]. A further member of HFam 239 is the ω-TA from Rugeria sp. TM1040 (PDB 
entry 3FCR) which was characterized as an (S)-selective ω-TA with activity towards small 
amino acids, 1-phenyl ethylamine (PEA), bicyclic acceptor molecules such as exo-3-amino-8-
aza-bicyclo[3.2.1]oct-8-yl-phenyl-methanone and succinic semialdehyde [14,55]. Other 
members of HFam 239 are the ω-TA from Chromobacterium violaceum (PDB entry 4AH3), 
which exhibited (S)-selectivity and a broad substrate range towards amines and amino acids, as 
well as aldehydes and ketones as acceptor molecules [73], and an ω-TA from 
Pseudomonas aeruginosa (UniProt ID V6A7F6) with activity towards mono- and diamines. 
This newly characterized enzyme converts cadaverine and spermidine and catalyzes the transfer 
of the amino group to aromatic ketone acceptor molecules [74]. These examples demonstrate 
the large diversity of substrate specificities in the largest homologous family of the Fold type I 
superfamily. 
The other homologous families consist of less than 400 sequences each (Hfam 35: 397 
sequences, HFam 134: 339 sequences and eight structures). The respective proteins are often 
annotated as (S)-selective ω-TA, mostly γ-aminobutyrate aminotransferases from eukaryotic 
organisms. 
 
Characterization of Fold type IV 
The smaller Fold type IV superfamily consists of 12,917 protein sequences assigned to 45 
homologous families (11% of the oTAED entries). It contains sequences annotated as (R)-
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selective ω-TA as well as (R)-selective D-α-TA (DATA). This class of enzymes is selective for 
D-α-amino acids like D-alanine or D-glutamate [75]. Furthermore, it contains L-branched-chain 
aminotransferases (L-BCAT) with activity towards aliphatic α-amino acids like valine, leucine, 
and isoleucine [76,77]. L-BCATs show a different enantiopreference in comparison to DATA 
and (R)-selective ω-TA, presumably caused by the reverse arrangement of the substrate in the 
active site [34]. Furthermore (R/S)-nomenclature for enzyme labeling is not stringent and allows 
misleading interpretations of substrate selectivity. However, the annotation in public databases 
such as NCBI or Uniprot is often restricted to DATA or L-BCAT [37], lacking differentiation 
between DATA/ L-BCAT and (R)-selective ω-TA. For this reason, names of Fold type I and IV 
are useless in the most public databases with exception of reviewed sequences.   
The largest homologous family (HFam 11) includes 90% of all Fold type IV sequences and 23 
annotated structures such as a branched-chain-amino-acid TA (PDB entry 4WHX) and an 
amino lyase with activity towards 4-amino-4-deoxychorismate (PDB entry 2Y4R) [9]. The 
second largest homologous family (HFam 10) contains 511 sequences and 9 structures. This 
HFam contains mostly ω-TA annotated as (R)-selective TAs, such as the ω-TA from 
Arthrobacter sp. (PDB entries 5FR9 and 3WWH) which was adapted by large site directed 
mutagenesis experiments for activity towards bulky substrates such as aromatic β-fluoroamines 
or sitagliptin [24,78], and two (R)-selective ω-TA from the fungi Aspergillus fumigatus and A. 
terreus (PDB entries 4CHI and 4CE5) showing activity towards aromatic amines [8,37,79]. The 
other homologous families of Fold type IV contain less than 200 sequences each. 
Conserved positions of Fold type I and IV 
Evolutionary conserved positions often point to structurally or functionally relevant residues, 
an amino acid exchange at these positions might cause drastic changes in activity as well as 
protein stability [80]. Therefore, these sites better be excluded in some contexts from enzyme 
engineering experiments [81]. Positions that are conserved but previously undescribed in 
literature could be investigated in future studies to elucidate their biochemical relevance. 
Therefore, the following overview comprises positions conserved in the sequences from the 
respective Fold type and is not limited to positions mentioned in literature. 
3.3.2) Fold type I sequence analysis 
By applying the standard numbering schemes for Fold types I, 44 conserved positions (present 
in more than 70% of the sequences) were identified (Table 3.3) with position numbers 
according to the ω-TA from Mesorhizobium sp. LUK (PDB accession 2YKU). 
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Table 3.3 Conserved positions in putative Fold type I (S)-selective ω-TA sequences with standard 
numbering according to the ω-TA from Mesorhizobium sp. LUK (PDB accession 2YKU) and their 
location inside the protein structure or annotated function. Positions listed here are conserved to at least 
70%. 
Standard position Conserved amino acids Location/function 
7 G (88%), N (5%) loop 
12 D (81%), L (6%)  
15 G (91%) α-turn [22] 
20 D (97%)   
31 G (98%) loop 
32 H (75%), Y (18%)  
40 A (83%)  
44 Q (75%), A (10%)  
81 G (98%) backbone hydrogen bond to PLP [22]  
83 E (72%), D (10%), V (6%)  
84 A (83%), S (10%)  
88 A (85%)  
90 K (70%), R (26%)  
92 A (80%), V (8%)  
109 H (98%) interaction with D189 [10] 
110 G (99%) loop 
151 A (79%), C (9%)  
152 A (78%), C (10%), G (9%)  
156 E (97%) hydrogen bond to PLP [82] 
157 P (79%), T (7%), A (5%) loop 
160 G (82%) loop 
163 G (92%) loop 
185 L (75%), V (13%)  
186 L (71%), F (15%), M (5%)  
187 I (75%), V (20%)  
189 D (100%) hydrogen bond to PLP [22][13] 
190 E (96%)  
194 G (93%) loop 
195 G (71%), R (15%), A (8%) loop 
196 R (82%), V (8%)  
198 G (84%), L (6%) loop 
201 A (70%), G (15%), S (6%)  
209 P (93%), A (6%) loop 
210 D (99%) salt bridge to arginine  (Figure 3.2) 
216 K (100%) catalytic lysine [22] 
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221 G (91%) loop 
223 P (88%), T (5%)  
250 T (94%), S (5%) backbone hydrogen bond to PLP [22] 
253 G (83%), A (11%) loop 
255 P (79%), A (6%)  
259 A (77%), V (5%)  
288 L (74%), I (7%), F (6%)  
302 R (77%), N (6%)  
305 G (94%) loop 
 
  
3) Analysis and creation of a systematic ω-TA database (oTAED) 
69 
 
The highly conserved positions D189 and K216 were found in all sequences of Fold type I. The 
side chain of D189 is fixed by interacting with H109 and is involved in binding the cofactor 
PLP by a hydrogen bond between the carboxylic group and the pyridine nitrogen, and thus is 
essential for all PLP-dependent enzymes. The conserved K216 forms a Schiff base with the 
intermediate or with the cofactor PLP. The role of the highly conserved D210 in (S)-selective 
ω-TA is still unknown, but it might participate in a conserved salt-bridge between an α-helix 
and a β-strand, since in most structures an arginine or asparagine residue is found in close 
distance to D210 (Figure 3.2).  
 
Figure 3.2 Conserved salt bridge within Fold type I ω-TA at D210. Showed for PDB structures 4AOA, 
2YKU, 5GFH and 3NUI. The conserved D210 seems to be an important salt bridge starting point, but 
the corresponding salt bridge partner residue is not conserved, the distance between arginine/asparagine 
and glutamate is less than 3.5Å. The position numbers are no standard numbers. The distances were 
calculated using Chimera 1.1 [83].   
Besides the functionally relevant positions, it is remarkable that 13 of the 44 conserved residues 
are glycines and 4 are prolines, most of them localized in loops (12 glycines and 2 prolines, 
respectively) and might therefore be involved in protein folding. For 23 conserved positions, 
the function is still unknown. 
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3.3.3) Fold type IV – sequence analysis 
In contrast for Fold type IV were at least 39 conserved positions identified. Using standard 
numbering scheme the conserved positions were presented in table 3.4 according to the ω-TA 
from Aspergillus terreus as representative sequence (PDB accession 4CE5). 
Table 3.4 Conserved positions in putative Fold IV ω-TA sequences with standard numbering 
according to the ω-TA from Aspergillus terreus (PDB accession 4CE5) annotated as in table 
3.3 
Standard position Conserved amino acids Location/function 
36 G (86%) loop 
44 A (83%)  
56 G (77%), A (17%), S (5%) loop 
61 E (89%), D (9%) salt bridge to standard position R79 
68 G (82%), T (5%) loop 
76 H (98%)  
79 R (100%) PLP binding cup [8] 
80 L (84%), F (11%)  
83 S (82%), G (11%)  
109 N (73%), S (9%)  
123 G (95%) loop 
158 G (86%) loop 
180 K (88%) catalytic lysine [8]; salt bridge to position  61 
194 A (83%)  
198 G (83%) loop 
201 E (72%), D (18%)  
209 G (89%) loop 
213 E (94%) 
hydrogen bond to PLP and interaction with 
position 169 (R:50%, W:11%)) [8]      
218 N (92%)  
220 F (76%), W (7%), Y (6%)  
222 V (73%), I (15%)  
225 G (77%), N (7%), D (5%) loop 
229 T (87%)  
230 P (78%), R (7%), H (5%)  
235 L (94%) PLP binding cup [8]   
237 G (97%) loop 
238 I (81%), V (10%) PLP binding cup [8]   
239 T (89%) PLP binding cup [8]   
240 R (90%)  
3) Analysis and creation of a systematic ω-TA database (oTAED) 
71 
 
256 E (75%), V (5%)  
267 A (84%), F (7%)  
268 D (72%), E (9%) salt bridge to position 223 (K: 51%, R: 24%) 
269 E (94%)  
271 F (83%), W (7%)  
273 T (72%), S (14%), C (8%)  
281 P (84%), A (8%)  
286 D (78%), G (8%)  
293 G (76%) loop 
296 G (89%) loop 
 
The highly conserved position R79 is present in all sequences and is part of the conserved PLP-
binding cup formed by E213, L235, I238, and T239 [8]. Furthermore a salt bridge or hydrogen 
bridge between standard position 61 and R79 can be observed and evolutionary allowed amino 
acids are glutamic acid, aspartic acid, but also threonine (Figure 3.3).    
 
Figure 3.3 Conserved salt bridge between R79 and D/T61 within Fold type IV. Furthermore the position 
Y67 enables a hydrogen bridge towards K180. The coordination of K180 can be performed by standard 
position 184. Branched chain transaminase: 1IYE and 5E25. 3WWH, 4CE5 are known as (R)-selective 
ω-TA. 5K3W is characterized as special Fold type IV-ω-TA [49]. 3CSW is annotated as putative Fold 
type IV ω-TA [8]. Distances were calculated using Chimera 1.1.   
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Moreover the non-conserved standard position Y60, is showing a hydrogen bridge towards 
K180 within the transaminases 3CSW, 3WWH and 4CE5. In contrast, an alignment of 
homologues of 4CE5 (sequence identity between 35 and 95%) showing that this position is 
highly conserved (Figure 3.3), but also tryptophan is an allowed alternative, which cannot seen 
using the global conservation analysis of all Fold type IV members of oTAED. Furthermore 
standard position 61 is conserved in both conservation analysis (Table 3.4 compared to 
Figure  3.4) but even in small set of quite similar sequences threonine and glutamic acid are 
allowed as alternative amino acid residues, which are all able to build a hydrogen bride or salt 
bridge to R79. The BCAT enzymes (also part of oTAED database) showing a phenylalanine at 
position 60 instead of a tyrosine residue.  Moreover, in putative BCAT enzymes standard 
position 184 is evolutionary conserved as Y184 and simultaneously standard position Y60 is 
changed to phenylalanine, which shows that a tyrosine residue in BCAT enzymes is not 
necessary anymore at this position.    
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Figure 3.4 Conservation analysis of the coordinating active site tyrosine in Fold type IV. Red brackets 
highlighting the positions of interest. A) For putative ω-TA showed representative to 4CE5 (position 60 
and 61). The position Y60 is highly conserved (probability 0.96), but also W60 is an evolutionary 
allowed residue (probability 0.04). D61 is also highly conserved (probability 0.967) and allowed 
alternatives are glutamic acid (0.02) and threonine (probability 0.013). B) Putative BCAT showed at 
standard position 60/61 a highly conserved F60 (probability 0.96). However also Y60, L60 and I60 are 
evolutionary allowed (probabilities 0.02, 0.013 and 0.007). According to A) standard position 61 is 
highly conserved as E61 and D61 (probability 0.98 and 0.007) but also the uncharged G61 is allowed 
(probability 0.013). Moreover the mentioned tyrosine residue switches to position 184 within 1IYE and 
homologues (putative BCATs). Standard position 184 showed to be totally conserved with a probability 
of 1.0. 150 sequences were utilized for creating alignments of closet related protein sequences 
(UniProtRef90) using ConSurf with sequential identities of 35 to 95% [84,85]. The results were 
visualized using Skylign [86].  
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Exemplary the branched-chain transaminases 5E25 and 1IYE are analyzed. Both showing an 
exchange towards phenylalanine and at the same time Y60 is compensated at standard position 
184 by a tyrosine residue. Y60 is also part of the motif from Höhne et al. [37]. This 
rearrangement can also be refund in the structure 5K3W, which was characterized as unusual 
Fold type IV (R)-ω-TA with activity towards D-amino acids and amines [49]. This enzyme 
seems to be a connection point between BCAT and (R)-selective ω-TA. The distance between 
K180 and Y178 is 4 Å and between Y178 and hydroxyl-moiety of PLP only 2.6 Å, which would 
allow a water bridges as well as hydrophobic interactions [87]. Y178 is clearly contributed in 
binding PLP, which is known for Fold type I ω-TA. Furthermore only F60 might be also able 
to coordinate PLP by π-interactions (stacking).  
Moreover E213 forms a hydrogen bond to the cofactor PLP and might form a salt bridge to 
R169 in some Fold type IV proteins [8]. Surprisingly the catalytically active lysine is only 
conserved in 88% of all sequences at Fold type IV standard position 180. As in Fold type I, the 
catalytic K180 might be able to form a salt bridge to the conserved E/D61, which is also aligned 
at R79. A further salt bridge could be present between D268 and the partly conserved K/R223. 
Moreover, 11 conserved glycines all of were located in loop-structures. According to Yan et al. 
they provide flexibility for enzymes and might be important for activity, which enables i.e. the 
adaption of the enzyme towards substrate [88,89]. For 20 conserved positions, the function is 
still unknown. 
 
3.3.4) Selectivity- and specificity-determining positions  
Considering that (S)-selective and (R)-selective ω-TA have a different fold, different substrate 
specificities, and different conserved amino acids in the substrate binding pockets, it is 
surprising that only one mutation can switch enantiopreference. By engineering the ω-TA of 
Artherobacter citreus (Fold type I), it was shown that a mutation at Fold type I standard position 
328 from valine to alanine changes the enantiopreference from (S) to (R) for the substrate 4-
fluoro-phenylacetone [90]. Other relevant positions in Fold type I are Y108 near the cofactor 
PLP, W26 inside the small binding pocket, and F53.1. Position F53.1 is missing in some Fold 
type I proteins, but was shown to have an influence in steric hindrance of bulky substrates for 
the ω-TA from Chromobacterium violaceum. [91]. With respect to the binding mechanism of 
substrate and cofactor of (R)- and (S)-selective ω-TA, the mechanism of binding the phosphate 
group of PLP via a hydrogen bond network in the phosphate-binding cup is common to both 
Fold types (Figure 3.5) [8,92,93]. 
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The planar cofactor PLP is sandwiched between Y108 and V191 in Fold type I (S)-selective ω-
TA and between L235 and F217 in Fold type IV (R)-selective ω-TA [24,94,95].  
To explore which positions are involved in substrate specificity and stereoselectivity of Fold 
type I (S)-selective ω-TA, two sequence motifs at 17 sites , and 36 Fold type I standard positions 
were examined which have been described in literature for different ω-TA to be involved in 
substrate interactions (Table 3.5). The standard numbering of Fold type I revealed that many 
positions that have been described in different enzymes are structurally equivalent. One 
example is position 192, which was described in Vibrio fluvialis and Pseudomonas putida as 
positions 259 and 262, respectively. This position is also part of the P-pocket (small pocket) 
motif, and mutations at the mentioned positions to less bulky residues can allow larger substrate 
molecules inside the small substrate binding pocket [23,96]. It is noteworthy that multiple 
functional roles have been suggested in literature for the same position. Fold type I standard 
position 53.1 is mentioned four times in literature for three different ω-TA. Mutation of this 
position resulted in changing substrate specificity or inversion of enantiopreference. Fold type 
I standard position 26 was mentioned seven times for six different ω-TA. The mutation from a 
large residue at this position to a smaller hydrophobic residue allows the conversion of larger 
aromatic and hydrophobic substrates. The previously described flipping R346 was described as 
an important site for dual substrate recognition [55,97]. It was also  mentioned in a motif for 
the recognition of α-carboxyl binding of amino-acceptor substrate and described for the ω-TA 
from Vibrio fluvialis, Pseudomonas sp. strain AAC and Silicibacter pomeroyi [13,55]. The 
flipping arginine is also known for the β-phenylalanine converting ω-TA from Variovorax 
paradoxus and Mesorhizobium sp. LUK. For the ω-TA from Sphaerobacter thermophilus, 
which transfers an amino group to the γ-position [20], this position is a leucine, but arginines 
are next to this position at 346.8 and 346.13. In contrast Mathew et al. determined the position 
0.41 (R41) as flipping arginine in Sphaerobacter thermophilus, which is located at the substrate 
binding pocket and not in the outer shell of the enzyme [20,22]. Overall, Fold type I standard 
position 108 seems to be an important site for the coordination of PLP, which was mentioned 
in literature at least four times (Table 3.5). 
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Table 3.5 Substrate specificity-determining positions and substrate-specific sequence motifs in 
Fold type I (S)-selective ω-transaminases. Standard positions refer to position numbers of the 
ω-TA from Mesorhizobium sp. LUK (PDB accession 2YKU). 
Standard 
position 
Position Function Source 
organism 
Uniprot ID Ref.  
0.19 
26 
53.1 
111 
118.1 
192 
346 
53.4 
F19W 
W57F 
F85A 
V153A 
K163F 
I259V 
R415F 
R88K 
higher activity towards β-keto 
esters  
V. fluvialis F2XBU9 [23] 
0.20 
0.23 
53.2 
108 
L20 
(Y/W/L)23 
(Y/F)88 
Y152 
hydrophobic L-pocket 
 
C. crescentus 
and others 
P28269 [96] 
0.36 R36 decrease of activity towards 
aromatic β-amino acid 
S. thermophilus D1C218 [20] 
0.41 R41 coordination of substrate 
carboxyl-group 
V.paradoxus H8WR05 
 
[22] 
0.41 
0.43 
0.50 
14 
15 
24 
25 
R41 
(A/V/I)43 
P50 
D65 
G66 
(E/D/N/Q)75 
(Y/F/W)76 
activity towards aromatic β-
amino acids 
V.paradoxus H8WR05 
 
[22] 
14 
26 
118.5 
126.5 
161 
165 
172 
175 
188 
346.9 
346.24 
346.36 
G48R 
Y60C 
Y164F 
R186S 
A242V 
A245T 
I252V 
F255I 
N268S 
T409R 
K424E 
V436A 
improved stability; activity 
towards aminotetralin 
A. citreus 
(alternative  B. 
megaterium) 
A0A1C7D1
91 
[12] 
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24 E75 interaction with R41 V. paradoxus H8WR05 
 
[22] 
25 Y85I shift of activity: from ornithine-
TA to γ-TA 
Homo sapiens P04181 [98] 
25 
26 
53.1 
111 
L56V 
W57C 
F85V 
V153A 
increase of activity towards 
branched chain substrates 
V. fluvialis F2XBU9 [67] 
25 
26 
L57A 
W58A 
allows for re-face attack; 
increased activity towards 
butyrophenone 
O. antrhopi A6WVC6 [99] 
26 W57F opening of P-pocket V. fluvialis F2XBU9 [23] 
26 W60C increase of enantioselectivity 
and activity towards aromatic 
substrate 
C. violaceum 
 
Q7NWG4 [91] 
[100] 
[101] 
26 W58L opening of substrate pocket; 
activity towards aromatic ketons 
O. anthropi ; V. 
fluvialis 
A6WVC6 [102] 
[23] 
26 Y59 determines size of the O-pocket Ruegeria sp. 
TM1040 
Q1GD43 
 
[55] 
[56] 
26 
161 
192 
W60 
S231 
I262 
determines size of the S-pocket  C. crescentus   P28269 Review
ed by 
[96] 
53.1 Y87 interacts with aromatic substrate 
in P-pocket 
Ruegeria sp. 
TM1040   
Q1GD43 
 
[55] 
[56] 
53.1 
111 
F85L 
V153A 
activity towards PEA and longer 
side chains 
V. fluvialis  F2XBU9 [23] 
[94] 
53.1 F85A increase of binding pocket V. fluvialis F2XBU9 [23] 
53.1 
161 
F88A 
A231F 
inversion of enantiopreference 
from (S) to (R) 
C. violaceum 
 
Q7NWG4 [91] 
[100] 
[101] 
53.2 F92V inhibits activity towards 
aromatic PEA 
Ruegeria sp. 
TM1040   
Q5LMU1 [55] 
47 G98M increase of stability  V. paradoxus 4AOA [103] 
108 Y152 coordinates PLP;  prevents 
activity towards aromatic 
substrates 
Ruegeria sp. 
TM1040   
Q1GD43 
 
[55] 
[56] 
108 Y153M/S/N switch from a α-TA to a ω-TA C. violaceum 
 
Q7NWG4 [91] 
[100] 
[101] 
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108 
111 
Y150F 
V153A 
higher activity towards amino 
alcohols 
V.fluvialis  F2XBU9 [94] 
108 
192 
Y152 
I262 
determines size of the  small 
pocket and allows only methyl 
residue of PEA 
P. putida  P28269 
 
[96] 
111 V153A increases size of P-pocket of ω-
TA; activity towards aliphatic α-
keto acids 
P.denitrificans A1B956 [104] 
118.1 
118.5  
N161I 
Y164L 
improved stability  P. mandelii 
PD30 
A0A059KS
X8 
[105] 
164 
220 
V228G 
N286A 
increase of activity towards 
aromatic β-amino acid C. crescentus 
Q7WWK8 [53] 
192 I259V tolerance for alcohol ester 
substrate 
V. fluvialis F2XBU9 [23] 
248 V328A 
 
Inversion of enantiopreference 
from (S) to (R) 
A.citreus A0A1C7D1
91 
[90] 
251 Y331C Increases enatiopreference for 
(S) 
A.citreus A0A1C7D1
91 
[90] 
346 R415 flipping arginine (dual substrate 
recognition) 
V. fluvialis F2XBU9 [23] 
346 R415F less polarity inside P-pocket V.fluvialis F2XBU9 [23] 
346.1 R414 flipping arginine (α-carboxyl 
binding site) 
C.crescentus P28269 [96] 
346.1 R414K loss of activity  Pseudomonas 
sp. strain AAC 
A0A081YA
Y5 
[13] 
346.4 P423 entrance of substrate pocket Ruegeria sp. 
TM1040   
Q1GD43 
 
[55] 
[56] 
346.20 R416 flipping arginine (dual substrate 
recognition) 
C. violaceum Q7NWG4 [106] 
 
In comparison to Fold type I, literature information about mutations in (R)-selective ω-TA in 
the Fold type IV superfamily is sparse, and only 17 Fold type IV standard positions were 
described (Table 3.6). Most mutation data were generated by engineering of Arthrobacter ω-
TA for activity against prositagliptin. Fold type IV standard position 62 is part of the small 
pocket. In ω-TA from Arthrobacter sp.117, the mutation of V62G increased the small pocket 
[24]. In ω-TA from Nectria haematococca, V62 was described as part of a motif which mediates 
specificity towards (R)-amines [95]. Besides that, a mutation at Fold type IV standard position 
62 is proposed to increase activity towards aromatic ketone substrates [24].  
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Table 3.6 Substrate specificity-determining positions and substrate-specific sequence motifs in 
Fold type IV (R)-selective ω-transaminases. Standard positions refer to position numbers of the 
ω-TA from Aspergillus terreus (PDB accession 4CE5). 
Standard 
position 
Position Function Source 
organism 
Uniprot ID Ref.  
55 
60 
62 
H53 
Y58 
V60 
specificity towards (R)-amines  Nectria 
haematococca 
C7YVL8 [95] 
55 H62A increase of activity towards 
aromatic ketone substrate 
Artherobacter 
117 
F7J696-1 [24] 
62 
115 
276 
V69G 
F122I 
A284G  
increases size of small pocket  
 
Artherobacter 
117 
 
F7J696-1 [24] 
125 
147 
E125 
E140 
entrance tunnel limiting the 
substrate size 
C.pusillum A0A1S4NY
F0 
[49] 
126 
127 
191 
201 
G136Y 
E137I 
V199I 
A209L 
increase of hydrophobic 
interaction with substrate 
Artherobacter 
117 
 
F7J696-1 [24] 
128 R138 interacting with keto group of 
the substrate 
Artherobacter 
117 
F7J696-1 [24] 
130 
133 
T130M 
E133F 
increase of thermostability  Aspergillus 
terreus 
Q0C8G1 [107] 
215 S223P increases size of large pocket Artherobacter 
117 
F7J696-1 [24] 
274 
275 
276 
T273 
T274 
A275 
enantiopreference by limiting 
space in small pocket 
Nectria 
haematococca 
 
C7YVL8 [95] 
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3.4) Discussion 
The ω-Transaminase Engineering Database (oTAED) was implemented as a public database 
for navigating the sequence space of the biotechnologically relevant ω-TA from Fold types I 
and IV. Besides the oTAED, databases have been published for Fold type IV [37] and Fold type 
I proteins [108]. The conserved positions in Fold type I and IV were analyzed by standard 
numbering schemes in the oTAED. For each Fold type, a standard numbering scheme allowed 
for the unambiguous comparison of structurally equivalent positions in different ω-TA 
described in literature. The annotation of previously identified sequence motifs and the 
comparison of functionally relevant positions are expected to facilitate the annotation of yet 
uncharacterized ω-TA [15,35,109]. 
 
Comparison of Fold types I and IV 
The putative (S) - and (R)-selective ω-TA of Fold type I and IV, respectively, have different 
sequence lengths, different folds, and lack global sequence similarity, and are thus 
evolutionarily separate (Figure 3.5). Despite their different folds, the substrate binding sites of 
both Fold types consist of a large O- and a small P-pocket [22,37], and the catalytically 
important residues are located in the same spatial arrangement with a highly conserved catalytic 
lysine (standard positions 216 or 180 in Fold types I or IV, respectively) pointing to the cofactor 
PLP from the si- or re-face (Figure 3.6). Thus, in respect to the cofactor and the catalytic lysine, 
both active sites are mirror images to each other, which explains the observed 
enantiocomplementarity of Fold type I and Fold type IV (R)-selective ω-TA [8,110]. In contrast 
to Fold type I (S)-selective ω-TA, Fold type IV (R)-selective ω-TA have no reported activity 
towards β- or γ-amino acids [35,37,78,111,112]. Both superfamilies show activity towards 
alanine, which is a hint at a similar mechanism for alanine binding, which might be also a result 
of the small size of alanine [8,35,37]. However, IPA is also a small amino donor, but it is not 
accepted by a variety of ω-TA [113,114]. 
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Figure 3.5 Structure comparison of Fold type I and IV. The pattern of Fold type I consists of an α/β/α 
pattern with the active site located of at the interface of the homodimer (only monomer is shown). Fold 
type IV consists of two clear separated domains. Domain 1 is a two layer sandwich. Domain 2 consists 
of an α-β barrel. The active site is also located at the interface of the homodimer. In general Fold type 
IV enzymes are smaller than Fold type I members.  
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Furthermore, it is striking that the PLP binding cup of Fold type IV is more strictly conserved 
than in Fold type I, which may be explained by the smaller number of currently known 
sequences for this superfamily. This database might be furthermore a starting point for deep 
machine learning to characterize sequences without experimental background, which was 
demonstrated to be an adequate method for prediction of enzyme function using the prediction 
of E.C. numbers. Such an algorithm using oTAED, might sensitive enough to separate even the 
different function of isozymes within the presented database [115]. 
 
Figure 3.6 The active sites of (R)- and (S)-selective ω-TA ( Fold type IV and I, respectively) as viewed 
from the re- and si-face, respectively. The functional residues were defined according to Lyskowski et 
al. and to Humble et al.[8,93]. For (S)-selective-ω-TA, the amino acid residues of the phosphate binding 
cup at position 82 are serine or threonine [11,93]. The catalytic lysine is showed as anchor point for re 
and si-face view. 
 
Subsequently, Fold type I and Fold type IV enzymes are still a relatively uncharted territory 
with a small fraction of discovered and described enzymes. Therefore might be the standard 
numbering a first tool for easy comparison of important ω-TA engineering sites. 
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Fold type I 
Using the example of putative Fold type I (S)-selective ω-TA, the standard numbering allows 
the determination of functional amino acid residues within different targets. Therefore the dual 
substrate recognition mechanism, which enables ω-TA to recognize quite different substrates, 
can be investigated. The flipping arginine at Fold type I standard positions 346 or 346.1 was 
predicted to mediate dual substrate recognition [2]. This position is conserved in 11,243 
sequences within Fold type I, and might thus serve as indicator of ω-TA activity. α-TA are 
absent in the Fold type I superfamily, because sequence similarities between α-TA and (S)-
selective ω-TA are very low [116]. However, they are functionally related, since a single 
mutation was sufficient to change an α-TA to an ω-TA [101]. Moreover, many enzyme families 
like GABA-transaminases or β-phenylalanine amine transaminases were described previously 
within this group [108]. The known fingerprints of sequence positions are helpful to predict 
catalytic function [108]. According to this fingerprint-based annotations, the largest group of 
ω-TA could be classified as glutamate-1-semialdehyde-aminomutases (12,667 sequences) and 
the second largest as β-phenylalanine transaminases (1527 sequences). In contrast, only 883 ω-
TA were predicted to have catalytic activity towards synthetically relevant amines [101]. Over 
11,243 sequences (11 %) contained at standard position 346 and 346.1 the mentioned flipping 
arginine. This shows that the flipping arginine is not only important for a sample size of tested 
enzymes, moreover the substrate recognition by this residue is very important. Nevertheless, in 
some groups are enzymes uncovered with different functions. Surprisingly the large group of 
glutamate-1-semialdehyde-aminomutases inhibits instead of aminomutases also ω-TA, which 
is misleadingly according to the title, but not unexpected when the similarity is analyzed [108]. 
This demonstrates also, that current motifs are not stringent enough for accurate classification. 
In addition Fold type I contains also 138 (0.1%) putative α-amino acid amide-racemases 
sequences, which were also identified by Steffen-Munsberg [108].    
 
Fold type IV 
Correspondingly, Fold type IV comprises different enzyme families with high global sequence 
similarity but different substrate specificity: ω-TA, 4-amino-4-deoxychorismate lyases, 
D-amino acid TA (DATA), and L-branched-chain amino acid TA (L-BCAT), which have been 
identified by specific sequence motifs (Table 3.7) [37,108], but could not be distinguished 
based on global sequence similarity [37]. 
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Relevant fingerprints of oTAED Fold Type IV standard positions as reported previously [117] 
for 4-amino-4-deoxychorismate lyase (ADCL), D-amino acid aminotransferases (DATA), L-
branched chain amino acid aminotransferases (L-BCAT) and (R)-selective ω-TA. The presented 
position Y60 is also part of the motif for ω-TA, but not for BCAT and ADCL. Standard position 
184 is not a part of this motif, but might be an important residue for differentiation of many 
unclassified as well as experimentally uncharacterized Fold type IV members. In addition, the 
catalytic lysine at Fold Type IV standard position 180 is conserved in the four subfamilies. 
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Table 3.7 Fingerprints of Fold type IV standard positions as reported previously  for (R)-selective ω-TA, 
4-amino-4-deoxychorismate lyase (ADCL), D-amino acid aminotransferases (DATA), L-branched 
chain amino acid aminotransferases (L-BCAT) and). In addition, the catalytic lysine at Fold type IV 
standard position K180 is conserved in the four subfamilies. [117] 
Standard positions 55 60 62  64 115- 128-130 
ADCL F/Y F T/S - (V/I/L)x(K/R) RGY 
DATA F Y/E/D V K/R x(V/I/L)Y(V/I/L)Q RxH 
L-BCAT Y F/E/D G R/K Y(V/I/L)R (V/I/L)G(V/I/L) 
ω-TA H/R Y V/T S/T/A/H/P (F/Y)V(E/A/S/N/Q) - 
 
Interestingly, L-BCAT, 4-amino-4-deoxychorismate lyases, and DATA enzymes are highly 
related to (R)-selective ω-TA within Fold type IV and appears in our database as separate branch 
(Figure 3.7) [37]. The different substrate specificities are reflected by specific binding sites. In 
(S)-selective L-BCAT, the α-carboxyl group is bound in the small P-pocket, while in (R)-
selective TAs it is bound in the larger O-pocket [37]. 
 
Figure 3.7 Graphical network of Fold type IV members. A) Putative (R)-selective α and ω-TA depicted 
in black. B) Putative ADCL (blue), DATA (black), L-BCAT (red) and (R)-selective ω-TA (green). White 
spots are sequences with unknown function. Classes were determined using sequence motifs from [37] 
and table 3.7. Nodes correspond to representative sequences of clusters formed by 30% identity in 
USEARCH. A cutoff of 50% pairwise sequence similarity is used to select the edges. The network is 
shown as force-directed layout, with pairs with higher similarity arranged in closer proximity (Attention 
string length does not mean the evolutive distances). Networks were designed by Patrick Buchholz.  
As a consequence, L-BCAT show an opposite enantiopreference in comparison to DATA and 
(R)-selective ω-TA [118], and were successfully engineered into ω-TA accepting large aliphatic 
substrates [37]. Furthermore, it is surprising that the arginine residue relevant for substrate 
recognition is not conserved within Fold type IV. This substrate recognition site was assigned 
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to Fold type IV standard position 128 [119]. Therefore, Fold type IV probably includes further 
enzyme classes other than ω-TA or several inactive enzymes.  
The sequence similarity network indicates that sequences with matching positions for potential 
(R)-selectivity did not form distinct groups, whereas sequences matching motifs for ADCL, 
DATA, L-BCAT, or ω-TA activity were found in different subgroups. It is, however, difficult 
to predict overlapping substrate scopes between different enzyme classes. Thus, enzymes 
marked as L-BCAT might have similar specificity towards non-α-amino acid substrates as ω-
TA as shown previously [120]. In addition the standard position 60 and 184 might be important 
for differentiation of L-BCAT and ω-TA. Like mentioned before, position 60 is in the most of 
Fold type IV ω-TA conserved as tyrosine whereas a phenylalanine is positioned in most of the 
BCAT sequences and additional they contain at 184 a tyrosine. This site might allow an 
arrangement of large aliphatic chains within the transaminases.  
 
3.4.1) Understanding the substrate specificity of ω-TA 
Substrate specificity depends on distinct amino acid residues in the substrate pockets [55]. 
Among them, Fold type I standard position 26 seems to be pivotal in mediating the P-pocket 
size. This position is relevant in ω-TA from Chromobacterium violaceum, Ochrobactrum 
anthropi, Vibrio fluvialis, Pseudomonas putida, Bacillus megaterium and Caulobacter 
crescentus mentioned in at least six publications (Table 3.5). The mutation from tryptophan to 
a smaller hydrophobic amino acid residue at Fold type I standard position 26 allowed for 
conversion of larger aromatic and hydrophobic substrates. Additionally, Fold type I standard 
position 53.1 was crucial for the conversion of large substrates, but this position is missing in 
some ω-TA like in the V. paradoxus ω-TA [91]. An exchange from a large residue like W/F to 
F/V/A opened the small binding pocket (P) towards larger residues and led to an inversion of 
enantioselectivity and a reduced activity towards 1-phenylethyl-amine, an amine donor which 
is accepted by all ω-TA [35,121]. However, the sequence region between 44 and 81 which is 
probably involved in substrate recognition showed low sequence conservation and thus could 
not be reliably aligned. Fold type I standard position 108 is a promising hotspot which mediates 
substrate recognition. This site can be exchanged with many different amino acids 
(Y/M/S/N/F/A) with varying effects on substrate specificity. It was expected that a smaller 
residue at position 108 would allow for higher flexibility of the PLP cofactor at the active site 
and decrease steric hindrance for bulky substrates [14]. It was even shown that this site has an 
influence on α- versus ω-TA activity by structural comparison of an α- with an ω-TA from C. 
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violaceum [101]. Beside the substrate specify, also the enzyme stability is target of enzyme 
engineering, which can be examined using oTAED.  
The residues Y60 and Y184 might be function for coordination of K180 or for coordinating of 
PLP via stacking. These standard positions might be hiding the same function as standard 
position 108 in Fold type I ω-TA, which was often engineered from tyrosine to phenylalanine.  
 
3.4.2) Thermostability of ω-TA 
Robustness of an enzyme towards harsh process conditions is often linked to its thermostability, 
which is therefore of major interest in enzyme design. In addition to the already mentioned 
method of enzyme thermostability engineering (Chapter 1), enzymes from thermophilic 
microorganisms, which are already naturally adapted to high temperatures, can be used. 
Furthermore, psychrophilic enzymes are interesting because of their high activity at low 
temperatures [122]. Until now, no psychrophilic ω-TA and only a few thermostable ω-TA are 
known for Fold type I [123]. Recently, three thermostable ω-TA genes from hot spring sources 
were found and characterized (Uniprot ID A0A1U9WZ51, A0A1U9WZ50, and 
A0A1U9WZ53). Further examples are ω-TA from Thermomicrobium roseum and from 
Sphaerobacter thermophilus [20,123]. The taxonomic sources of sequence entries in the 
oTAED were searched for matching entries in the BacDive database (release 27.02.2017) which 
comprises environmental conditions of the two domains Bacteria and Archaea [124]. For Fold 
type I, 2923 sequences from thermophilic, 1171 sequences from hyperthermophilic, and 2434 
sequences from psychrophilic source organisms were identified. For Fold type IV, 449 
sequences from thermophilic and 40 sequences from hyperthermophilic source organisms were 
identified. In contrast, the motifs (V/I)xLDxR and PFG(K/H)YL from Stekhanova et al. for 
thermostable ω-TA matched with only 12 sequences [125]. Sequences from extremophilic 
source organisms did not form separate clusters, but were distributed across the respective 
sequence network (Figure 3.8). 
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Figure 3.8 Putative ω-TA of A) Fold type I (A) and B) Fold type IV in respect to thermophile. Nodes 
from  psychrophilic (green), thermophilic (red), and hyperthermophilic (black) sources retrieved from 
the BacDive database [124] and the representative node (orange) containing the motifs for thermostable 
Fold IV sequences (V/I)xLDxR and PFG(K/H)YL Stekhanova et al. 2017  are annotated[125]. The 
nodes correspond to representative sequences of clusters formed by 30% identity in USEARCH [64]. 
Network settings according to Figure 3.8. (Networks were designed by Patrick Buchholz)  
 
Noteworthy, the representative node matching the motifs from Stekhanova et al. is not 
necessarily surrounded by matches from thermo- or hyperthermophilic sources.  
3.5) Conclusion 
The biocatnet platform allows fast comparison of engineering sites, structures and can be 
utilized as helpful navigation tool for orientation within Fold type I and IV ω-TA. Furthermore 
the results are showing, that ω-TA within both Fold types are closely related to other 
transaminase and to other enzyme classes. Surprisingly Fold type I α-TA are absent from 
database, because they differ according to their sequence significantly from ω-TA and therefore 
they cannot be found within the superfamily. However, the level of knowledge, especially for 
Fold type IV enzymes, is still relatively low. More Fold type IV ω-TA have to be uncovered 
and characterized to determine with higher certainty the differences between BCAT, DATA 
and ω-TA. Until now the nomenclature of many enzymes is doubtful within the Fold type IV 
family and actually no commonly accepted standard substrate exists as a reference for 
transaminase-activity classes. Therefore, it would be beneficial to determine standard amine-
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substrate tests for classification. However, a huge amount of sequences cannot defined by 
sequential fingerprints until now and in case of doubt only experimental data can verify enzyme 
function, but the analysis of this and other databases helps to understand the structure-sequence-
function relationship and might allowing in the near future directed enzyme designs.  
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In the following chapter the thermostability improvement of the Variovorax paradoxus ω-TA is 
demonstrated using in-silico predicted site directed mutagenesis. The existing different 
computational methods are described in chapter 4.1. to understand the function of the protein 
stabilization algorithm(s) with focus on FoldX. In addition, the predictive quality of FoldX has 
been compared with other algorithms. 
 The aim of this project was to increase the long-term stability and activity of the mentioned ω-
TA. Furthermore this stabilized enzyme should be a starting point for further enzyme 
engineering experiments and enzymatic processes (chapter 4.2). Additionally covalent binding 
energies should be increased by introduction of artificial disulfide bonds (chapter 4.3).    
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4.1) FoldX as protein stability engineering tool 
This section is mainly based on the publication 
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4.1.1) Relevance of thermostability of proteins  
Increasing protein stability is a desirable goal for different life science purposes, this includes 
design of therapeutic proteins like antibodies, human cell biology and biotechnology. It is 
expected that such improvements result in lower process costs and in enhanced long-term 
stability of the applied proteins. Enhanced protein stability in general can be achieved due to 
various factors, e.g. by increasing thermostability, salt tolerance or tolerance towards organic 
solvents, and consequently, involves different bioinformatics approaches. The emphasis for 
application of proteins for medical and chemical purposes is focused on the fields of biosensors 
(e.g. blood sugar test strips [1]), biomedical drugs (e.g. antibodies against cancer cells [2]) or 
on the synthesis of complex as well as chiral substances for food (e.g. high fructose corn syrup 
[3])  and pharmaceutical industry (e.g. the mentioned sitagliptin) [4]. Obviously biosensors for 
medical use assisting to diagnose several diseases like breast cancer [5], diabetes [6] or 
infectious diseases [7] have to be functional and reliable for a defined period of time.   It seems, 
for example, to be beneficial to gain more thermostable antibodies for treatment of cancer 
diseases [8]. Furthermore, for the synthesis processes of drugs and pharmaceutically relevant 
intermediates, applied enzymes have to be active and functional for long batch times to prevent 
drastic increases in costs per unit of product [9–12]. For industrial enzymes improved stability 
against heat, solvents and other relevant process parameters, e.g. acidic or basic pH, often 
becomes crucial [13]. In addition, improved thermostability of enzymes might prevent thermal 
inactivation and conformational changes at higher reaction temperature, which could in turn be 
beneficial to raise turnover rates and substrate concentrations[14–18]. According to the Q10-
rule of thumb, biological systems and enzymes tend to have a Q-factor of 2, i.e. a temperature 
increase of about 10 K results in doubling the reaction rate [19,20]. Contrary, stabilization also 
can lead to more rigid enzymes, which are less active at the same temperature, but show the 
same activity at elevated temperatures. This can be observed when enzymes from 
hyperthermophilic and mesophilic sources are compared with respect to their reaction rates 
[21]. A thermostabilized enzyme might be less active at a certain temperature, but longer active 
at higher temperatures, which allows to apply the Q10-rule on the condition that the activity can 
be maintained for longer time periods at elevated temperatures [22,23]. However, it is also 
possible that a thermostabilized enzyme is not impaired in activity at moderate temperatures 
and is even more active at higher temperatures [24–28]. Arnold et al. demonstrated, that an 
enzyme can be simultaneously developed towards higher stability and activity [23,29–31].  
4) Thermostability engineering of the V. paradoxus ω-TA 
100 
Protein denaturation and degradation due to both heat and solvents are based on the same 
protein unfolding processes. The most important forces for protein stability, which are relevant 
targets for the improvement of protein stability, are intramolecular interactions, i.e. disulfide 
bridges, ion interactions, hydrogen bonds, hydrophobic interactions and core packings [21]. 
The rigidity and flexibility of proteins seem to be the key parameters [32] and both can be 
influenced by using immobilization techniques or enzymatic engineering in order to expand the 
durability of protein applications.  
4.1.2) Techniques for thermostabilization 
The well-known technique to immobilize proteins to gain stabilized proteins is applied for 
antibody to increase the thermostability [33,34]. Beside the improvement of thermostability 
using immobilization techniques, directed evolution is an alternative approach, but the 
existence of a robust high-throughput screening assay for the selected protein is an important 
prerequisite[10,35–40]. For enzymes, activity can be used as parameter for functionality at 
elevated temperatures, but for non-catalyzing proteins a more sophisticated assay or even 
protein purification is necessary. Furthermore, the number of necessary protein variants, created 
by using e.g. error prone PCR or other techniques, is mostly about 103 to 105 and even higher. 
However, in case of enzymes, selection might easily be performed by heating up unpurified 
crude extracts from cells [41]. Using this technique, protein melting temperature Tm can be 
improved in the best screenings by far more than 10°C [42,41,43–46] The artificial evolution 
approach can result in an 140-fold increase in long-term enzymatic activity like demonstrated 
for the alkaline pectate lyase [47]. Also for antibodies or antibody fragments evolutionary 
approaches can be used [48]. For example, the protein melting temperature of a human antibody 
domain was improved by more than 10°C [49].  
Directed evolution can be a successful strategy but might not be applicable at any time, 
especially when missing a high-throughput screening or protein purification for stability 
measurements is necessary. Therefore, this mini-review focusses on protein/enzyme 
engineering for thermostabilization using structure guided site-directed mutagenesis. This 
strategy helps to reduce screening effort and also costs, which is an issue in large screenings. 
Furthermore, we selected the popular FoldX algorithm and would like to answer the question: 
how powerful is FoldX for common protein stability improvements? FoldX is a frequently used 
algorithm and many studies about protein stabilization experiments are described in literature. 
A second reason is the user-friendliness of FoldX, because it can easily be used as plugin in the 
protein structure visualizer YASARA [50]. In contrast to other, command-line based in silico 
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approaches, which are without graphical interface, scientists not familiar with programming 
languages like python, Java, R-script and so on and hide a larger workload for these kind of 
approaches. 
4.1.3) Computational approaches for stability engineering     
Besides FoldX, several other algorithms used for site-directed mutagenesis are also known 
aiming at different inter- and intra-protein interactions. One target is the introduction of 
artificial disulfide bridges into proteins. As a covalent bond, a disulfide bridge is a strong 
physical force which helps to stabilize the 3D-structure within a protein chain or between 
monomers raising the protein melting temperature (Tm) up to 30°C, and can achieve an increase 
of thermal stability by more than 40% at distinct temperature levels [51–53]. However, 
introduction of disulfide bridges can also lower the Tm up to -2.4°C [54]. Starting with the 
protein structure as basis for molecular dynamic simulations and energy calculations, amino 
acid positions can be selected which are potentially suitable for engineering of disulfide bridges. 
However, these approaches need  profound understanding of different prediction and 
calculation software, often without graphical interfaces [55]. Two examples are the algorithms 
for fast recognition of disulfide mutation sites FRESCO and the open access webtool “Disulfide 
by Design 2” (DD2), but only DD2 can be easily used with graphical interface [56–58]. Using 
FRESCO, a temperature improvement of 35°C was achieved due to the combination of single 
disulfide bridges. Jo et al. increased the Tm  of the α-type carbonic anhydrase by 7.8°C due to 
an introduction of a disulfide bond efficiently predicted by DD2 [59]. Albeit the promising 
examples, it has to be mentioned, that the extensive FRESCO strategy cannot be understood as 
an end-user script, but more or less as a blue script for improving thermostability. Wijma et al. 
further improved FRESCO by integrating FoldX and Rosetta as additional energy improvement 
tools and combined these results with an own Dynamic Disulfide Discovery algorithm based 
on molecular dynamic simulations [56]. After in silico elimination of less stable variants, they 
expressed, tested and combined beneficial point mutation sites and disulfide bonds to gain two 
variants with drastically increased Tm of 34.6 and 35.5°C, respectively.  However, this strategy 
is very extensive and many point mutations have to be tested and combined.  
Beside the possible de novo design of disulfide bridges, further computational methods like 
helix dipole stabilization or core repacking exist. Core repacking aims only at the core region 
of proteins to increase hydrophobic interactions. Vlassi et al. showed that a reduction of 
hydrophobic interaction decreases the protein stability [60] and computational tools like 
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RosettaDesign and Monte Carlo simulations are used for the optimization process [61–63]. 
Adapted and automated RosettaDesign framework for repacking are available, but profound 
programming capabilities are needed for applying [63]. In contrast, helix dipole stabilization 
methods lead to improvements of molecular interactions at the end of helices, which can also 
result in drastically increased Tm by more than 30°C [64,65]. However, for this strategy 
elaborate electrostatic calculations and molecular simulations are needed to select mutation 
sites. Beside these strategies, consensus sequences can also help to improve protein stability 
using multiple sequence alignments. In so-called consensus guided mutagenesis, sequences are 
compared according to their amino acid frequencies to elucidate consensus sequences. 
Replacing amino acid residues at certain positions with the most prevalent ones often result in 
highly beneficial energy improvements stabilizing proteins [66][67][68][69]. Huang et al. 
demonstrated that by using consensus approach it was possible to improve the stability of the 
reductase CgKR1 𝑇5015 (temperature at which the enzyme activity is halved within 15 min) by 
more than 10°C [70].  
4.1.4) Un/folding energy algorithms  
At least 22 standalone calculation tools are described for the prediction of beneficial single and 
multiple point mutation sites to reduce the Gibbs free energy of proteins. The broad diversity 
of these standalone software was reviewed by Modarres et al. and beside the mentioned FoldX 
algorithm, other tools like PoPMuSiC, CUPSAT, ZEMu, iRDP web server or SDM were 
mentioned [71–74]. These calculation tools are structure or sequence dependent and use energy 
calculation functions or machine learning algorithms. Also databases collecting changes in 
protein stability (e.g. for Gibbs free energy changes and melting temperatures) are available 
like ProTherm (others are e.g. MODEL, DSBASE), but it should be mentioned that 70% of the 
logged mutations are destabilizing which leads to unintended biases [72,75]. Beside the more 
popular algorithms others are published like mCSM, BeAtMuSiC and ENCoM using different 
calculation approaches [76–78]. Moreover, it is also possible to use crystallographic data gained 
by X-ray analysis of protein structure. The B-factor is an indicator for the flexibility of positions 
within the protein. Reetz et al. used this factor for increasing protein stability [79].  
4.1.4.1) FoldX  
Considering the diversity of available algorithms, it seems to be very difficult to choose an 
efficient tool for protein stabilization. In this review we concentrated on the force field 
algorithm FoldX, which we have used by ourselves to create a more stable ω-transaminase[80]. 
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The force field algorithm, which was originally created by Guerois et al. 2002, became popular 
as webtool in 2005 by Schymkowitz et al. and was refined to the currently last version FoldX 
4.0 [81–83] .  
The software package FoldX includes different subroutines e.g. RepairPDB, BuildModel, 
PrintNetworks, AnalyseComplex, stability and so on. For example the repair function of FoldX 
reduces the energy content of a protein-structure model to a minimum by rearranging side 
chains and the function BuildModel introduces mutations and optimizes the structure of the 
new protein variant. The energy function of FoldX is only able to calculate the energy difference 
in accurate manner between the wildtype and a new variant of the protein [82].  
ΔΔG  = ΔGwildtype – ΔGvariant [kcal mol-1] 
FoldX is also able to calculate total energies of objects, but this function is only valid to predict, 
whether a problem with the structure is given or not. The total energy results are not able to 
predict experimental results [50,82]. The core function of FoldX, the empirical force field 
algorithm, is based on free energy (ΔG) terms aiming to calculate the change of ΔG in 
kcal mol-1. This equation includes terms for polar and hydrophobic desolvation or hydrogen 
bond energy ∆𝐺𝑤𝑏 of a protein interacting with solvent and within the protein chain. Increased 
protein rigidity works against entropy and consequently, results in entropy costs (e.g. loss of 
rotational entropy). 
 ∆𝐺 = 𝑎 ∆𝐺𝑣𝑑𝑤 +  𝑏 ∆𝐺𝑠𝑜𝑙𝑣𝐻 +  𝑐 ∆𝐺𝑠𝑜𝑙𝑣𝑃 + 𝑑 ∆𝐺𝑤𝑏 + 𝑒 ∆𝐺ℎ𝑏𝑜𝑛𝑑 +𝑓 ∆𝐺𝑒𝑙 + 𝑔 ∆𝐺𝑘𝑜𝑛 + ℎ  𝑇𝛥𝑆𝑚𝑐 + 𝑖 ∆𝐺𝑐𝑙𝑎𝑠ℎ  
 
Furthermore the energy algorithm also addresses the free energy change at protein interfaces of 
oligomeric proteins. These term is mainly ΔGkon which calculates the electrostatic contribution 
of interactions at interfaces [82]. The parameters which are important for the energy calculation 
were determined in laboratory experiments, e.g. for amino acid residues and explored on protein 
chains. Beside this distinct parameters the letters of the total energy equation, a to i, represent 
the weights of separate terms [82]. The algorithm works with optimal accuracy when the 
hypothetical unfolding energy difference of the hypothetical energy from a wild-type variant is 
determined in comparison to a mutated protein. For this purpose, FoldX uses the 3D structure 
to calculate the hypothetical unfolding energy. The algorithm was first implemented as free 
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available web server tool and is now a commercially available software, which can be used free 
of charge for academic purposes. As a prerequisite, a highly resolved crystal structure is 
necessary to calculate the energy changes for site-directed mutagenesis experiments. Users can 
also automate the calculations e.g. by using the programming code Python to calculate whole 
protein amino acid exchanges at every distinct position [84,85]. Furthermore, FoldX shows 
very good performance with respect to calculation time even on single core computers. 
Compared to e.g. ZEMu, FoldX needs only half the time for calculating single site mutations 
(calculated on one single processor) and is faster than RosettaDDG [86,74]. As mentioned 
earlier, it can be used with a graphical user interface as plugin tool in YASARA, which opens 
FoldX towards a broad community of researchers.       
4.1.4.2) FoldX-Applications  
FoldX was applied for different stability tests, especially when protein design was performed 
to predict whether distinct mutations are destabilizing. Therefore FoldX shows to be beneficial 
for different approaches and is not strictly limited to a distinct function. Moreover the peptides, 
individual domains and multi-domain proteins can be addressed for experiments [87,88]. The 
algorithm has been used to explain and predict stability improvements when designing solvent 
stable enzymes. The group of U. Schwaneberg designed a laccase with improved resistance in 
ionic liquids for using hardly soluble lignin lysates and increased tolerance towards high 
molarity of salts [89]. Beside its suitability for protein energy calculations, it is also possible to 
calculate the energy changes of DNA-protein interactions [90]. Furthermore, FoldX is 
implemented in a lot of approaches like Fireprot, FRESCO, TANGO or in combination with 
Voronoia 1.0. Voronoia helps to engineer protein core packing and is based on energy 
calculations using FoldX as force field algorithm [91,92]. The program FRESCO (Framework 
for Rapid Enzyme Stabilization by Computational libraries) joins Rosetta with FoldX energy 
calculations and combines single point mutations with disulfide predictions for drastic energy 
improvements of enzymes [56]. The direct alternative to FoldX is the Rosetta energy algorithm. 
It was shown, that Rosetta predicts other possible mutation sites than FoldX for energy 
improvements, but only 25% of all mutations were predicted by both algorithms for the same 
protein [56]. Additionally, the authors of this work excluded 52% of the selected mutations 
manually, e.g. excluding hydrophobic mutations on surface exposed sites and mutations to a 
proline residue or a proline residue to a non-proline residue. At the end around 65% of the 
predicted mutation sites were calculated by FoldX and thereby 35% of all predicted sites were 
discarded. Voronoia in combination with FoldX helps to predict and to explain why 
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hydrophobic interactions in the core region can have a huge impact on protein stability, as it 
was demonstrated for the thermophilic lipase T1 [92]. Another approach is TANGO, which 
helps to predict the aggregation of proteins and, in combination with FoldX, is a powerful tool 
for the investigation of predicted mutations regarding solubility, e.g. protective site-directed 
mutations for the Alzheimers’ αβ peptide [82,93,94]. Furthermore, FoldX can also support 
protein design. For engineering the zinc-finger nuclease, FoldX was used as prediction 
algorithm to detect if the binding energy of a distinct DNA-sequence was increased or decreased 
[95]. Also, FoldX can help to estimate protein-protein binding energy and resulting stabilities 
of protein complexes. Szczepek et al. redesigned the interface between dimeric zinc finger 
nucleases using FoldX as prediction tool [96]. After deeper in silico calculations, only 9.3 % of 
predicted variants were expressed and proved to be beneficial for stability [96]. Considering 
these and other experiments the performance for FoldX should be critically evaluated. 
Therefore, we gathered FoldX experiments and analyzed available publications if FoldX was 
helpful for increasing protein stability (Table 4.1). In general, the amount of standalone FoldX 
calculations for protein stability improvement in literature is relatively low compared to 
approaches, which are using FoldX as an additional tool for stability calculation. Furthermore, 
FoldX is often only used as algorithm for explanations of the impact of mutagenesis in proteins 
with respect to stability or towards predictions of protein-protein or protein-DNA binding. 
Therefore, in table 4.1 only mutations with effects based on FoldX predictions are pointed out, 
even when authors used additional calculation tools. When no pre-selection of distinct protein 
sites are indicated, a complete calculation of every position in the protein was performed. In 
this case, every amino acid was exchanged with the 19 standard amino acid residues. This 
calculation setup results very fast in high numbers of predicted variants. One criterion for 
excluding many variants is to set an energy barrier for ΔΔG between -0.75 and -5 kcal mol-1 for 
stabilizing mutations and for destabilizing mutations of  > + 1 kcal mol-1 in accordance to the 
Gaussian distribution of FoldX predictions (SD for FoldX 1.78 kcal mol-1[94]) [97]. After this 
pre-selection a large number of variants can be excluded. Furthermore, mutations nearby active 
sites, proline residue mutations or variants which seem to be critical for protein structure can 
be also excluded. In addition to manual exclusion of variants, also MD-simulations can be 
performed to exclude more variants. Aiming to indicate the grade of improvement, protein 
melting temperature Tm or half-life activity are frequently used. The largest positive changes in 
stability were reached for the T1 lipase, phosphotriesterase, Flavin-mononucleotide-based-
fluorescent-protein and for the haloalcohol dehalogenase ranging from 8 up to 13°C using 
single site mutations [98]. However, FoldX also allows prediction of destabilizing mutations, 
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which were performed very accurately for the thermoalkalophilic lipase with a negative ΔTm of 
10°C. Noticeably, stabilizing predictions are useful for biotechnology and are therefore 
mentioned in studies with biotechnological background, whereas destabilizing predictions seem 
to be more applicable for human disease studies [94]. Beside mere stability studies, also protein 
design was performed towards specific enzyme-DNA binding or antibody-antigen binding, 
which can reduce the size of antibody libraries for distinct antigen targets. Moreover, FoldX 
can also be used to adapt or to select mutations to increase stability in ionic liquids. For this, 
FoldX calculations were performed with increasing salt concentration during the simulations, 
but currently no further experiments towards ionic liquid improvement can be found. In 
literature also numerous examples can be found dealing with diseases caused by protein 
mutations. These investigations aim to prove whether human proteins are less stable with a 
mutation compared to the wild-type or might interact differently with other proteins [99–101].  
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Table 4.1 Summary of different FoldX applications for single point mutations regarding stability and ligand binding. The changes achieved i.e. Tm is listed for 
changes in protein melting temperature. ΔΔG displays the change in free energy by mutation/design of proteins. “Criteria” describes the settings for experiments. 
“Cut-off” means, that the authors excluded those indicated FoldX predictions (with a higher or lower ΔΔG) from further experiments. ΔΔG is defined as: ΔΔG = 
ΔGfold(mutation)-ΔGfold(wild type) 
Aim of the 
study 
 Protein/Source Criteria Number of 
tested 
predictions 
Number of 
correct 
predictions 
Greatest impact Resolution 
crystal 
structure  
Ref. 
Enzyme 
stabilization  
 Endoglucanase (Hypocrea jecorina) Cut off value < 
ΔΔG -1.75  kcal mol-
1) 
43  6  Stabilization (ΔTm = 
3.2°C) 
1.62 Å [102] 
Enzyme 
stabilization 
 Phosphotriesterase (Pseudomonas 
oleovorans) 
Cut off value < 
ΔΔG -0.72  kcal mol-
1) 
52  32  Stabilization (ΔTm =8.6°C) 2.25 Å  [103] 
Enzyme 
stabilization  
 T1 Lipase (Geobacillus zalihae) One mutation site was 
selected and 
exchanged against 
Val, Ile, Met, Phe, Trp 
compared to wild type   
7  1  Stabilization (+ΔTopt-= 
10°C) 
1.5 Å [92] 
Enzyme 
stabilization 
 Thermoalkalophilic lipase (Bacillus 
thermocatenulatus) 
3 sites preselected and 
amino acids were 
exchanged against 
Phe, Try and Trp.  
9  2 Destabilizing variants 
(ΔTm = - 10°C)  
2.0 Å [104] 
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Enzyme 
stabilization 
 Haloalkane dehalogenase (WT and 
one mutant) Sphingomonas 
paucimobilis 
Cut off value < ΔΔG -
0.84 kcal mol-1) + 
visual inspection and 
MD-simulation  
Less than 150 5 Stabilization (ΔTm = 3°C) 
 
0.95 Å  [105] 
Enzyme 
stabilization  
 Limonene-1,2-epoxide hydrolase 
(Rhodococcus erythropolis) 
Cut off ( ΔΔG < - 1.2 
kcal mol-1) 
performed 
additionally further 
pre-selection 
21 6  Stabilization  ΔTm = 6°C 
 
1.2 Å [56] 
Enzyme 
stabilization 
 Cellobiohydrolase (Hypocrea 
jecorina) 
43 mutations selected 
( ΔΔG < -0.75 kcal 
mol-1) 
43 10 Stabilization ΔTm = 0.7°C 2.35 Å [69] 
Enzyme 
stabilization 
 ω-transaminase (Variovorax 
paradoxus ) 
Cut off value ΔΔG < -
6.5 kcal mol-1 
11 3 ΔTm = 4°C 2.28 Å [80] 
Enzyme 
stabilization 
 Amine transaminase (Aspergillus 
terreus) 
B-factor was used as 
pre-filter for FoldX 
predictions towards 
stabilization 
19 6  Stabilization Δ𝑇1/210𝑚𝑖𝑛= 
3.5°C 
1.63 Å [106] 
Enzyme 
stabilization  
 Laccase (Trametes versicolor and  
fungus PM1) 
Molecular dynamic 
averaged structures 
were used for FoldX 
calculation  
11 Standard deviation max. 
ΔΔG < 1 kcal/mol-1 
ΔTm = 3-5°C 
 
2.4 Å [107] 
Enzyme 
stabilization 
 Haloalcohol dehalogenase 
(Agrobacterium tumefaciens) 
Cut off ( ΔΔG < -1.2 
kcal mol-1) 775 
mutants were 
predicted by FoldX 
and reduced using 
55 29 Stabilizing ΔTm = 13°C 
 
1.9 Å [98] 
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Rosetta-dgg and MD-
simulation  
Enzyme 
stabilization  
 Chalcone synthase (Physcomitrella 
patens) 
Calculation of total 
energy ΔG = -63 up to 
67 kcal mol-1 
Single site variant  
19 2  1 variant showed high 
thermal stability  
Homology 
modeling 
[108] 
Enzyme 
stabilization 
 Carbonyl reductase (Streptomyces 
coelicolor) 
Variants with ΔΔG < 
- 4 kJ mol-1 were 
selected 
3 1  Stabilization of Δ𝑇5015 =1.3°𝐶 1.6 Å [109] 
Enzyme 
stabilization 
 Peptide Amidase (Stenotrophomonas 
maltophilia) 
Cut off value ΔΔG < -
5 kJ mol-1  
44 6 Stabilizing ΔTm = 6°C  1.8 Å [110] 
Enzyme 
stabilization 
and comparison 
to other tools 
 Penicillin G acylase (Escherichia coli) Not reported -  21 8  - 1.9 Å  [111] 
Enzyme 
destabilization 
 Triosephosphate isomerase 
(Saccharomyces cerevisiae) 
Selection of all 
energy predictions 
between ΔΔG = 3 – 
8.5 kcal mol-1 
23 6  No correlation between T1/2 
and ΔΔGFoldx observed  
1.9 Å [112] 
Protein-Protein 
interaction 
prediction  
 SH2 domain (Gallus gallus)  Random sequences 
for binding  
50,000 Area under the ROC 
curve 0.79 (accuracy)   
FoldX can predict better 
than random binding 
events 
2.1 Å [113] 
Improvement 
of DNA 
binding 
 Zinc finger nucleases (Homo sapiens) Cut off value < ΔΔG -
5 kcal mol-1) 420 
predicted engineering 
sites  
420  60 % (low binding 
energy) 
95 % (high binding 
energy) 
Improved DNA binding (-
13 kcal mol-1) 
1.6 Å [95] 
4) Thermostability engineering of the V. paradoxus ω-TA 
110 
Cut off value < ΔΔG - 
10 kcal mol-1 
Protein 
stabilization 
 Anti-hVEGF antibody (Homo 
sapiens) 
Single point 
mutations no cut off 
value reported  
60  40% of tested sites were 
more stable  
Stabilization (+ΔTm = 
2.2°C (single site)) 
ΔTm = 7°C (combination) 
Structure 
modeling  
[85] 
Destabilization 
of salt bridges  
 Subtilisin-like proteinase (Thermus 
aquaticus) 
Salt bridge amino 
acids were mutated to 
Phe, Gln, Asn, Glu. 
FoldX calculation 
were performed 5 
times and averaged 
for each mutation. 
8  6    Highest destabilization (-
ΔTm = -8.8°C)  
1.55 Å [114] 
Protein 
stabilization 
 Growth factor 2 (Homo apiens) Cut off ( ΔΔG < - 1 
kcal mol-1)  
5 2  
 
Stabilization ΔTm = 3.7°C 
 
1.6 Å [115] 
Protein 
stabilization  
 Flavin mononucleotide based 
fluorescent 
Protein (Bacillus subtilis) 
Cut off ( ΔΔG< -1 
kcal mol-1) performed 
additionally further 
pre-selections  
22 15 Stabilization ΔTm = 11.4°C 
 
Resolution 
under  2.2 Å 
[116] 
Protein 
stabilization 
 Endolysin PlyC (Bacteriophage) Cut off ( ΔΔG < -1 
kcal mol-1) 92 
mutants were 
determined by FoldX 
and reduced by visual 
inspection and by 
Rosetta  
12 3  Stabilization ΔTm = 2.2°C 
 
3.3 Å refined 
using Rosetta 
Relax  
[117] 
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Protein 
stabilization 
 Database (known mutations) Cut off value Δ∆G < -
1.0 kcal mol-1 
30 20  n.d 1.5 to 2.25 Å [86] 
Protein 
destabilization 
 Repair protein MSH2 (Homo sapiens) Cut off value (ΔΔG > 
5 kcal/mol-1) 
24 22  Destabilization of > 3 kcal 
mol-1  
3.3 Å [84] 
Protein 
destabilization  
 cblA-type methylmalonic aciduria 
(Homo sapiens)  
Cut off value ∆∆G 
between 3.48 to 
11.15 kcal mol-1 
22 22 - 2.64 Å [118] 
Investigation of 
proline 
influence on 
stability 
 fungal chimeric cellobiohydrolase 
Cel6A (Humicola insolens) 
ΔΔG of exchanges of 
wild type amino acid 
against Pro exchange 
was calculated  
17  57 % were predicted 
correctly as 
destabilizing 
43 % as stabilizing 
Destabilization ΔTm = - 
4°C  
Stabilization ΔTm = +4°C  
 
 
1.3 Å  [119] 
Influence of 
core residue 
substitutions on 
stability 
 Glycoside-hydrolase (Neisseria 
polysaccharea) 
Settings not reported. 
133 (7 sites) mutants 
were investigated 
towards stabilization 
or destabilization  
57 (stabilizing) 
76 (rest) 
9 (stabilizing) 
24 (destabilizing)  
Stabilizing up to ΔTm = 2° 
-Destabilizing ΔTm = - 6°C  
 
 
1.4 Å [120] 
Validation of 
estimations 
using FoldX 
 Laccase (T. versicolor) 2 sites selected as 
targets for stability in 
Ionic liquid 
2 2 1 variant showed stability 
improvement in ionic 
liquid 
2.4 Å [89] 
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4.1.5) Accuracy of FoldX 
From the FoldX studies summarized in table 4.1 it can be deduced that the crystal-structure 
quality is crucial for accurate calculations. From a benchmark test on myoglobin mutants 
Kepp (2015) concluded that some protein stability predicting algorithms are extremely sensitive 
towards crystal structure quality and some are very robust [121]. It seems plausible that 
interactions are in the order of atomic resolutions and therefore the crystal structure quality has 
an important influence on energy calculations [107,121–123]. However, for the prediction 
algorithms PoPmuSic, I-Mutant 3.0 and other tools the influence of the crystal structure quality 
was only in the order of 0.2 kcal mol-1 (standard deviation using different structure data of 
superoxide dismutase 1) [123].According to Christensen et al.. FoldX belongs to the more 
structure sensitive methods  and Kepp suggested to use only structures solved in scales of near-
atomic-resolutions [107,121]. With reference to table 4.1, all cited studies were based on crystal 
structures with an resolution better than 3.3 Å and an average resolution of 1.87 Å which is 
nearby atomic resolution (1 Å is approximately the diameter of an atom plus the surrounding 
cloud of electrons). Furthermore, also protein-protein interactions might have an influence on 
the prediction power, which are not addressed in some performance studies like from Tokuriki 
et al., because only monomeric proteins were selected [124], but e.g. Pey et al. and Dourado et 
al. showed that also oligomers can be utilized for calculations (using extra terms: ΔGkon 
electrostatic interaction, ΔStr translational and rotational entropy) [74,125]. The root-mean-
square deviation (RMSD) in a dataset of protein complexes, with known energy impacts, was 
determined to be 1.55 kcal mol-1 (for single mutants) [74]. In contrast the algorithm ZEMu 
addresses such mutations on interfaces better than FoldX [74].   
Based on experimental results, it can be concluded that the prediction of destabilizing mutations 
is more accurate than prediction of stabilizing mutations. After pre-selection of experiments 
with the aim to increase stability, it can be concluded that the approximate success rate for 
mutations predicted as stabilizing (according to their negative ΔΔG-values) is only 29.4% 
(focusing on 13 single mutation experiments). For experiments with focus on detection of 
destabilizing mutations or for simple proof of destabilizing events, sample size is only five but 
the average success rate is 69%. However, with regard to the small sample size a valid statement 
about success rates cannot be made. It is likely that many unsuccessful experiments were not 
published and therefore, the real success rate might be much lower. Khan et al. evaluated the 
performance of 11 protein stability predictors by using a dataset containing more than 1,700 
mutations in 80 proteins which were taken from ProTherm database. It was shown that FoldX 
was among the three most reliable algorithms for stability increasing cases (ΔΔG ≤ 
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- 0.5 kcal/mol), predicting 86 true positives, 133 false positives, corresponding to a success rate 
of 39.2 % for stabilizing mutations. Only Dmutant and MultiMutate were comparably 
successful in predicting stabilization events [101].  
Compared to other results, this success rate might be higher than expected. As an example for 
an investigation of the performance of an adapted FoldX algorithm, laccase isoenzymes were 
used. The large calculation setup included 9,424 FoldX predictions per isoenzyme using an 
adapted algorithm. These calculations were evaluated by using molecular dynamic simulations 
and additional different settings within FoldX were tested. Like mentioned before, the authors 
remarked that FoldX needs high-resolution crystal structures of proteins and that FoldX 
performs well in predicting stability trends, but not in a quantitative accuracy [75]. Using the 
deciphering protein (DPP) as an example, Kumar et al. showed on the basis of 54 DPP mutants 
how accurate the prediction power of FoldX is compared to other tools. The study focused on 
destabilizing mutation events, which were described in medical data sets of DPP and concluded 
that the R-value (correlation coefficient) was only 0.45 to 0.53. The quality of the crystal 
structures in this study ranged between 1.07 and 1.93 Å [76]. Potapov et al. utilized for 
performance investigation a protein database set regarding 2156 variants in 59 proteins. The 
crystal structure qualities were not reported. However, they concluded that 81.4 % of Tm 
changes were qualitatively predicted correctly [126].  
Furthermore Potapov et al. headlined their work for analyzing different protein stability tools 
“Assessing computational methods for predicting protein stability upon mutation: good on 
average but not in the details”, and proved that FoldX has potential to predict if a certain 
mutation is stabilizing or destabilizing, but its prediction power decreases, when ∆∆G is 
correlated with ΔΔGexperimental or with stability parameters like Tm [126]. The correlation 
coefficient R, plotting ΔΔGtheoretical against ΔΔGexperimental values from databases was only 0.5 
(for negative and positive ΔΔG), but it also depends on the crystal structure and on the nature 
of the protein [126].  
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Table 4.2 Summary of different algorithms evaluated in performance tests considering prediction 
accuracy in comparison to experimentally investigated mutations and calculated statistical parameters. 
This table displays reported standard deviations of predicted true positives and true negatives. Accuracy 
is defined as ratio of true positives/true negatives to the total number of predictions. R-values 
(correlation coefficients) describe how precisely the predicted energies fit to database values.   
Algorithm Standard deviation  Accuracy range (min.-max.) R-values 
FoldX 1.0to 1.78kcal mol-1 [127] 
[94] 
0.38 to 0.8[128] 
Average Accuracy: 0.69 [86,103,126,129] 
0.29[130] to 
0.73[127] 
BeatMuSiC 1.2 kcal mol-1 [76]  0.46[76] 
CUPSAT 1.8 kcal mol-1 [76] 0.5 [101]  0.3[76] 
I-Mutant 
2.0/3.0 
1.2 to 1.52 kcal mol-1[76] 
[94] 
0.48[101] to 0.75[126] 0.16[76] to 
0.51[94] 
PoPMuSiC 1.1 kcal mol-1 to 1.32 [76] 
[94] 
0.62[129] to 0.85[129]  0.51 to 
0.55[94]  [76]   
mCSM 3.2 kcal mol-1 [76]  0.23[76] 
ENCoM 1.5 kcal mol-1 [76]  0.04[76] 
Rosetta-ddG 2.3 kcal mol-1 [94]  0.71[126] to 0.76[86] 0.26 [126] to 
0.54 [94]   
 
For better comparison, we summarized statistical parameters given for the different algorithms 
derived from Kumar et al, and other studies (as indicated) in table 4.2, but not for every 
algorithm we were able to find a full set of data. For example, Kumar et al. analyzed the 
predictive power of eight different tools,  i.e. PoPMuSiC 3.1, BeatMuSiC, CUPSAT, I-Mutant 
2.0/3.0, mCSM, ENCoM and FoldX, using the example of the human superoxide dismutase1 
[73] which is involved in the motor neuron disease [131].  In this benchmark test FoldX and 
PoPMuSiC performed best by far. FoldX showed in this test a correlation coefficient R of 0.53 
and a standard error of 1.1 kcal mol-1, which was only slightly surpassed by PoPMuSiC [76]. 
In conclusion, the authors described FoldX as more sensitive and accurate towards difficult 
mutation sites but PoPMuSiC as more accurate to all kinds of mutations. Also, they 
demonstrated that FoldX can interpret patient data for dismutase diseases quite well with an R 
of 0.45 compared to other tools. Bednar et al. compared FoldX with Rosetta-ddG, ERIS and 
CUPSAT [86] and determined FoldX and Rosetta-ddG as best algorithms for improving 
stability. Foit et al. showed for the immunity protein 7 that FoldX was able to predict 
destabilizing mutations very well (Coefficient of determination (R2) of 0.62), but the algorithm 
was unable to predict the influence of stabilizing mutants. However in comparison to I-Mutant 
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2.0, PoPMuSiC and Eris, FoldX showed a better performance for prediction of destabilizing 
mutagenesis events (R²-values of : 0.34, 0.24, 0.3) [132]. Tian et al. and by Broom et al. 
determined the R-value of FoldX with known true positives and true negatives to be 0.5 with 
an accuracy of 0.67 [97,127]. Ayuso-Tejedor et al. determined R-value with 0.20 to 0.29 for 
the corresponding mutants against predicted negative ΔΔG-values [130]. In contrast, by 
investigating 582 mutants of seven proteins, R was 0.73 with a standard deviation of 1.02 kcal 
mol-1 [133]. The best result was a correlation coefficient of 0.73 for a lysozyme structure [126] 
and was increased to 0.74, when only hotspot areas were chosen for prediction. The standard 
deviation (1.37 kcal mol-1) was in the same range of Broom et al. (1.78 kcal mol-1) [127]. 
However, Tokuriki et al. calculated that the average ΔΔG for any protein is + 0.9 kcal mol-1 
ΔΔG, which clearly shows, that the probability of destabilization events is much higher, which 
concludes that the number of stabilizing theoretical mutants is much lower [134]. Not only the 
number of theoretical stabilizing mutations seems to be lower, also the correlation for predicted 
stabilizing mutations towards real stabilization is weaker than for destabilizing mutations 
[56,111]. In contrast, Khan et al. showed for human proteins that FoldX predicts more stability 
increasing variants than destabilizing variants, which might be a hint that human proteins are 
relatively non-rigid and less thermostable compared to other protein sources or that distribution 
of ΔΔGcalculated against the frequency of stabilizing and destabilizing mutations is only protein 
depending [101]. Furthermore, the calculated ΔΔGFoldx energies deviate from real ΔΔG 
measurements. The values can be recalculated using an experimental factor ΔΔGexperimental = 
(ΔΔGcalculated +0.078) 1.14-1 [134,135]. Depending on the method used to evaluate FoldX, the 
accuracy will be in the range from 0.38 to 0.80 [101,129]. Obviously, FoldX can predict 
positions which are important for stability, but the discrimination between different amino acid 
residues at one site is not really powerful, e.g. an exchange of lysine to glutamate did not result 
in any change of ΔG, but experimentally a stabilization was observed [120,128]. The 
summarized results in table 2 demonstrate that actually all algorithms are not able to design or 
predict single mutation events towards trustworthy one mutation protein designs. However, 
FoldX shows a good performance in most of the studies compared to other algorithms, but it is 
necessary to increase the number of experimental mutations above 3 to achieve probable true 
positive results for protein engineering experiments. A general disadvantage of FoldX and other 
algorithms seems to be that FoldX often predicts hydrophobic interactions but at the expense 
of protein solubility [94].  
4) Thermostability engineering of the V. paradoxus ω-TA 
116 
4.1.6) The next generation of FoldX based predictions 
Due to the low accuracy of all algorithms for stabilization mutations, algorithms often are 
combined to find coincident predictions or to prove predictions with a second algorithm. A 
popular combination is FoldX and Rosetta-ddG to gain more stabilizing mutation predictions. 
It was shown that FoldX and Rosetta-ddG predictions overlapped only  in 12 %, 15% or 25 %, 
respectively, which means that a good coverage of beneficial mutations can only be achieved 
when more than one tool is used [86,56,105]. As a consequence of low prediction accuracy, 
popular algorithms are continuously improved. Recently a refinement of the Rosetta energy 
algorithm was reported with increased accuracy and faster calculation times. This demonstrates 
also the continuing importance of stability prediction in the field of protein engineering, but the 
authors stated that it is still far away from a final gold standard in the field of energy content 
prediction [136]. 
A sophisticated approach is the freeware webtool FireProt [137]. The FireProt algorithm uses 
FoldX as a pre-filter to select beneficial mutations which are subsequently proved in a second 
round using Rosetta-ddG. Only if Rosetta-ddG also predicts these mutations as putatively 
stabilizing they will be used for the experimental realization of these amino acid exchanges. 
Furthermore, the algorithm uses a consensus analysis of the protein-sequences to predict 
evolutionary beneficial mutation sites towards stability. These selected sites are then evaluated 
for their suitability using FoldX. The algorithm is divided into three stages using different 
methods for crosschecking the accuracy of the calculations and combines putative beneficial 
mutations to gain further improvement of stability. The free webtool of FireProt allows even 
inexperienced users to perform protein energy calculations. Bednar et al. demonstrated at two 
examples the utility of this algorithm using the example of two enzymes and combined many 
mutation sites with overall improvements of ΔTm of 21°C and 24°C for the combination of all 
sites [86]. However, to verify if FireProt is useful or not, more studies are necessary. 
Furthermore, the core function of FoldX algorithm does not simulate backbone movements of 
the protein, which might be a potential factor to improve FoldX [74]. The stability prediction 
tool of Goldenzweig et al. might be an alternative to the mentioned Fireprot -algorithm. Similar 
to Fireprot, it combines information gained in sequence homology alignments and of energy 
calculations using crystal structure data and Rosetta-ddG. Using the human 
acetylcholinesterase, an improvement in stability (ΔTm = 20°C) was demonstrated and 
simultaneously, the expression level in E. coli BL21 was increased. They hypothesized, that 
putatively destabilizing mutations can be excluded from mutation libraries using homologous 
sequence alignments to prohibit certain types of amino acid exchanges [138]. 
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4.1.7) Conclusion 
The performance of FoldX depends drastically on the quality of the crystal structure and it is 
unclear if the protein source might have an influence on the accuracy of such algorithms. 
Nevertheless, FoldX seems to be more accurate for the prediction of destabilizing mutations 
and less accurate for the prediction of stabilizing mutations, but in both cases it was shown that 
FoldX is clearly better than random approaches: e.g. Christensen et al. described FoldX as one 
of the most accurate single site stability predictors and Potapov et al. even described the 
accuracy of FoldX as impressive compared to other algorithms [122,126]. The natural success 
rate for random mutagenesis is only ~2%, which was surpassed by most experiments [94,139]. 
Therefore, FoldX seems to be a promising tool for protein design, but as mentioned by Thiltgen 
et al. it can be said that FoldX cannot serve as a gold-standard for generally improving stability 
of proteins. Moreover, using FoldX together with other algorithms for reciprocal control of 
calculation results, Rosetta-ddG or PoPmuSiC as filter for true positive results will most 
probably increase the accuracy and the success rate of thermostability engineering 
[86,127,140]. In general the accuracy can be improved additionally, when mutation outliers are 
eliminated or additional MD-simulations are performed [82]. FoldX was used successfully in 
different approaches (Table 4.1) aiming from enzyme stabilization towards predictions of 
protein-protein interactions (especially for drug design) or for the prediction of disease-
associated mutant proteins, making FoldX a versatile tool for life science [80,141–143].The 
progress in protein stability prediction is striking, however up to now no in silico calculation 
can fully spare experimental procedures, although the existing tools can reduce the amount of 
lab experiments significantly.  
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4.2) Thermostabilization of the V. paradoxus ω-TA using FoldX 
 
This chapter is based on the modified pre-peer reviewed version of the following publication. 
Furthermore unpublished experiments regarding disulfide bond engineering were included:  
  
Improvement of the thermostability of a β-amino acid converting ω-transaminase using 
FoldX. 
Oliver Buß a, Delphine Muller a, Sven Jager b, Jens Rudat a and Kersten S. Rabe c  
a Institute of Process Engineering in Life sciences, Section II: Technical Biology, Karlsruhe 
Institute of Technology, Karlsruhe Germany. b Computional Biology Technische Universität 
Darmstadt, Schnittspahnstraße, 64287 Darmstadt. c Institute for Biological Interfaces I, 
Karlsruhe Institute of Technology (KIT), Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-
Leopoldshafen, Germany 
 
 
Publishing details: 
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http://onlinelibrary.wiley.com/doi/10.1002/cbic.201700467/abstract 
Author-Rights:  “This is the pre-peer reviewed version of the following article: [O. Buß, D. 
Muller, S. Jager, J. Rudat, K. S. Rabe, ChemBioChem 2018, 19, 379.], which has been 
published in final form at doi.org/10.1002/cbic.201700467. This article may be used for non-
commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.” 
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4.2.1) Introduction on the thermostabilization of ω-transaminases  
 
The outstanding importance of ω-TA for synthesis approaches makes them a rewarding target 
for enzyme engineering to improve the characteristics of them. Like mentioned in chapter 1.3, 
there are a lot of possibilities to utilize different ω-TA for synthesis of chiral amines and amino 
acids. However, they differentiate in the enantiopreference, which is accompanied by the Fold 
types IV (R) and I (S) of PLP-dependent enzymes [144,145]. The acceptor molecules can vary 
from classical α-keto acids to β-, γ- or ε-keto acids and even ketones and aldehydes are 
converted by this class of enzymes [146].  
Although there is an increasing number of ω-TA being described, certain limitations concerning 
the substrate scope and physicochemical properties such as stability are still hampering their 
application. The pool of (R)-selective ω-TA is still much smaller than for (S)-selective ω-TA 
and especially more bulky substrates are still challenging. To overcome the latter limitation, the 
pharmaceutical companies Merck and Codexis performed a sophisticated directed evolution of 
an (R)-selective ω-TA to gain an enzyme with activity towards the substrate prositagliptin. In 
this process the activity, solvent stability and thermostability were improved by several rounds 
of random and site directed mutagenesis experiments [147]. In total 27 mutations were 
introduced into the ω-TA, which originates from Arthrobacter sp. KNK 168. There are further 
examples for the redesign of an (S)-selective ω-TAs by Midelfort et al. and Pavlidis et 
al.[42,148] Midelfort et al. redesigned an (S)-selective ω-TA from Vibrio fluvialis towards 
higher activity to the aliphatic β-keto ester substrate, ethyl 5-methyl 3-oxooctanoate, and 
towards higher stability in organic solvents.  
4.2.1.1) Thermostability of ω-TA 
Apart from engineering the substrate scope, improving the stability of an enzyme can lead to 
more efficient production processes and enable the enzyme to tolerate more mutations in 
general. Deepankumar et al. have shown the incorporation of the non-canonical α-amino acid 
fluoro-tyrosine in an (S)-selective ω-TA from Vibrio fluvialis. The resulting enzyme showed an 
increase in thermostability about 2.3 fold as compared to the wild type. The experiments were 
performed at an incubation temperature of 50°C and the researchers observed an improved half-
life time of 7.0 h in comparison to 3.0 h for the wildtype enzyme. However, the melting 
temperature was not reported [149]. Pannuri et al. utilized 5 cycles of error prone PCR and 
screening, resulting in an enzyme, based on an (S)-selective-ω-TA (CNB05-01) from 
Arthrobacter citreus, with improved stability. This was mainly due to an important exchange 
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of a cysteine to a tyrosine residue located near the active site. Topt has been enhanced from 30°C 
to 55°C and increased the activity about 260-fold, without compromising the enantioselectivity 
[150,151]. A rational thermostabilization strategy has recently been shown for the fold type IV 
(R)-selective ω-TA from Aspergillus terreus by calculation of ΔΔGfold, combined with the 
crystallography B-factor set as a pre-filter for ΔΔGfold calculations resulting in 2.2 fold half-life 
improvement at 40°C with a single mutation [152]. 
Apart from engineering ω-TA from mesophilic sources, thermostable variants can in general 
also be established by screening enzymes from thermophilic organisms. The first (S)-selective 
ω-TA which was labeled as thermostable was discovered by an in silico screening in the 
thermophilic microorganism Sphaerobacter thermophilus. This enzyme showed a remarkable 
stability retaining its full activity at 60°C for at least 2 h [153]. The same research group 
identified and characterized a thermostable ω-TA with activity towards amines using a modified 
NCBI-blast search in the thermophilic microorganism Thermomicrobium roseum. This enzyme 
showed a Tm of 87°C [154]. The ω-TA lost only half of the initial activity after 12.5 h of 
incubation at 60°C. Ferrandi et al. discovered three thermostable ω-TA from hot spring 
metagenomes, with the best being a ω-TA from an unknown microorganism, labeled as B3-TA, 
with a Tm of 88°C [155]. This enzyme is very robust and shows a long-term stability at 80°C 
for at least 2 weeks, losing only 60 % of its initial activity under these conditions. The other 
two enzymes, Is3 and It6 showed a Tm of 79°C and 57°C, respectively.  
In summary, up to now only five (S)-selective ω-TA are described exhibiting high 
thermostability and only one of these ω-TA from S. thermophiles showed activity towards rac-
β-phenylanine (β-PA). β-PA and derivatives thereof, could be also utilized in β-peptides, as 
inhibitor for peptidase IV and in drug delivery systems [158–160]. The β-PA converting ω-TA 
from S. thermophiles shows only a low activity of 3.3 U mg-1 compared to ω-TA from 
V. paradoxus with a specific activity of 17.5 U mg-1 at 37°C [161]. Thus the transaminase from 
V. paradoxus is an interesting candidate for enzyme engineering taking into account its high 
enzymatic activity and lack of data concerning thermostabilization.  
 
The aim of this study was the optimization of the thermostability of the V. paradoxus 
transaminase (ω-VpTA) using an in silico approach in combination with site directed 
mutagenesis to generate an enzyme with a longer life time at temperatures above 50°C. The 
FoldX software was utilized to identify potentially stabilizing mutations in order to reduce 
necessary sample throughput and to avoid large enzyme libraries and the corresponding need 
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for a high throughput screen [162]. FoldX can be used to calculate the change in free energy 
caused by an amino acid substitution and to predict the change in the free energy to fold/unfold 
(ΔΔG) a protein [162]. We sequentially exchanged every amino acid position in ω-VpTA 
against any standard α-amino acid and performed the free energy calculations. The hits with 
highest beneficial energy stabilization were selected for site directed mutagenesis. Variants with 
high activity in cell lysate were purified and characterized in detail regarding their 
thermostability and specific activity. Furthermore the long-term activity was studied and 
compared to that of the wild type enzyme.  
As alternative and additional approach also disulfide bond engineering was performed. In 
contrast to FoldX engineering also the introduction of covalent disulfide bonds is possible. 
Therefore the MD-calculations of 4AOA were analyzed to detected amino acid positions which 
are nearby but not protein sequential neighbors.  
 
4.2.3) Methods and Materials 
 
Chemicals 
Unless stated otherwise all chemicals were purchased from Sigma Aldrich (St.Louis, US) and 
Carl Roth (Karlsruhe, Germany) in analytical grade. All enantiopure β-amino acids were 
purchased from PepTech Corporation (Bedford, US). 
FoldX Setup 
In order to calculate the change in free energy of unfolding, the FoldX 3.0 algorithm was applied 
[162]. As starting point the PDB structure 4AOA of ω-VpTA was used [161]. The in silico 
temperature was set to 298 K. After applying the automatic RepairPDB function, all mutations 
were created using the FoldX-function BuildModel. In order to automate this process a script 
written in Phyton was utilized to change every single amino acid position into all standard α-
amino acids possible. Other options were set to default.  All resulting data for every position 
was ranked from lowest to highest ΔΔG. The best nine hits showing the lowest ΔΔG were 
chosen for mutation experiments and in addition two amino acid exchanges were selected which 
showed a high energy benefit in the terms of the FoldX energy function and a relatively high 
ΔΔG.   
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Mutagenesis PCR 
The mutations were generated by site directed mutagenesis PCR employing a touch down PCR. 
10 PCR cycles were performed decreasing the annealing temperature by 0.5°C each cycle, 
followed by 25 cycles at the calculated melting temperature of the primers. The utilized 
oligomer primers are displayed in table 4.3 and table 4.4 for mutation experiments regarding 
artificial disulfide bonds. PCR reaction mixture was mixed according to the protocol of the 
Phusion DNA polymerase (Thermo Fischer Scientific, USA) and additionally each PCR run 
was performed with and without of 3 % (v/v) DMSO. In order to remove the initial DNA vector 
template, 1 µL of the endonuclease DpnI (NEB, USA) was added to the PCR product and the 
mixture was incubated for at least 1 h at 37°C. Subsequently 10 µL of the PCR product was 
transformed into 90 µL of chemical competent Escherichia coli XL10 Gold (Agilent 
Technologies, USA ) cells. Single colonies were sequence verified by DNA sequencing of 
purified vector DNA (GATC, Germany).  
Table 4.3 Oligomers for site directed mutagenesis of FoldX predicted mutations. The oligomers were 
ordered from Thermo Fischer Scientific. They were designed only to overlap partially.   
Position Exchange Tm Direction primer-sequence 
19 D to M 64°C fw ATCGTCGTTTTACCATGGCAAATCCGGCAAGC 
19 D to M 64°C rv GGTAAAACGACGATATGCATCTGCCAGTGCC 
98 G to M 62°C fw TATTGAAGCAATGCAGATGGGTATTAATCTGACAG
GTCAT 
98 G to M 60°C rv CTGCATTGCTTCAATAACTGCATCACGAATTTCC 
165 G to M 64°C Fw CATGGTGGTGTTCTG ATG TTTGGTGCACGTCC 
165 G to M 64°C Rv CAGAACACCACCATGATAACCACCGCTAAAAACAA
CA 
243 M to R 64°C Fw CTGGTTTTTGATGAAGTT CGT ACCAGTCGCCTGGC 
243 M to R 63.2°
C 
Rv AACTTCATCAAAAACCAGCAGTGCACCAACCTG 
325 G to D 64°C Fw CCGGAAGCAGCCGATGCACTGGCCGAA 
325 G to D 64°C Rv GGCTGCTTCCGGTGTAAACAGTTTGGTC 
345 E to F 62°C Fw GCACTGTGTGCAAAT TTCGGTGTTGCAATGC   
345 E to F 62°C Rv ATTTGCACACAGTGCATTCAGACGGGC 
391 E to R 61°C Fw TTTTTCATCTGCTGAATAGAGATATCTATAGCAGTC
CG 
391 E to R 61°C Rv ATTCAGCAGATGAAAAAACAGCAGCTGACG 
392 D to K 62°C Fw TTTCATCTGCTGAATGAAAAGATCTATAGCAGTCC
GC 
392 D to K 62°C Rv TTCATTCAGCAGATGAAAAAACAGCAGCTGACG 
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395 S to I 62°C Fw CATGGTGGTGTTCTG ATC TTTGGTGCACGTCC   
395 S to I 62°C Rv ATAGATATCTTCATTCAGCAGATGAAAAAACAGCA
GCTG 
408 D to D 64°C Fw GCCTGCCGCTG GAT GATGCCGATATTGATC 
408 D to D 64°C Rv CAG CGG CAG GCT CAG AAC AAC AAA ACC AC 
420 G to E 62°C Fw GTGGCAGCGATT GAG AGCTTTATTGGTGGT 
420 G to E 60°C Rv AATCGCTGCCACATAACGATCAATATCGG 
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Table 4.4 Oligomers for site directed mutagenesis of disulfide-bond engineering sites. The oligomers 
were ordered from Thermo Fischer Scientific. They were designed only to overlap partially. *different 
variants were utilized for mutagenesis PCR. High differences between Tm of oligomer primer pairs are 
a result of high degree of mismatch of the mutagenesis Fw-primer.  
Position Exchange Tm Direction primer-sequence 
5 A to C 56 °C Fw ATGATGACCCATGCATGTATTGATCAGGCACTG 
5 A to C 56 °C Rv TGCATGGGTCATATGGGTG 
59 A to C 60 °C Fw CACGTGGTGAAGGTTGCGCACTGTGGGATGCAG 
59 A to C 61 °C Rv ACCTTCACCACGTGCAATGGTCA 
90* D to C 61 °C Fw CACCGGAAATTCGTGTTGCAGTTATTGAAGCAAT* 
90* D to C 64°C Rv CACGAATTTCCGGTGCGCTATGACCAT 
92 V to C 64°C Fw GGAAATTCGTGATGCATGTAATTGAAGCAATGCAG
GGTG 
92 V to C 64°C Rv TGCATCACGAATTTCCGGTGCGC 
125 Q to C 67 °C Fw GTTTTCCGCAGATTGAATGTCTGCGTTTTACCAATA
GCGG 
125 Q to C 64°C Rv TTCAATCTGCGGAAAACGTTCACAAATCAGACG 
363 V to C 60°C Fw CCTGATGAATGCACATTTTTGTCAGGGTGATGTTCG
TAG 
363 V to C 65°C Rv AAAATGTGCATTCATCAGGCTACCAATGCCG 
388 L to C 54 °C Fw AGCTGCTGTTTTTTCATTGCCTGAATGAAGATATCT
ATAG 
388 L to C 60°C Rv ATGAAAAAACAGCAGCTGACGCAGAC 
404 S to C 62 °C Fw GTGGTTTTGTTGTTCTGTGCCTGCCGCTGA 
404 S to C 64 °C Rv CAGAACAACAAAACCACGCGGACTGC 
421 S to C 60 °C Fw CAGCGATTGGTTGCTTTATTGGTGGTCAT 
421 S to C 62 °C Rv ACCAATCGCTGCCACATAACGATCAATATC 
435 N to C 64 °C Fw TGCCTCGTGCCTGTTAACTCGAG 
435 N to C 64 °C Rv GCACGAGGCAGCAGGGCAC 
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Figure 4.1 Vector map of V. paradoxus ω-TA with resistance gene towards ampicillin in T7-promotor 
system. The gene-code was codon-optimized towards Escherichia coli BL21 usage. For gene sequence 
see appendix 8.1 
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Enzyme purification 
In order to express the ω-VpTA in a T7 expression system, the sequence verified plasmids were 
transformed into BL21 (DE3) cells. The synthetic ω-VpTA gene was ordered containing an 
N-terminal hexahistidine tag for purification using immobilized metal ion affinity 
chromatography. 1 mL of precultures grown in Luria Bertani-medium (LB) was sedimented by 
centrifugation in a benchtop centrifuge (Thermo Fisher Scientific, USA) at 13.300 rpm. After 
washing the pellet with fresh LB-medium, 1 mL was resuspended in 400 mL auto inducing 
medium (AIM) (Formedium, Great Britain) containing 100 µg/mL ampicillin. Initially, the 
cultures were grown in an incubator (Infors, Switzerland) at a shaking rate of 120 rpm and 
37°C. After 4 h, the temperature was decreased to 20°C and the incubation continued for 20 h. 
The protein expression is self-induced, when the D-glucose is completely consumed and the 
only remaining carbon source is lactose. After 24 h of incubation, the cells were collected by 
centrifugation at 8,000 rpm in a JA-10 rotor with a Beckman Centrifuge (Coulter-Beckman, 
USA). The supernatant was discarded and the cells were resuspended in 10 mL of lysis buffer 
(50 mM sodium phosphate, pH 7.8, 0.3 M NaCl, 10 mM imidazole and 0.1 mM of pyridoxal-
5-phosphat cofactor). In order to lyse the cells, they were incubated with lysozyme for 30 min 
at room temperature and subsequently homogenized using ultra-sonification. The cell debris 
was removed by centrifugation at 49,500 g for 30 min at 4°C in a Beckman centrifuge. The 
purified ω-TA was obtained by Ni-NTA affinity chromatography with a 1 mL Ni-NTA column 
(Thermo Fisher Scientific, USA) on an ÄKTA start system (GE-Healthcare, Great Britain). In 
order to elute the ω-TA, a gradient ranging from 20 mM imidazole (lysis buffer) to 500 mM 
imidazole was applied at a flow rate of 1 mL/min. Fractions with ω-TA could be identified by 
visual inspection due to their slight yellow color caused by the bounded PLP, absorbing at 
395nm [163].  Fractions containing the ω-TA were pooled and concentrated using centrifugal 
filters with a MWCO of 30 kDa (Millipore). The samples used for thermal shift assay were 
subjected to one freeze and thaw cycle. The purity was checked using SDS-polyacrylamide gel-
electrophorese with 12 % (v/v) acrylamide gels according to Lämmli et al. [164]. For 
determination of Tm the buffer of the ω-TA samples was exchanged to 40 mM sodium 
phosphate (pH 7.2). The ω-TA samples for activity testes were mixed with glycerol 20 % (v/v) 
and stored at -80°C. The protein concentration was determined using the Bradford assay with 
BSA-standard samples of known protein concentration. An adapted protocol from Zor et al. 
was used, analyzing the wavelength at 450 nm and 595 nm [165]. 
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Activity test 
The activities of ω-TA samples was tested in sodium phosphate buffered solutions (pH 7.2) 
containing 0.1 mM of pyridoxal-5-phosphate. The concentration of the substrate was set to 15 
mM of rac-β PA (amino donor) and 15 mM of α-ketoglutaric acid (amino acceptor). The 
standard reaction temperature was set to 40°C and the mixtures were preincubated prior to 
starting the reaction by the addition of 10 µL enzyme solution to 210 µL reaction mixture. If 
not marked otherwise the final concentration of the ω-TA was 2.5 µM. 50 µL samples were 
collected after 15 s and 90 s and the reaction was stopped immediately by the addition to 150 
µL preheated buffer solution (99°C) with 1 mM l-leucine as internal standard. The samples 
were centrifuged in a benchtop centrifuge to remove all precipitates. The experiments were 
conducted in triplicates. To quantify the activity of the ω-TAs one unit (U) was defined as the 
conversion of 1 µmol (S)-β-phenylalanine per min.  
HPLC-analytic  
Samples were analyzed via HPLC (Agilent 1200 Series, USA) with an automated precolumn 
derivatization protocol using ortho-phtaldialdehyde (according to Brucher et al.) [166]. A 
reversed phase C18 column (150 x 4.6 mm HyperClone 5 µm, Phenomenex Inc., Germany) 
was operated with a mobile phase of 55 % methanol and 45 % 40 mM sodium phosphate buffer 
(pH 6.5) at a constant flow rate of 1 ml/min at 40°C. The elution of compounds from the column 
was analyzed at a wavelength of 337 nm using a UV detector. The injection volume of the 
samples for the derivatization mixture was set to 0.5 µL. 7.5 µL of the derivatization mixture 
were injected onto the column. A calibration was performed using defined concentrations of 
rac-β PA. β-PA was diluted in 40 mM sodium phosphate with 1 mL of L-leucine. Optically 
pure (R)- and (S)-enantiomers from Peptech were used to calibrate the retention times 
(Burlington, USA). 
Thermal shift assay 
Determination of Tm was conducted with 5 µM solutions of freshly purified ω-TA in 40 mM 
sodium phosphate solution at pH of 7.2. SYPRO-Orange (5000 x) was used as fluorescence dye 
and diluted to a working solution of 200 x in buffer. 3 µL of the dye solution were added to 27 
µL of protein solution and the fluorescence was recorded with a qPCR-cycler in transparent 
qPCR-stripes (Eppendorf, Germany). The solution was pre-incubated for 5 min at 20°C in the 
cycler. A temperature gradient increasing the temperature by 0.5°C per 30 s was employed until 
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90°C were reached. The Tm was determined at the maximal slope of fluorescence intensity 
against the time. Experiments were conducted in triplicates with ω-TA samples from two 
independent protein expressions. 
Molecular dynamic simulations   
All ω-TA simulations were performed using the GROMACS software suite (version 4.6.5). As 
protein structure we used the dimer structure of the β-phenylalanine from V. paradoxus with a 
resolution of 0.228 nm [161]. To add water molecules, we used the SPC/E model while the 
protein interacts through the AMBER03 force ﬁeld [167]. The simulations were conducted in 
0.9 % (w/v) NaCl solution. The system was ﬁrst energy minimized using a conjugate gradient 
and equilibrated for 2 ns in the NVT-ensemble at 300 K and for 5 ns in the NpT-ensemble at 
300 K, while the pressure was set to 1 bar. During the equilibration, temperature was controlled 
using the velocity-rescale thermostat (τ T = 0.1 ps) and pressure was controlled using the 
Parrinello-Rahman (τ P = 0.5 ps). Isothermal compressibility was set to 4.5 × 10−5 bar−1, which 
is the corresponding value for water [168] [169]. Production runs were performed for 100 ns. 
The temperature was controlled using the Nosé-Hoover thermostat (τ T = 1 ps) and pressure 
was controlled using the Parrinello-Rahman barostat (τ P = 1 ps) during the production runs. 
Bond lengths were constrained using the LINCS algorithm [170] [171] [172] [173]. The 
Lennard-Jones non-bonded interactions were evaluated using a cutoﬀ distance of 1.4 nm. The 
electrostatic interactions were evaluated using the particle mesh Ewald method with a real space 
cutoﬀ 1.4 nm and a grid-spacing 0.12 nm. Long-range corrections to energy and pressure due 
to the truncation of Lennard-Jones potential were accounted. The equations of motion were 
integrated using a 2 fs time step. In order to analyze structural ﬂuctuations the root mean square 
ﬂuctuation was computed (Equation 2). 
𝑅𝑀𝑆𝐹 = √1𝑡  ∑ (𝑥𝑖(𝑡𝑗) − 𝑥?̅?)2𝑇𝑡𝑗=1  (2) 
T is defined as the duration of the simulation (time steps) and xi the coordinates of atom xi at 
time tj. 
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Analysis of molecular dynamic simulations for disulfide bond engineering 
For the analysis of the trajectory over 100 ns, possible contact points were filtered for the 
disulfide bonding engineering. Therefore the gained data were analyzed using StreaMD, 
StreAM-Tg algorithms to detect motifs and α-carbon atoms within the range of 9 Å with high 
contact probability [174,175]. Sequentially adjacent amino acid positions were excluded for 
further proceeding. 
Calculation of free energy change 
ΔΔGunfold was calculated according to equation of Christensen and Kepp [176]. To this end the 
concentration of folded and unfolded protein was approximated using the fluorescence intensity 
at 55°C for the wild type compared to the mutants (Equation 1).  
∆∆𝐺 =  −𝑅𝑇 ln ( [𝑀𝑢𝑡𝑓𝑜𝑙𝑑𝑒𝑑][𝑊𝑡𝑢𝑛𝑓𝑜𝑙𝑑𝑒𝑑] [𝑊𝑡𝑓𝑜𝑙𝑑𝑒𝑑][𝑀𝑢𝑡𝑢𝑛𝑓𝑜𝑙𝑑𝑒𝑑]) 
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4.2.5) Results and Discussion 
The improvement of the thermostability of the ω-VpTA was carried out using FoldX guided 
site directed mutagenesis and disulfide bond engineering using molecular dynamic (MD) 
simulations.  
FoldX guided enzyme engineering 
Different positions within the ω-TA were analyzed by determining the melting temperature of 
the resulting proteins and following their reaction with rac-β-PA and α-ketoglutaric acid as 
substrates at different temperatures. After calculating ΔΔG-values for all 8246 possible single 
site mutations, we selected the eleven most stabilizing mutations with ΔΔG-values ranging from 
-30.1 to -54.3 kcal mol-1. Interestingly, amongst these eleven the FoldX algorithm suggested to 
mutate glycine into much larger residues in four of these eleven cases at the positions 165, 325, 
420 and 98. Many of the suggested mutation sites can be found at the surface of the enzyme 
and in a distance of more than 20 Å from the center of the enzyme, defined by the active site 
lysine (K267, see also Scheme 1) binding the cofactor (Table 4.5 and Figure 4.2). However, 
three proposed mutation sites were closer to the active center and M243 is the nearest amino 
acid residue at a distance of 5.0 Å from the catalytically center (K267).  
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Table 4.5 Mutation sites with the most negative ΔΔG as predicted by FoldX. The last two mutations 
(M243 and T408) were selected because they showed a predicted stabilization with a high energy benefit 
in parts of the whole energy equation. The distances to the active site lysine binding the cofactor (K267) 
were calculated using Chimera 1.1.[177] 
Position Original 
amino acid 
Best amino acid 
mutation 
ΔΔG [kcal mol-1] Distance to K267 [Å] 
165 G M -54.3 13.5 
391 E K -42.9 24.5 
325 G D -35.9 20.4 
420 G E -35.5 26.5 
19 D M -34.6 29.3 
98 G M -34.2 29.1 
345 E F -33.5 31.2 
392 D K -30.9 21.5 
395 S I -30.1 13.2 
408 T D -11.7 21.2 
243 M R -9.5 5.0 
 
The variants were generated in a codon optimized ω-VpTA gene using touch down PCR with 
mismatch primers and expressed in E. coli BL21. In order to reduce the number of proteins 
which had to be purified, the enzymatic activity was preliminary checked in the lysate of small 
expression cultures. M243R, G325D and G420E showed no or low activity in the lysate towards 
(S)-β-PA and were thus excluded from further studies. M243R might be too close to the 
catalytically active lysine and also introduces a positive charge into the substrate pocket. 
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Figure 4.2 Locations of the eleven mutations predicted to be most stabilizing. Only one monomer of 
the dimeric V. paradoxus ω-TA is shown (PDB ID 4AOA)[161]. Only one monomer (chain A) is shown, 
note that the interface area is about one quarter of the whole protein surface (4,400 Å2). The solvent 
accessible parts of the mutation sites are colored in red and the two active sites are visualized by 4'-
deoxy-4'-acetylyamino-pyridoxal-5'-phosphate from the crystal structure. The active site lysine K267 is 
colored in blue. The structure is rotated 90° to show the interface site on the right site of the figure.  
For the efficient expression of ω-VpTA, it was shown that the auto-induction medium provided 
the highest yields of the product. The clear advantages of the auto-induction medium are that 
higher cell densities can be achieved, metabolizing at the beginning only D-glucose (without 
induction), and the expression strain starts by it-self the expression by ingestion of lactose at 
the given time. The E. coli culture defines by it-self the starting point of the expression in 
contrast to IPTG induced protein expression, the expression rate increases slowly [178]. For 
therapeutic protein expression of interferon cIFN-α using auto-induction medium results in 
higher protein yields and furthermore lowering the temperature of expression results in more 
soluble protein yields [178]. In addition fermentation processes in bioreactors and high 
throughput screenings are simplified and protein expression is tighter controlled [179,180].    
All other of the hexa-histidine-tagged variants were expressed and purified using immobilized 
metal ion affinity chromatography (IMAC). Variants with low protein yield in E. coli BL21 
resulted in a low grade of purity and were also excluded. For the experiments two independent 
protein expressions were performed and the quality and purity controlled using SDS-PAGE 
(Figure 4.3) shows an example of expression and purification). The ratio of the variant proteins 
versus other protein impurities was too high for the determination of the melting temperatures 
in those cases. An average Tm was calculated based on data determined using a thermal shift 
4) Thermostability engineering of the V. paradoxus ω-TA 
133 
 
assay with SYPRO-orange as protein-binding fluorescence dye in a classical qPCR-cycler 
system (exemplary shown in Figure S2). 
  
Figure 4.3 Purification of wild-type ω-VpTA by Ni-NTA affinity chromatography. Fractions 6 to 9 
show slight contaminations of E. coli BL21 proteins. Fraction 10 is considered pure for the purpose of 
this work. The gradient starts at 15 mM of imidazole and reaches 500 mM at 100 %. After filtration via 
30 kDa centrifugal filter a pure enzyme product is obtained.  
 
Of the five enzyme variants analyzed, the G98M mutation showed the highest increase in Tm 
of + 4°C in comparison to the wildtype enzyme. The mutations at E345F and D392K also 
showed an increase of the Tm of + 0.9°C and + 1.4°C respectively. However, the experimental 
error in these cases was in the same range as the change. As can be seen from the comparison 
of experimental Tm and theoretical ΔΔG-values in Table 2Additionally, we combined the 
second and third best variant with G98M to gain an additional increase in Tm. However, no 
significant improvement could be achieved, which also suggests that the improvement for the 
single site variants was not significant. In order to analyze the effect of the mutations on the 
specific enzyme activity all selected variants were compared to the wild type enzyme (Table 
4.6).  
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Table 4.6 Experimental thermostability analysis of FoldX predicted ω-VpTA variants. The 
measurement was conducted in triplicates and expression of every variant was performed twice. 
Standard deviation is determined between different expression setups.  
Variant Location Tm [°C] ΔTm [°C] Standard 
deviation 
Wild type  55.3 0 0.2 
G165M Loop (active site) 56.0 +0.7 0.2 
E391K Loop (surface) 54.3 -1.0 0.1 
G98M α-helix (interface) 59.3 +4.0 0.7 
E345F α-helix (surface) 56.2 +0.9 1.0 
D392K Loop (surface) 56.7 +1.4 1.0 
G98M+E345F  58.8 +3.5 0.5 
G98M+D392K  59.4 +4.1 0.7 
 
In order to analyze whether the mutations introduced compromised the specific activity of the 
mutant enzymes, the reaction catalyzed by all variants was analyzed (Figure 4.4). The reactions 
were carried out at 40°C with 15 mM rac-β-PA and 15 mM of the amino acceptor substrate α-
ketoglutarate, which was shown to be the best substrate for the (S)-selective ω-TA from 
V. paradoxus.[161]. 
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Figure 4.4 Comparison of specific enzyme activity of selected mutant variants against wild type ω-TA. 
The reaction mixture contained 15 mM of rac-β-PA and 15 mM α-ketoglutarate. The activity was 
measured at 40°C in 40 mM sodium phosphate buffer (pH 7.2) and determined between 15 and 90 
seconds. 
 
The specific activity of the wildtype ω-TA under these conditions was determined to be 26 U 
mg-1, which fits well with the results of Crismaru et al. They determined a specific activity of 
17.5 U mg-1 at 30°C and 33 U mg-1 at 50°C for the conversion β-phenylalanine. Our most 
thermostable variant G98M showed a slightly lower specific activity of 24 U mg-1, followed by 
D392K with 22 U mg-1. All other variants were clearly less active than the wild type enzyme. 
The mutation G165M showed the lowest activity, possibly due to the relatively close proximity 
to the active site (compare Table 4.5).  Based on these results, the variants G98M, D392K and 
their combination were selected to be further investigated regarding heat stability and compared 
to the wild type enzyme (Figure 4.5). The enzymes were incubated at defined temperatures 
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(50, 55, 60 and 65°C) in buffer solution for 20 min. After incubation, samples of the variants 
were retrieved and the activities were determined at 40°C with rac-β-PA as substrate. 
 
Figure 4.5 Enzyme activity of the best ω-TA variants and the wild type after preincubation at 50, 55, 
60 and 65°C. 4 µM of the purified enzyme variants were preincubated for 20 min and the subsequently 
employed to convert rac-β-PA at 40°C.  
In accordance to the data from the determination of Tm (Table 4.6), the preincubation activity 
test showed that the wild type rapidly loses activity at temperatures above 55 °C. However, at 
this temperature the variants G98M and the double mutant G98M D392K retained a relative 
enzymatic activity of 62 % and 70 % respectively, as is reflected by the higher Tm of 59.3°C 
and 59.4°C. The single mutation D392K showed a behavior comparable to the wild type. At 
65°C no variant showed any significant remaining activity, which is in agreement with the Tm 
experiments. Since 55°C has been described as the temperature optimum of ω-VpTA the long-
term stability of the wild type and our best mutant G98M at this incubation temperature was 
investigated (Figure 4.7) [161]. While after 30 min at this temperature the remaining activity 
of the wild type enzyme is only 20 %, our best variant G98M retains 80 % of its activity for 30 
min and still shows about 50% of the initial activity after 1.5 h of incubation.  
The quite long retention of the activity over the time shows that the mutation site G98M is very 
beneficial for the stability of the enzyme. The improvement of ΔΔG calculated based on Tm 
(ΔTm of 4°C) measurements was ~15 kcal mol-1 [176]. In contrast calculations using 
PoPMuSiCv3.1 resulting in a ΔΔG of only -0.3 kcal mol-1 [181]. Additionally HoTMuSiC was 
used for calculation resulting in a predicted neutral stability-change (ΔTm -0.08 °C) [182]. This 
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would allow reactions at 55°C with higher total turnovers of β-PA without decrease of optimum 
activity. By contrast the only known thermostable β-PA converting ω-TA from Sphaerobacter 
thermophiles shows higher stability up to even 60°C, but a more than 80 % lower activity of 
3.3 U mg-1 at 37°C and no absolute activity was given for 60°C [153]. It is also worth 
mentioning that the variant G98M has a pH dependency of its activity comparable to the wild 
type enzyme (Figure 4.6). In accordance with Crismaru et al. we could determine a broad pH 
activity of ω-VpTA from pH 5 to pH 9 but not above pH 9 [161]. 
 
Figure 4.6 pH-dependent activity profile of the wild type ω-VpTA and G98M. The activity is described 
as mM min-1 towards conversion of (S)-β-PA. For pH 7.5 and pH 8.0 40 mM sodium phosphate was 
used. From pH 8.0 to pH 10 40 mM TRIS buffer was used. pH 8 was measured in TRIS as well as 
sodium phosphate buffer.  
Wild type and G98M are constantly active between pH 7.5 and pH 9.0. At pH 9.5 the activity 
is reduced around 40 % and at pH 10 both showing only activity within the limits of standard 
error. Furthermore, the size of the standard error did not allow a statement, whether wild type 
or G98M is more active at higher pH-levels. In general most ω-TA are described for activity in 
slightly alkaline medium (pH 7.0 to 9.0) [153,161,183,184], this might be reasoned by the 
properties of the amino-moiety. The amino-moiety is normally protonated under neutral or 
acidic conditions, but the higher the pH, the less amino-moieties are protonated, which could 
have an influence on the reaction between PLP and amino donor. For example L-alanine shows 
a pKa-value of the amino group of 9.87 [185]. 
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Figure 4.7 Time-activity correlation for the analysis of enzyme stability over a period of time. The ω-
VpTA wild type was compared to G98M. The reaction was carried out with 15 mM of rac-β-PA and 15 
mM α-ketoglutarate as substrates at 40°C. 4 µM of enzyme solution was incubated in a PCR cycler to 
prevent condensation of water at the reaction tube lid and incubated in 40 mM sodium phosphate at pH 
7.2 for a defined time. 
Furthermore, the solvent stability is also an important aim of stabilization. The 
thermostabilization can also increase the enzyme stability in solvents, which could not be 
proofed with certainty by the demonstrated experiments, but it was shown the first time that the 
ω-VpTA is active also above 40% of DMSO. The activity of mutant and wild type showed to 
be equivalent to each other at every DMSO content, but with a slight tendency to higher 
activities for G98M (Figure 4.8). The co-solvent is important for increasing the solubility of 
many hydrophobic substrates. 
// 
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Figure 4.8 Dependence of enzyme activity on DMSO content in the reaction batch. DMSO is a general 
enzyme compatible solvent and can be mixed with water. For this the 2.5 µM of ω-VpTA wild type and 
of G98M were compared. The reaction was carried out as mentioned before at 40°C. 
 
The solubility of aromatic amino acids is also a function of the temperature and the higher 
solvent concentrations and higher DMSO concentrations allows to solve higher amounts of 
substrate, which is important to yield  higher space time yields [186,187]. According to 
synthesis strategy for β-PA from 3-oxo-3-phenylpropanoic esters (oPP), by cascade reactions, 
a higher solubility of the substrate would be highly recommended because of the low solubility 
of oPP (~ 2 mM) in buffer [188]. The instable intermediate, have to converted very fast, because 
it shows a high decarboxylation rate [189,190]. 
 
In summary, it was clearly demonstrated that FoldX calculations can minimize experimental 
effort for directed mutagenesis experiments, especially when no suitable high throughput 
screening assay is available. On the other hand, it is known that FoldX libraries contain many 
predicted sites which even destabilize proteins or have no influence on stability [191]. To 
enhance the prospects of FoldX, Komor et al. performed their predictions using a sophisticated 
approach to gain a consensus sequence by comparisons of calculations with closely related 
enzymes to increase the stability [192]. Using this strategy, the thermostability was increased 
for the fungal cellobiohydrolase I by 2.1°C via single mutation and the authors could show that 
24 % of their selected FoldX predictions were stabilizing [192]. We also found that 
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approximately 20 % of the predicted mutant proteins, which were expressed, resulted in a 
stabilization. The quality of FoldX is further discussed in chapter 4.1   
 
Our best ΔΔG prediction, G165M, showed a 3.3 fold reduced enzymatic activity and an only 
slight improvement of the Tm, stressing the importance of experimental evaluation of the 
theoretical data. For this specific mutation the distance to the catalytically active K267 is 13.5 
Å, but only 5.0 Å to Y159. Y159 is important for the coordination of the cofactor PLP at the 
active site and can be found in many (S)-selective ω-TAs at the same position at amino acid 
residue ~150 [144,148,161,193]. Such important sides are not automatically excluded by FoldX 
and have to be selected manually. Mentioned in chapter 4.1, the low correlation of ΔΔGFoldx’ to 
ΔΔGReal is known for FoldX, which can be seen at the example of the two mutation sites G165M 
and for E391K which showing both a large discrepancy between prediction and experimental 
measurement. The results of these experiments conform, that FoldX is able to predict stability 
trends, but not with high precision. More particularly, FoldX seems to be unable to predict 
accurately high ΔΔG-values, but this might be also a result of low crystal-structure qualities 
[78,123,126,134,135]. Also it should be mentioned that the general standard error FoldX is 
known to be only between 1.0 and 1.7 kcal mol-1, which is compared to high theoretical ΔΔG 
of G165M and E391K very low [127]. Additionally a conservation analysis should be 
performed to avoid nonfunctional proteins by excluding highly conserved amino acid positions. 
Also other algorithm might be utilized like FireProt or Rosetta-ddG (see chapter 4.1).  
Our best variant, G98M, is located close to the only point of symmetry of the dimer (position 
92) at the end of an α-helix, which is oriented parallel to the same α-helix in chain B. The 
protein Interface allows stabilization be interaction with other monomers or ligands, which can 
also stabilize, the own protein stability. For the activity of ω-TA, the interface is quite important, 
because relevant amino acid residues, for coordination of PLP or substrate, are from a second 
monomer [149,194,195]. The interaction between two subunits is often mediated by 
hydrophobic interactions [196–198]. As an example, the exchange of glycine towards 
methionine might be support such hydrophobic interactions directly or indirectly. Furthermore 
the side chain of M98 is known to interact with oxygen atoms. This can be explained by the 
weak dipole of M, which makes M at the same time an acceptor for hydrogen bonds. M is also 
known for hydrophobic interaction with residues at short distances [199]. The distance of 
interaction with non-hydroxyl oxygen atoms is often within 4.0 Å. Also well-known are 
interactions of the sulfur atom with aromatic amino acids at a very similar distance range of 3.6 
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Å [200]. To identify possible points of interaction of the G98M mutation and gain insight into 
the structural reasons for the thermostabilization, we calculated the rotamers of M98 based on 
the 4AOA structure and assessed the distances to the neighboring amino acids rotamers with 
the highest probability in an area of 6.5 Å (Figure 4.9). In this range no aromatic residue can 
be found, excluding the stabilization via this interaction. Only the oxygen containing E94 is in 
a short distance of 5.8 Å and this might lead to the formation of a hydrogen bond between E94 
and M98 [200]. The chain B residue R55 is in a distance of 5.7 Å. The closest neighboring 
amino acid would be A54 (chain B) with 3.7 Å. In addition, a hydrophobic interaction with 
residues around M98 (magenta colored) would be possible.  
 
Figure 4.9 The mutation site M98 is oriented towards residue A54. The conformation of the rotamers 
of G98M were predicted and visualized with Chimera 1.1 [177]. Only the most likely ones (probability 
> 0.2) are displayed as green-yellow sticks. The most likely one is showed in red. The interacting E94 
is showed in orange and R55 in blue-grey. In general hydrophobic residues are colored magenta and 
charged residues are orange. 
 
To further elucidate the molecular basis for the stabilization of ω-VpTA, a molecular dynamic 
simulation was performed using the structure 4AOA of the wild type enzyme. One measure for 
the macromolecular flexibility and movement of amino acid residues is the root-mean-square 
ﬂuctuation (RMSF)-value, which is a very sensitive parameter for comparison of distance of 
the atom positions during a trajectory [201]. Low RMSF-values means rigid parts of the protein, 
high values stands for flexible parts. According to the calculated RMSF-values G98M is 
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positioned in an environment which seems to be a highly flexible part of the enzyme 
(Figure 4.10). Also the mutation site G165M, which was the best FoldX energy hit, is a highly 
flexible residue in the simulation. Flexible residues as target for potential stabilizing mutations 
are a promising approach which has been evaluated by several groups [191,201]. According to 
the Wood-barrel theory, these residues are more important for stability than residues in rigid 
parts of the protein [202]. One approach to describe flexible residues is the B-factor, also known 
as Debye–Waller factor, represents the thermal motion of the atoms or residues within a protein 
structure and is determined by X-ray scattering of the protein crystals[203,204]. Huang et al. 
pre-selected mutation sites for an enzyme stabilization, guided by the B-factor as a parameter 
for the dynamic mobility of parts of the enzyme and identifying one single mutation with an Tm 
improvement of 5°C. 
 
Figure 4.10 B-Factor as measure for movement of 4AOA. The mutated residue G98M is located at the 
interface between subunit A and B. Subunit B is displayed with a transparent surface. High flexibility 
(High-B factor value) is colored in red, blue represents rigid parts of the protein.  
Additionally they selected some sites with minor improvements. The prediction success rate for 
the (R)-selective ω-TA from Aspergillus terreus was 21 % and a control experiment without 
pre-selection was missing, but only the comparison could show if the pre-selection can lead to 
an more robust approach [152]. The B-factor of crystal structures might be an interesting 
indicator to detect regions within the protein with higher flexibility, but for the pre-selection of 
mutations it has to be taken into account that flexibility can also be important for the activity of 
an enzyme as in case of substrate induced conformational changes or surface activations. In the 
case of the VpTA, MD-calculation clearly show, that the stabilizing position G98 and the non-
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beneficial position G165 are both located at highly flexible parts within the amino acid 
sequence. An MD-simulation can predict further flexible parts, which are not shown by B-
factor[191]. In the present study, no clear correlation between B-factor and energy stabilizing 
mutation was observed, because G98M is according to the B-factor a structure part with low 
flexibility. Only the N- and C- terminus of the ω-TA showing a high structural variation, which 
is known for many other proteins [205]. However, the α-helix next to G98M seems to be slightly 
more flexible than other residues and structural elements. For that reason G98M might function 
as structural element, which is stabilizing the following α-helix and lowers the flexibility of the 
loop in front of the α-helix. This could therefore have a global impact on protein instability. 
The RMSF-plot shows, that globally a change in flexibility can be observed, which might be a 
result of stabilization of only one-structural part of the protein (Figure 4.11).  
 
Figure 4.11 Difference of amino acid residue flexibility of WT compared to G98M at 333 K (59.85 °C) 
using dimeric MD-simulation over 100 ns. The simulation was performed in sodium phosphate solution 
at neutral pH. The amino acid position are shown for one monomer (PDB 4AOA). The positive 
difference of RMSF is a hint that the variant is globally more rigid than the wild type enzyme. (ΔRMSF 
= RMSFwildtype – RMSFG98M.)(see also Figure S3) 
 
FoldX predicted mutations, which were predicted to have a large energy benefit, but which 
were showing only slightly or no energy benefit, can be found in areas with a low flexibility of 
0.15 nm. The theory that a pre-selection by RMSF-calculation or by comparison to B-factor is 
highly recommended and should be further investigated.  
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Figure 4.12. Monomeric MD-simulation of ω-VpTA to show regions with high flexibility as compared 
to the B-Factor. (Left) MD-simulation for the monomer. (Right) B-factor of crystal structure for one 
monomer (according to PDB ID: 4AOA [161]). The red and green circles highlight the residues G98 
and G165 respectively. Blue circles indicate the mutated residues with low impact on thermostability 
according to the experimental data.  
 
For example the FoldX predicted mutation E391K, which showed a decrease of the Tm, is even 
in a very rigid region with an RMSF value under 0.1 nm (Figure 4.12), which shows that FoldX 
predictions do not correlate necessarily with flexibility. G98M is situated in a region at the 
monomer-monomer interface, which is showing a high flexibility and is at the same time a 
FoldX predicted site for energy improvement. Since the monomer-monomer interaction is 
crucial for the enzymes’ activity but cannot be calculated easily, a mutation at this site might 
give rise to an additional benefit in the binding energy. 
However, the stability improvement might also be caused by a global effect on the protein 
flexibility, changing the fluctuation of the whole protein. To investigate such an effect we 
performed MD-simulations based on the dimeric protein and compared the global flexibility of 
the wildtype and the G98M variant.  
The simulation showed clearly, that the global flexibility of the whole protein, shown as 
ΔRMSF (wild type to G98M) value for each position, was reduced, when glycine 98 was 
exchanged to methionine, especially when the temperature was increased to 333K (59.85°C). 
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At this temperature the wild type enzyme starts to unfold and the mutant retains folded. All the 
effects described here can contribute to the observed gain in thermostability.  
This demonstrates that the prediction and explanation of (de)stabilization effects is multi-
dimensional and can be explained using many approaches. The interactions of amino acid 
residues can be explained by direct physical interactions with other residues at the short 
distance, but changes in stability could also be derived from a global context, which cannot be 
predicted using FoldX calculations. However, since FoldX cannot generate covalent bonds that 
can cause major changes in protein instability, disulfide-bonding engineering was also carried 
out as an alternative approach.   
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4.2.6) Disulfide bond engineering 
 
Disulfide bridges as stabilizing covalent bonds have long been known as enzyme engineering 
object of proteins. Crosslinking via disulfide bonds makes proteins and enzymes more resistant 
against environmental and destructive forces [206]. Therefore molecular dynamic simulations 
of 100 ns were performed of ω-VpTA and residues with high contact probability were selected 
(Figure 4.13). The most of all amino acid residues showing no contact-probabilities towards 
far-away neighbors (more than 7 amino acid positions).  
 
Figure 4.13 Contact probabilities within the ω-TA dimer subunit. Red-pixel means high contact 
probability, for this reason the diagonal is mainly red (contact residues to itself or to direct neighbors). 
Green means a probability of 0.5 (only a few interactions). Sites which are not directly adjacent and 
have at least a probability > 0.5 were selected for directed mutagenesis. In circles hot spots for contact 
are highlighted. In circles hot spots for contact are highlighted.  
This is expected, because only direct neighboring amino acid residues getting mainly in contact. 
For disulfide bridges between secondary structures are amino acid residues from interest, which 
are separated by at least 7 amino acid positions. Furthermore these sites were ranked according 
to evolutionary allowed exchanges using multiple sequence alignments. In total seven sites 
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were selected for mutagenesis experiments (Figure 4.15). Furthermore also an amino acid with 
intermolecular contact was chosen, namely D92 and in addition also D90 next to it was selected. 
Interestingly D90 is naturally exchanged against cysteine in the protein sequence of 
Sinorhizobium medicae/meliloti (WP_024312421 and UniProt ID A0A222GPX9). Therefore 
this site could be a point with high probability for a natural occurring disulfide bond. The gene 
is recommended for Fold type I aspartate aminotransferase family protein (or as glutamate-1-
semialdehyde 2,1-aminomutase) with high sequence identity towards V. paradoxus 
ω-TAs  (> 50%) and is therefore a promising approach for site directed mutagenesis. In general 
the distances between the backbone’s α-atoms were between 6.6 and 9.7 Å (static) and during 
the simulation in the range up to 9 Å. This is also the distance between naturally occurring 
cysteine residues of disulfide bonds in the reduced state [207,208]. The distance between the 
terminal atoms (sulfur atom) should be around 2 to 3 Å for formation of a disulfide bond [209]. 
However, the positions of amino acid residues are generally not static at room temperatures and 
the whole enzyme is in motion (like shown in Figure 4.13 and 4.14), especially secondary 
structures are moving, which could be observed during MD-simulations.  
 
Figure 4.14 Putative sites for disulfide bridge engineering. These sites were determined according to 
evolutionary existing exchanges and according to their contact probability during MD-simulations over 
100 ns. The shown sites were successfully expressed and tested according to their melting point. 
The mutations selected mainly on the basis of the simulation, with the exception of D90, were 
all successfully mutated (Table 4.5). Using different DNA-oligomers and PCR mutagenesis 
strategies did not result in a successful amino acid exchange at position 90. Furthermore beside 
general problems of mutated proteins i.e. loss of stability, solubility and functionality, the 
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protein expression of disulfide bridges containing proteins is challenging, because most 
expression strains like E. coli BL21 do not show oxidizing conditions within their cytoplasm. 
For this reason the expression was not only performed in standard E. coli BL21 but also in 
E. coli SHuffle strain which shows oxidative conditions within its cytoplasm. E. coli Shuffle 
(USA, NEB), original K12-strain, is able to form disulfide bridges within heterologously 
expressed proteins, because an important protein (trxB gor) in the cytoplasmic reductive 
pathways is suppressed. Furthermore this strain contains a disulfide bond isomerase, which 
supports the formation of disulfide bonds [210]. The authors of this study also recommend to 
utilize autoinduction for protein expression, which has been done for protein expressions. In 
contrast as an alternative also the E. coli strain Origami B (DE) (Germany, Merck-Millpore) 
was tested. This strain is a mutant of BL21, which is recommended for expression of eukaryotic 
protein as well as proteins with disulfide bonds but showed no expression at all. 
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Table 4.7 Disulfide-bridge engineering. The variants were expressed in E. coli BL21. Shown in brackets 
after several months’ incubation at -80°C. The expression was conducted in auto induction LB-medium 
at 37°C for 6 h, followed by 20°C for 20 h. Melting points were determined using 5 µM of protein.  
Variant Expression Distance 
between 
bridge α-
C-atoms 
(backbone) 
Activity Stability 
change 
Tm [°C] 
A59C + S404C Successful  7.1 Å Yes No improvement 55 
D90C No (mutagenesis 
failed)  
- - - - 
D92C  Successful 8.5 Å Yes no improvement 
(After 8 months at 
-80°C, also no 
changes) 
54.5 
(55°C,68 °C) 
L388C + 
S421C 
Successful 9.7 Å No Strong 
precipitation 
- 
V363C + 435C Successful 8.8 Å No Slow precipitation 55 
C117 + S125C Successful 6.6 Å Yes Loses PLP 
binding capacity  
54.5 
A5C + L429C Successful 7.3 Å Yes no improvement 
(after 8 months 
at -80°C 
improvement ) 
55 (58°C, 
68°C)  
 
The in E. coli BL21 expressed disulfide variants showed no improvement according to their 
melting point. The second tested expression host, E. coli SHuffel, produced generally less ω-
TA than BL21. Furthermore the temperature of the expression culture had to be reduced at the 
beginning (lag-phase and beginning of log-phase) from 37°C to 30°C, followed by 20 h of 
incubation at 20°C. The expressed variants L388C +S421C and V363C + N435C showed 
reduced solubility and were sensitive towards low temperatures (> -20 °C). Especially when 
they were expressed inside the less reductive E. coli Strain SHuffle, they showed drastically 
reduced stability in sodium phosphate buffer. However, a general disadvantage of this strain 
was the reduced yield of expressed protein compared to BL21. Therefore the purity was 
reduced, because the ratio of E. coli host proteins to target protein was increased (Figure 4.16). 
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Formation of disulfide bridges at -80°C ? 
The tested variants did not show any improvement in protein stability compared to the wild-
type. Surprisingly two variants, expressed in BL21, showed a shifted and a second melting point 
after incubation at -80°C in 25 % glycerol for 8 months. The second melting point was 10 °C 
higher than known for the wild type (see Table 4.7). It is generally known that glycerol 
increases the stability of proteins, and therefore the variants were compared to the purified wild 
type ω-TA, which was incubated also in 25 % (v/v) of glycerol for at least 8 months. The final 
concentration of glycerol was 5 % (v/v) for all samples. The measurements, which were 
performed in this mixture showed a melting point of 58°C (for wild type), which is 3°C higher 
than known for tests without glycerol. Therefore glycerol might be the reason for the shift of 
the first melting point but the resulting second melting point of the disulfide variants might be 
caused by a different folding state of the ω-TA as well as a result of formed disulfide bridges. 
A deeper analysis of the reason for the change in the melting point during storage was not 
carried out. Since the storage time for a repetition of the experiment was too long. 
 
E. coli SHuffle expression of disulfide bridge variants 
However, the successful expression of ω-VpTA variants in E. coli SHuffle resulted in hardly 
predictable melting curves with many local minima. The purification and expression was shown 
by SDS-PAGE (Figure 4.15). 
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Figure 4.15 Purification of disulfide mutants of ω-VpTA. The variants were expressed in E. coli SHuffle 
and purified using Ni-NTA chromatography. The gel-picture was captured by Peter Klausmann [211].  
The variants 5C+429C and 125C showed clear melting curves (only one minimum), but without 
a hint for an increase of thermostability. On the contrary, they even showed a deterioration of 
the melting point (53.5 °C). The variants 59C and 404C showed in contrast no clear Tm points. 
Moreover the derivation of the melting curve function showed several minima and therefore no 
determination of a single Tm was possible (Figure 4.16).  
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Figure 4.16 Melting curves of different disulfide engineering variants. The second derivation of the 
curves did not show one clear turning point, in contrast more than one maximum can be determined for 
the slope. Therefore Tm could not be determined. a) 59+404 b) 92. In appendix Figure S4 unequivocal 
curves for 125C and 5C+429C are showed as contrast example. Different turning points can be a result 
of protein contaminations or of different folding states of the ω-TA.   
This can also be a hint, that different energy states of the enzyme are present. However, protein 
precipitations were observed at high protein concentrations and at lower temperatures. This 
might be an additional hint for disulfide bridges, which, conversely, could have reduced the 
solubility of the protein. Therefore it cannot be ruled out that disulfide bonds may have formed. 
The protein stability determination using thermal shift assay did not prove to be the method of 
choice for determining whether disulfide bonds were formed.  
Furthermore those variants were investigated using SDS-PAGE. The enzyme samples were 
denatured using non-reducing SDS-sample buffer, without 2-mercaptoethanol, resulting in no 
clear difference compared to reduced samples. Even at higher contents of polyacrylamide 
(18%) a shift of the protein bands was not observed, which would be expected when a disulfide 
bond is present. Summarizing no improvements of protein stability could be clearly shown. 
Summarizing no improvements of protein stability could be clearly showed.   
Whether disulfide bonds form or not can depend on many factors. For example the disulfide 
forming cysteine residues might be not solvent exposed and oriented towards the core region 
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of the ω-TA; in this case, an oxidation of the cysteine residues would be less likely. However, 
the variant 5-429 shows to be surface and solvent exposed at the N and C-terminus of ω-VpTA, 
but did also not result in a clearly stabilizing disulfide bond. Furthermore a disulfide bond do 
not have necessarily have to increase the protein melting temperature, even many destabilizing 
disulfide bonds are reported [212]. Calculations for the (de)stabilization effect of disulfide 
bridges showed that entropy could be adversely affected and thus paradoxically a disulfide bond 
within the protein could have a destabilizing effect (Reviewed by [213]). Perhaps a disulfide 
bridge that have no effect on the structure could change the hydration shell of the protein and 
could therefore have a negative effect on stability [214]. On the other hand, Matsumura et al. 
suggested that disulfide bridges within rigid proteins might be destabilizing [215]. This 
corresponds to the theory that a disulfide destabilizes the protein in a region that finally begins 
to unfold in an unfolding process [216]. 
Moreover until now no disulfide bonds have been reported within Fold type I ω-VpTA, 
therefore general ω-TA properties might be able to avoid the formation of disulfide bonds (So 
far, there are no theories on this). In contrast, for Fold type IV ω-TA Xie et al. reported the 
engineering of stabilizing disulfide bonds within Aspergillus terreus ω-TA. The most 
stabilizing disulfide bond was located at the surface of the ω-TA and resulted in an increase of 
5.5 °C at T5010 (temperature at which 50 % of the activity is remained after 10 min of incubation) 
[217]. Moreover their MD-simulations could not confirm a great change in flexibility and 
stability of the investigated mutant compared to the wild type enzyme. Furthermore they 
utilized only E. coli BL21 for expression of disulfide mutants, which is not recommended for 
expression of disulfide bond consisting proteins. Furthermore, Xie showed no further evidence 
that a disulfide bridge was actually present. Therefore it might be possible, that the resulting 
variants are only proteins with improvement refolding capabilities at T5010.   
4.4) Conclusion 
In this work a ω-VpTA variant with an improved Tm of Δ 4°C was created by FoldX and site 
directed mutagenesis. The FoldX predicted improvement of -34 kcal mol-1 ΔΔGunfold was 
considerably lower than for the experimentally determined ΔΔGunfold of -15 kcal mol-1 for the 
single site mutant G98M. This also shows that FoldX does not calculate the true energies, but 
only determines them on an arbitrary scale that only applies to the comparison of FoldX energy 
units. (within one calculation setup). However, the best ω-VpTA variant showed a similar 
activity compared to the wild type enzyme, but had an at least 3 fold increase half-life time at 
the reaction temperature optimum of 55°C. The variant G98M can thus be used as starting point 
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for further random mutagenesis experiments and for screening towards new substrate 
specificities. For these reasons, this variant could be used as a more efficient enzyme for chiral 
resolution of rac-β-PA (improved long-term stability. In contrast, disulfide bridge engineering 
was not successful and it could not be established as a supplement method, but further activity 
tests and long-term incubation tests could show whether disulfide bridges were actually formed.  
In future experiments the possibilities of more sophisticated computational approaches should 
be investigated to generate small smart enzyme libraries for the generation of thermostable 
enzymatically active proteins. However, the data presented here as well as in other studies 
emphatically underline the need for experimental confirmation of the bioinformatics-
predictions. Computer-aided predictions are already a useful tool, but new techniques such as 
deep-machine learning could improve the chances of success of these methods
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This following chapter reports experiments aiming to the synthesis of β-amino acid ester in an 
asymmetric manner using engineered ω-transaminases. The subsection 5.1) describes an 
engineering approach to change the substrate selectivity towards aromatic β-amino acid esters. 
The following subsection 5.2) reports the screening of an ω-TA library to indicate engineered 
and wild type ω-TAs.    
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In the following chapter the engineering of the V. paradoxus ω-TA is documented using 
information gained by OTAED (chapter 3) and by literature analysis. Therefor the key amino 
acid residues were identified and mutated. The aim of this project was to create a ω-TA with 
activity towards the β-keto ester ethyl 3-oxo-3-phenylpropanoate for synthesis of β-
phenylalanine.    
 
 
 
 
 
 
 
5.1) Substrate profile engineering of V. paradoxus ω-TA 
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5.1.1) Alternative synthesis route to the lipase-ω-TA cascade reaction for the 
production of chiral β-PA  
 
The asymmetric synthesis of β-amino acids is still challenging and different approaches are 
tryring to solve these challenges. ω-TA catalyzed reaction are challenging until now, because 
instable β-keto acids have to be utilized, which decarboxylate fast in aqueous solutions [1,2]. 
An alternative would be the utilization of β-keto ester substrates, which do not undergo 
spontaneous decarboxylation, but currently no adequate β-keto ester active ω-TAs are available 
for this purpose. Therefore alternatives were established by Kim et al. and Mathew et al. (see 
also chapter 1) 
5.1.1.1) Disadvantage of established cascade reactions 
Both groups reported as an alternative approach cascade reactions using lipase/nitrilase (starting 
with asymmetric nitrile substrate) and β-PA-converting ω-TA with different yields of (S)-β-PA 
product [3–5]. However, this strategy has the major disadvantage that the unstable β-keto acid 
forms during the reaction and the keto acid must therefore be reduced directly to the 
corresponding amino acid as well as that the activity of ω-TA nitrilase/lipase must be adjusted. 
As reported in chapter 1, the enzyme concentrations of lipase or nitrilase are unfortunately 
quite high (Table 5.1).  
Table 5.1 Advantages and disadvantages of a lipase-ω-TA cascade reaction for the synthesis of β-PA. 
Advantages Disadvantages 
✅ One-pot reaction  ✘ Undefined lipase formulation (with at least protease 
activity) 
✅ Relative high product concentrations ✘ High lipase ( up to 30 mg mL-1) and ω-TA 
concentrations (> 2.5 mg mL-1) 
✅ Lipase commercially available  ✘ Reaction mixture is more a suspension than a 
solution  
 ✘ Instable intermediate is formed (β-keto acid)  
 ✘ Difficult product purification  
 ✘ Reaction cascade cannot be spatially separated (e.g. 
for flow-cell-reactors)  
 ✘Upscale might a problem (high enzyme 
concentrations necessary)  
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Furthermore, some uncertainties arise from the work of Mathew et al., since the aromatic 
β-keto ester was hydrolyzed with the mentioned lipase concentration within 3 h, but the reaction 
time was more than 24 h. Within the first hour most of the ester should be hydrolyzed towards 
the free β-keto acid. In parallel, the transaminase reaction starts with whole-cell extracts or 
purified ω-TA. However, the exact enzyme activity is unknown for this part of the reaction, as 
the unstable β-keto acid cannot be used as a pure substance for activity tests. For this reason, 
Mathew et al. determined the activity of the ω-TA using the proper product (β-PA). But this 
reverse reaction is not valid for calculation of the activity for synthesis reaction constants. 
Starting from β-PA as substrate, the resulting product (β-keto acid) is naturally removed from 
the equilibrium. Therefore the reaction equilibrium is shifted by the ongoing decarboxylation 
of the β-keto acid. Another as yet unanswered question is what happens to β-keto acid 
intermediate. The accumulating intermediate β-keto acid will at least in part decarboxylate 
before it can be converted by an ω-TA [1,2,5]. Although it would be conceivable to lower the 
temperature of the reaction solution to slow down decarboxylation, this would also reduce at 
the same time the ω-TA activity. Additionally, the lyophilized lipase from Candida rugosa 
(L8525 Sigma-Aldrich), which was utilized by Mathew et al., also exhibits proteolytic activity 
(0.001 U/mg), which might cause degradation of proteins over the time and results in an 
increase of amino acids contaminations, like α-PA. Overall, it is very difficult to characterize 
the reaction in detail and adapt it for a possible application. In addition, the group of Hyungdon 
Yun is the only one having reported an ω-TA containing enzymatic cascade strategy as highly 
successful in an aqueous reaction systems. In contrast, Zhang et al. demonstrated in 2018 in a 
two phase reaction, with a newly characterzied nitrilase and an ω-TA, that the reaction from 
β-keto nitrile to β-PA is possible using high enzyme concentrations (concentration in water 
phase 30 mg m L-1 of ω-TA powder and 20 mg m L-1 of nitrilase powder) [6]. In contrast, within 
this thesis in unpublished preliminary experiments, using the ω-VpTA (1.2 mg mL-1 purified) 
and Candida rugosa lipase (CRL, 20 mg mL-1) the obtained yields ranged only between 7.2 
and 16 %, which was already reported by Kim et al. in 2007 [3]. However, lower concentrations 
of CRL (1 mg mL-1) resulted in no product formation. Furthermore nearly 50 % of the 
decarboxylation product, acetophenone, was obtained. Moreover, in the reports of Mathew et 
al. no preparative synthesis and purification of the product was carried out, therefore it is not 
possible to indicate product yields for this type of reaction strategy. 
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Disadvantage of whole-cell extracts  
As an alternative, this research group also reported the use of whole extracts as biocatalysts for 
cascade reactions. In total the reported protein and cell concentration was about 50 mg mL-1, 
which causes the challenge that amino acid contaminations can also be introduced into the 
reaction mixture by whole-cells. For example 100 mg of E. coli cells can result in 299 to 
1549 µg of intracellular free α-amino acids depending on the used E. coli  strain. At least 0.25 
up to 1.5 % of cell dry weight are free amino acids [7]. Therefore it cannot be excluded that e.g. 
α-phenylalanine interacts during analysis and complicates the purification of β-PA.  
 
5.1.1.2) Alternative reaction towards β-amino esters  
For these reasons, an alternative synthesis strategy would be interesting in order to avoid some 
limitations in the reaction process. An alternative would be the synthesis of β-phenylalanine 
esters, which could be extractable (using an organic solvents) and avoiding at the same time the 
usage of two enzymes (Figure 5.1). In addition, β-amino esters are soluble in organic solvents 
and can be used for further chemical reactions or modifications, because in many cases the β-
amino acid is not the desried product but mostly only an intermediate. If necessary, the free 
acid can easily be obtained from the ester with the help of a lipase. Midelfort et al. engineered 
the (S)-selective ω-TA from V. fluvialis for the conversion of an aliphatic β-keto ester substrate 
(ethyl 5-methyl 3-oxooctanoate). In this large mutation study, they showed that synthesis seems 
to be possible in principle. Further it was inter alia demonstrated that low transaminase 
concentrations (72 to 74 µg mL-1) were already sufficient for the determination of enzymatic 
activities. But for scale up experiments they used whole-cells to convert at least 1 g of substrate.  
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Figure 5.1 Synthesis and purification of chiral β-phenylalanine (ester). A) Strategy according to Mathew 
et al. The intermediate is able to degrade to carbon dioxide and acetophenone by a six-membered cyclic 
transition state or by a stepwise mechanism [8,9] .The resulting enol-product of the decarboxylation 
underlies a keto-enol tautomerization reaction to acetophenone. B) Alternative synthesis strategy to 
avoid an intermediate degradation.      
Finally, after product isolation with methyl tert-butyl ether, they have achieved a yield of 28% 
[10]. In contrast Mathew et al. did not report a product yield (isolated product) for the cascade 
reaction towards β-PA.  
Table 5.2 Postulated advantages and disadvantages for synthesis of β-amino acid esters using ω-TA. 
Advantages Disadvantages 
✅ One-step reaction to get amino function ✘ No ω-TA with activity for aromatic β-keto 
esters reported (therefore screening or 
engineering necessary) 
✅ Product extraction with organic solvents 
(e.g. EtOAc, Methyl tert-butyl ether) 
✘  Hydrolysis of the β-keto ester can still lead to 
decarboxylation (e.g. if contaminations of 
hydrolases are present)  
✅ Spatially separable reaction cascade 
possible (with lipase to gain β-amino acids)  
✘ Other unforeseeable disadvantages (i.g. low 
activities, purification challenges)  
✅ Higher substrate stability   
✅ Upscale might be easier (if only one enzyme 
is used) 
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Moreover the strategy of Midelfort et al. simplifies the product isolation and in a second step 
the β-amino ester can be hydrolyzed enantioselectively using a lipase (Table 5.2). 
 
5.1.2) Engineering V. paradoxus ω-TA 
It has not been reported whether the V. fluvialis ω-TA is able to convert aromatic β-amino acids 
or esters. Therefore the ω-TA from V. paradoxus was selected as a starting point, because this 
enzyme shows high activity towards conversion of β-phenylalanine (33 U mg-1 at 30°C, for the 
reverse reaction unknown) and moreover a crystal structure is available to investigate the 
enzyme function at a molecular level. In pre-tests, the ω-VpTA showed no direct conversion of 
β-keto ester substrates. Therefore amino acid residues were selected within ω-VpTA analyzing 
knowledge from literature database in respect of described engineering sites at the substrate 
binding pockets from Fold type I ω-TA. Furthermore the docking of the imino-intermediate 
(Substrate + PLP) was simulated with the wild type structure and the sequence tolerance of the 
selected engineering sites was investigated.          
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5.1.3) Materials and Methods 
 
ROSIE-Ligand docking 
For calculation of the binding energy the Rosetta-online server (ROSIE) was utilized. For this 
the crystal structure of 4AOA (resolution 2.26 Å) was utilized and with ChemBio3D Ultra 
(version 14.0, PerkinElmer) the 3D structure of the intermediate was built (aldimine of β-
phenylalanine ethyl ester and PLP) and implicit hydrogens were added [11]. Ligand structure 
conformers were generated using the tool BCL [12]. The ligand docking was performed 
according to the manual of ROSIE and all values were set to be default. The number of 
conformers of the ligand was set to 200. The 3D-coordinates (X/Y/Z) of the intermediate 
(inhibitor) molecules was determined using Chimera 1.1[13]. The resulting intermediate-
enzyme structures were ranked according to the binding energy and due to arrangement in the 
substrate binding pocket.  
Mutagenesis PCR  
For performing site-directed mutagenesis the Q5-site-directed mutagenesis Kit from NEB was 
utilized and the experiments performed according to the user manual. The mutagenesis PCR 
was performed with pET-ω-TA gene from V. paradoxus. The oligomers were designed using 
the NEB-base changer tool of NEB. The mutagenesis DNA-oligomers were produced by 
Thermo-Fischer.  
Table 5.3 Oligomer mismatch primer for site directed mutagenesis PCR of position R41, Y76, Y159 
and R398. *using PCR strategy from chapter 4  
Position Exchange Tm Direction primer-sequence 
41 R to S 60°C fw TGCAAATAGCtcaAGCGTTCTGTTTTATG 
41 R to S 60°C rv CCAGGCATATAACGTGCC 
41 R to K 60°C fw TGCAAATAGCaaaAGCGTTCTGTTTTATG 
41 R to K 60°C rv CCAGGCATATAACGTGCC 
41 R to A 60°C Fw TGCAAATAGCgccAGCGTTCTGTTTTATG 
41 R to A 60°C Rv CCAGGCATATAACGTGCC 
76 Y to F 61°C Fw TATTGCAGAGttcACCGCAGGCG 
76 Y to F 61°C Rv AAATCTGCATAACGATGACCATC 
76 Y to S 62°C Fw GATTTTATTGCAGAGTCTACCGCAGGCGTTTATG* 
76 Y to S 62°C Rv CATAAACGCCTGCGGTAGACTCTGCAATAAAATC* 
76 Y to A 61°C Fw TATTGCAGAGtcaACCGCAGGCG 
76 Y to A 61°C Rv AAATCTGCATAACGATGACCATC 
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159 Y to F 60°C Fw TAGCGGTGGTttcCATGGTGGTG 
159 Y to F 63°C Rv AAAACAACAATTTTACGACGAC 
159 Y to S 63°C Fw TAGCGGTGGTtcaCATGGTGGTG 
159 Y to S 62°C Rv AAAACAACAATTTTACGACGACC 
398 R to L 57°C Fw TAGCAGTCCGctgGGTTTTGTTG 
398 R to K 57°C Fw TAGCAGTCCGaaaGGTTTTGTTG 
398 R to S 57°C FW TAGCAGTCCGagcGGTTTTGTTG 
398 R to  57°C Rv TAGATATCTTCATTCAGCAG 
 
Enzyme purification 
Methods for the production and purification of the ω-TA variants from V. paradoxus are 
described in chapter 4. 
Activity tests 
The activity of enzyme variants were tested using different amino donors and amino acceptors 
according to table 5.4. The reactions were performed for 24 h at 30°C using 2 µM of purified 
ω-VpTA and 0.1 mM of PLP (otherwise mentioned). For poorly water soluble substrates 
different contents of DMSO were used. The conversion was determined using HPLC, like 
described in section 4). The reactions were performed in 220 µL and started by addition of 
enzyme solution. For PA-KG, samples were taken after 15 and 90s and after 5 min. Samples of 
PE-KG, AB-KG and AL-KG were taken after 7 min and 21.5 h, because very slow consumption 
rates were expected.    
Table 5.4 Activity test solutions using 50 mM sodium phosphate buffer pH 7.2.    
Short cut  Amino donor Amino acceptor Co-solvent 
PA-KG 15 mM rac β-PA 15 mM α-keto 
glutarate  
- 
PE-KG 40 mM PEA 15 mM α-keto 
glutarate 
10 % (v/v) DMSO 
AB-KG 40 mM 3-amino 
butyric acid  
15 mM α-keto 
glutarate 
10 % (v/v) DMSO 
AL-KG 40 mM L-alanine 15 mM α-keto 
glutarate 
10 % (v/v) DMSO 
PE-EOPP 40 mM PEA 15 mM ethyl-3-oxo-
phenylpropanoate  
10 % (v/v) DMSO 
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HPLC analysis 
For HPLC analysis see chapter 4. Exemplary chromatograms of the different amino donors are 
presented within the Figure S8.   
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5.1.3) Results and Discussion 
Before ω-VpTA engineering was performed, it was tested, whether the enzyme is able to use 
other substrates than β-amino acids as amino donors. It was shown, that PEA and L-alanine are 
accepted amino donor substrates for amination of α-ketoglutarate. However for L-alanine a co-
product removal system was necessary, consisting of 250 mM of L-alanine and lactate 
dehydrogenase (USA, Megazyme) starting with 1 mM of the reduction equivalent NADH. This 
result is of particular importance: first, no activity for non-β amino acids has been reported 
before and secondly because it is desirable for the synthesis of β-phenylalanine (esters) to use 
non-β amino acids as amino donor source. PEA and alanine are commonly used amino donors 
for ω-TA reactions. In addition, both tests could be used as a basis for the development of 
screening assays. 
5.1.3.1) Analysis of engineering sites  
The wildtype ω-VpTA shows no activity towards β-phenylalanine ethyl ester (β-PAEE) or to 
the corresponding β-keto ester substrate at all. Until now the capability to convert β-PA as ethyl 
ester was never reported for transaminase reactions and only one example for conversion of an 
aliphatic β-keto esters is described [14]. Therefore little is known about the binding of aromatic 
β-keto esters within ω-TA and in order to gain insights the binding was investigated using 
in-silico binding energy calculations.    
The binding probability was investigate using the Rosetta based ligand docking calculation tool 
(ROSIE-ligand docking), which includes also the conformation of the binding amino acid 
residues [11]. The arbitrary binding energies were calculated using the intermediate (aldimine), 
because this reaction-step is the result of the reaction of aldehyde moiety with the amino group 
of β-PAEE. This intermediate occupies the most of the substrate pocket space and has to fit 
inside the substrate binding pocket during the reaction cycle. Clashes with amino acid residues 
would result in weaker binding energies. To get an insight whether binding is possible at all, 
the binding event was simulated. The binding was ranked in comparison to the inhibitor relative 
binding energy of 4'-deoxy-4'-acetylyamino-pyridoxal-5'-phosphate (DAPP). Therefore the 
inhibitor coordination was utilized, which is known from X-ray structure analysis of ω-VpTA 
(PDB ID 4AOA).  
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Binding of β-PAEE  
In general, inhibitors are quite similar to transition states of substrates and therefore inhibit the 
reactivity of enzymes, because they fit generally well within the substrate binding pocket 
[15,16]. To analyze whether the binding calculation was performed accurately, the calculated 
structure was compared to the crystal structure coordination of DAPP. The binding energy of 
DAPP was -16.2 Rosetta energy units (REU, on an arbitrary scale) and is in accordance with 
the 4AOA structure. The best binding energy hit of the β-PAEE-PLP intermediate was shown 
to be -11.4 REU, which 30% less of binding energy than compared to DAPP (Figure 5.2).  
 
Figure 5.2 Ligand-docking in the V. paradoxus ω-TA using Rosetta. 200 conformational structures were 
tested for the docking A) Docking of inhibitor in 4AOA, best energy hit showed similar coordination 
compared to crystal structure with 4AOA. B) Docking of hypothetical β-phenylalanine-ethyl ester-PLP 
intermediate in 4AOA.(Docking was performed using ROSIE docking server [11]). The binding 
energies are presented on an arbitrary scale (Rosetta Energy Units).  
Furthermore also other conformers were analyzed using visual inspection. The second and third 
best β-phenylalanine ethyl ester-PLP intermediates (PEEP) were oriented in different angles or 
fitted badly in the substrate binding pocket (clashes or orientation to substrate entrance 
channel).  
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Hence, the most important amino acid residues and position of the ligand of the original 4AOA-
structure of the DAPP-calculations and of PEEP-calculations were displayed in figure 5.3. The 
intermediates were quite similar oriented within the binding pocket, but the position of the 
pyridine ring of PEEP was slightly shifted towards the larger binding pocket (O-pocket) of the 
ω-VpTA. The aldimine bond of PEEP is located 5.0 Å away from the closest hydrogen of the 
ε-amino moiety of amino acid residue lysine 267. The distance from the nitrogen atom of the 
pyridine ring to the coordinating amino acid residue Y159 is 9.2 Å which is 3.8 Å further than 
determined for the distance of the DAPP pyridine nitrogen (5.4 Å) to Y159.    
 
Figure 5.3 Substrate-intermediate binding showed with target substrate β-phenylalanine-ethyl-ester 
compared to inhibitor. Structure A (brown) is showed as visualization of the crystal structure PDB-ID 
4AOA in combination with the inhibitor 4’deoxy-4’actylyamino-pyridoxal-5’-phosphate (not shown). 
Structure B (blue) is the result of the simulation using ROSIE, the 4AOA structure (without inhibitor) 
and 4’deoxy-4’actylyamino-pyridoxal-5’-phosphate (green). The inhibitor ligand of structure A and B 
fits quite well. Structure C shows the docking with the target substrate (PLP- β-phenylalanine-ethyl-
ester-intermediate). The docking was performed using ROSIE-software. The arbitrative binding 
energies are displayed in Figure 5.2.  
Furthermore also the amino acid residues are reoriented slightly, especially Y159 
(movement ΔÅ 3.3). On the one hand the differences and the lower relative binding energy are 
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an indication for the inhibition of the binding of β-PAEE, on the other hand it shows that a 
binding at least possible.  
In contrast using the example of the α-phenylalanine ethyl-ester-PLP intermediate, the clashes 
are so strong that Y159 is clearly reoriented (Figure 5.4). Moreover, also R41, an amino acid 
residue which coordinates the carboxylic moiety of β-PA is reoriented to avoid a clash with the 
intermediate [17]. However, these are only hints, that the binding of β-PAEE is possible, 
although unfavorable. Also the structure quality of 4AOA has to be taken into account, because 
the crystal structure resolution of 4AOA is only 2.2 Å. The suspicion, that β-PAEE might be 
able to bind inside the substrate pocket, though less affine, is interesting in regard of further 
engineering experiments aiming to expand the substrate binding pocket and to avoid 
electrostatic barriers. 
 
Figure 5.4 α-L-phenylalanine-ester-intermediate (blue) binding causes rearrangement of PLP 
coordination residue Y159. The ethyl moiety is oriented towards Y159(A), which results in a movement 
of Y159(B). This demonstrates, that small changes in substrate structure cause rearrangements of 
intermediates on the cost of binding energy. The position of the inhibitor is shown in green. 
To identify engineering sites, the results from other Fold type I (S-selective) ω-TA engineering 
experiments were analyzed to identify putative interesting sites within ω-VpTA. Furthermore 
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also residues were taken into account which have been described to have a special function (i.e. 
change in specific activity, substrate interaction). 
Identification of engineering sites 
As already shown in chapter 3, all ω-TA engineering experiments were summarized and 
analyzed using the standard numbering scheme from oTAED. Sites of interest were relocated 
in ω-VpTA (PDB ID 4AOA) and additionally promising sites were analyzed. Weiß et al. 
showed in experiments with the ω-TA from Ruegeria sp. TM1040 that the residue Y59, Y87 
and Y152 are highly important to generate activity for bulky substrates like exo-3-amino-8-aza-
bicyclo[3.2.1]oct-8-yl-phenyl-methanone [18]. Furthermore Midelfort et al. demonstrated at 
the example of the ω-TA from Vibrio fluvialis that the residues W57F and R414 are important 
towards β-keto ester activity using the aliphatic ester substrate ethyl-3-oxohexanoate [19]. 
Moreover Pavlidis et al. reported that Y153 in Ruegeria sp. and Y152 in Mesorhizobium loti 
are important residues for activity towards bulky chiral amines. In addition it was reported, that 
Y153 coordinates the PLP at the active site and an exchange of tyrosine to phenylalanine 
decreases the polarity and stabilizes at the same time PLP at the active site. The lower polarity 
is important for the conversion of bulky and less charged substrates [20].  
Selection of mutation sites 
Those reports also highlighted that Y59 and W57 are prominent sites for increasing the activity 
towards bulky substrates. Furthermore Y87, also located in the small binding pocket (P-pocket), 
is limiting the space and mutations towards phenylalanine provide more space caused by the 
missing hydroxyl moiety and decrease the polarity in the P-pocket. Mutations towards smaller 
hydrophobic residues led to drastic decrease of ω-TA activity [20]. To identify those and other 
residues the oTAED standard numbering scheme (see Table S1 ) was used for transferring the 
engineering onto 4AOA (Chapter 3).  
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Figure 5.5 Space limiting position W57 of V. fluvialis ω-TA is in V. paradoxus a less space extensive 
threonine residue. The PDB structures 4AOA and 3E4Q were utilized for structurally matching. The 
structures were matched using Chimera 1.1 [13]. 
The sequence identity of both sequences is 24.87 % and the calculation of structural identity 
resulted in a ΔRMSD of 1.13 (of 193 pruned pairs) and in total 6.9 Å (of 394 pairing residues). 
Relocating W57 inside of 4AOA resulted in detection of T77 inside V. paradoxus ω-TA. T77 
and W57 show an RMSD of 1.4 Å, which is quite similar, but the threonine residue of 4AOA 
is less space extensive than W57, therefore T77 should not be space limiting inside the P-pocket 
(Figure 5.5). Furthermore the engineered variant W57F of V. fluvialis, which is not less space-
saving than threonine, showed activity against the aliphatic ethyl ester substrate tested by 
Midelfort et al.. Moreover in V. fluvialis a loop structure is present, which is shifted within 
V. paradoxus and cannot be relocated at the same position (Figure 5.6). 
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Figure 5.6 Superimpose of the structures of V. fluvialis (blue) and V. paradoxus ω-TA (brown). The 
main structural difference between both ω-TA is located at the P-pocket site. At this structural element 
of V. paradoxus (red) R41 can be found, which is absent in V. fluvialis. The structures were matched 
using Chimera 1.1 [13]. 
 
Especially in the side view is it obvious that the loop of V. paradoxus ω-TA is oriented 
differently in the small substrate binding pocket (P-pocket) and is arranged deeper inside the 
pocket than by V. fluvialis. The substrate binding carboxyl-moiety R41 can be relocated at the 
protrusion (inside 4AOA) [17]. Furthermore the sequence homology in this part is very low and 
therefore not alignable. Overall, T77 might have an influence on the hydrophobicity, but was 
excluded for the first engineering experiments.  
Taken together the results of the V. fluvialis engineering experiments can only be used to a 
limited extent, but they show that beside W57 also the flipping arginine is important towards 
activity of ester substrates [14]. In the following only the residues R41 (substrate binding 
residue), Y71 (limiting space within P-pocket), Y159 (coordinating cofactor) and R398 
(putative flipping arginine) were selected for further site directed mutagenesis experiments 
(showed in Figure 5.7). The expected effects are outlined in the next section.  
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Figure 5.7 ω-VpTA engineering sites with suspected influence on β-keto ester activity. Figure was 
created using Chimera 1.1.  
The residue R41 was mutated to L-serine, L-lysine and L-alanine. L-Lysine was chosen as 
smaller but positively charged amino acid residue and alanine as short and hydrophobic residue, 
which reduces the polarity at the P-pocket. L-Serine was selected as amino acid residue, which 
is smaller and able to form hydrogen-bonds, which might be necessary for the structure keeping 
of 4AOA, because R41 forming a salt bridge to E75. Therefore also E75 was mutated to alanine 
and to serine and combinations of R41 with E75 were created. 
Moreover Y76 was exchanged against L-serine, L-phenylalanine and L-alanine. L-Serine was 
selected as residue, because it maintains the hydroxyl function of the L-tyrosine residue but less 
space consuming. In contrast L-phenylalanine reduces the polarity at the P-pocket side due to 
the lacking of the hydroxyl moiety and alanine is the smallest, but hydrophobic residue and able 
to enlarge the binding pocket.  
Y159 was exchanged against L-phenylalanine and L-alanine. It is well known that a mutation 
to L-phenylalanine increases the activity towards bulky substrates of ω-TA, which causes a 
polarity reduction and increases the flexibility of the cofactor PLP. This enables the 
intermediate to have room for movements within the substrate binding pocket [21].  
Furthermore the putative flipping L-arginine (R398) [19,22], reported in chapter 3, was 
exchanged against L-leucine, L- serine and L-lysine. The exchange to lysine was reported with 
the complete loss of activity towards charged substrate [23]. Therefore it might be interesting 
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to investigate, if uncharged substrates like β-keto esters will be converted. Moreover, the 
conservation of these mentioned amino acid residues was analyzed in respect of evolutionary 
allowed or forbidden exchanges. Therefore the ROSIE tool –sequence tolerance- was utilized 
to investigate amino acid exchanges, which might be able to influence stability or function of 
4AOA. Conserved amino acids within protein sequences often hide fundamental protein 
functions regarding to stability and function.  
Table 5.5 Sequence tolerance of 4AOA at the positions R41, Y76, Y159 and R398. The table was 
created using the sequence tolerance tool of the Kortemme lab [24,25]. The dashed line marks 10 % of 
sequence frequency. The blue and purple field showing the predicted frequency, that a residue can be 
observed at a distinct position according to the stability of them.   
 
R41 is mostly permutated against L-asparagine, L-glutamic acid, but also in some cases (less 
than 10% frequency) also mutations to L-leucine and L-lysine seem to be allowed. The residue 
Y76 is in the majority of variants a L-phenylalanine or L-tyrosine, but also an L-arginine, L-
glutamate or even a L-glutamine residue are likely. The PLP coordinating residue Y159 is also 
allowed to mutate to L-phenylalanine, which was reported in literature, interestingly also 
L-tryptophan, L-glutamate and L-threonine are rarely permutated but they are allowed 
exchanges. The putative flipping L-arginine is in the most of the cases a serine residue and only 
in approx. 10 % of cases an L-arginine. Also the predicted frequency shows that L-serine is 
clearly favored, but it could be a hint that R398 is an important residue for at least 
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β-phenylalanine transaminases (compare to chapter 3.3). As previously described, are 11,243 
Fold type I proteins with flipping arginine, which are 11 % of all oTAED entries. This confirms 
also the results of ROSIE sequence tolerance analysis. This position might have an influence 
on the substrate class of Fold type I enzymes.  
Sequence analysis of the ω-TA family members with high similarity to VpTA 
The evolutionary conservation of the ω-VpTA is shown in figure 5.8, which highlights that in 
particular the active site and some residues inside of helices are highly conserved (dark 
purple). 
 
Figure 5.8 Conservation of amino acid residues of 4AOA. Highly conserved residues are shown in dark 
purple, conserved residues in white medium and highly variable residues in green. The frequency was 
calculated using ConSurf server using the PDB structure 4AOA [26,27]. The inhibitors of both subunits 
are displayed. The right inhibitor indicates the position of the active site of the second subunit.   
Furthermore the relatives of 4AOA (35 and 95% sequence identity) were assembled for creating 
conservation analysis by ConSurf-protocol. The homologues sequences were collected from 
UniProt reference cluster UNIREF90 [26–28]. The next relatives to the ω-TA from 
V. paradoxus originate from quite different species. The closest relatives are exemplarily listed:  
Variovorax sp. CF313 (ID J3CA53), Elioraea tepidiphila (ID UPI000369FBA1), 
Paraburkholderia phymatum (ID B2JW91), Phialocephala scopiformis (ID A0A194X0V1), 
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Bosea lupine (A0A1H7T9F8), Magnaporthe oryzae (ID L7I9P9) and from Claophialophora 
psammophila CBS 110553 (ID W9WU23) (Figure 5.9).  
It was not surprising that Variovorax contain ω-TA with a high grade of similarity, but it was 
not expected that also C. psammophila, an asexual yeast-like fungi and E. tepidiphila, an 
α-proteobacteria, are showing quite similar protein sequences [29,30]. This relatives have in 
common a gap, compared all other sequences, of approximately 14 amino acid positions. This 
gap is located in 4AOA at the position R168 and A169. More than 130 sequences are showing 
four or twelve amino acid residues at this area in the alignment. This evolutionary deletion is 
located in a distance of 17.6 Å to the active site and located at the substrate entrance of 4AOA.  
 
Figure 5.9 4AOA alignment for conservation analysis. 4AOA and close relatives showing a gap within 
the sequence alignment between positions 168 and 169 (grey box). This gap could be characteristic at 
substrate entrance for β-PA converting ω-TA. Purple color (high conversation), blue (medium 
conservation) no color (no conservation) and points indicating gaps. The sequence ID are UniProt 
shortcuts: Seed sequence was 4A0A (Input_pdb). The alignment was visualized using Chimera 1.1 [13]. 
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The function of this part is not reported, but the location close to the substance entrance of the 
ω-TA might be important for the movement of aromatic substrates into the active site. An 
alignment is hardly interpretable by visual inspection, therefore the mentioned engineering 
positions were analyzed using the graphical interpreter Skylign [31]. The created alignment 
(Figure 5.9) was utilized and each position of interest was analyzed.  
In most of the cases the PLP-binding residue Y159 is clearly conserved as tyrosine (probability 
0.987), but an exchange to phenylalanine is also allowed (probability 0.013). However, no other 
amino acid residues are permitted at this position and the neighboring positions are strictly a 
histidine (H160) and next to it a glycine (G161). Moreover the carboxyl-moiety coordinating 
position R41 is strictly conserved as arginine within the small pool of close relatives, but 
compared to a larger set of less homologue sequences R41 gets variable to other amino acid 
residues (table 5.5). This is an additional hint that R41 is especially important for β-PA 
converting ω-TAs, but is lacking in different (S)-selective ω-TA like in V. fluvialis [17,32,33]. 
Furthermore the second arginine residue, which was selected as engineering site R398, is not 
conserved (probability 0.178) and can be exchanged against several different amino acids. Also 
Y76 is not conserved (probability 0.156) and the sequential entropy shows clearly that 
tryptophan (probability 0.725) and phenylalanine (probability 0.094) are allowed, but also other 
non-aryl amino acid residues are occurring like histidine and methionine.   
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Figure 5.10 Conservation of engineered positions within 150 homologues sequences. Red bracket 
amino acid position of interest: A) R41: probability 1.0, is highly conserved no other residues found. B) 
Y76: probability 0.156, most frequent amino acid W. C) Y159: probability 0.987, conserved but F is 
allowed. D) R398: probability 0.178, other occurring amino acids are S, A, L, Y. Large letters 
symbolizes the frequency compared to other amino acid residues at this position. The higher the letter, 
the more the relative entropy of the amino acid position [34]. Alignments were performed using the 
visualization tool Skylign [31].  
It is notable that R41 is the only strictly conserved residue in the presented engineering concept. 
Likewise this means that a change of R41 will cause a change in enzyme properties, because 
otherwise this position would show higher sequence entropy. Besides, the exchanges Y76F, 
Y159F and R398S exist in nature and those positions are not strictly conserved. Nonetheless, 
also not naturally occurring amino acid exchanges were performed at these positions to 
investigate the influence.    
 
5.1.3.2) Creation and activity tests of selected engineering sites           
All mentioned mutations were created using site directed mutagenesis PCR with mismatching 
DNA-oligomers. The resulting variants were sequence analyzed to identify whether the amino 
acid exchange was successful. The exchanges were performed as single site mutations and 
combinations were built of R398 and to Y76.  
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All variants were successfully expressed, but some variants like Y159A, showed no binding of 
PLP, which is reasonable with regard to binding mechanism of PLP. The assumption is that 
useful exchanges lead to enzyme variants which are losing their activity towards the charged 
substrates like β-PA and α-glutamic acid. Therefor the variants were using different amino 
donors and different acceptors. Finally also the acceptor ethyl-3-oxo-phenylpropanoic acid was 
tested. The results are reported in table 5.6.  
β-PA conversion – test of initial activity  
The wild type enzyme shows activity towards different amino donor substance like 3-amino 
butyrate and slightly towards L-alanine and PEA. However, the highest enzymatic activity can 
be seen with β-PA. This can also be explained by the decarboxylation of the resulting β-keto 
acid and is comparable to the results of Crismaru et al. 2013 [17]. Therefore the reaction time 
of β-PA tests were only 90 s and all other reaction mixtures were performed for at least 21.5 h 
due to the low activity of the ω-VpTA. Beside the mentioned wild type substrate β-PA, also the 
low rac-3-amino-buytric acid activity, which was reported by Crismaru et al., was confirmed 
for the wild type variant and for Y76F. The variants Y76A/S, R41S/A, E75S and Y76F + 
R398K lost their former activity towards the reference substrate β-PA (Table 5.6).  
R41 as important residue for β-phenylalanine binding 
Furthermore Crismaru et al. performed also activity tests using the variant R41A resulting in a 
non-active ω-VpTA towards β-phenylalanine, which is also observed in this activity test. 
However, R41A showed activity towards non-β-phenylalanine substrates which might be a hint 
that R41 is particularly important for the conversion of this β-amino acid. 
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Table 5.6 Specific transamination activity (U mg-1) of different ω-VpTA variants against different 
amino acceptor and amino donors. U was defined as µmol min-1 of amino donor substrate turnover. The 
reaction mixture contents and reaction conditions are showed in table 5.2. The standard variation (±) is 
calculated from two independent reactions. Black filled fields showing no activity. *determined after 
90 s. determined after 21.5 h. (slow reactions) 
 PA-KG* PE-KG AB-KG AL-KG  PE-EOPP 
Wild type 10.2 ± 0.2 0.03 ± 0.002 0.25 ± 0.02 0.016 ± 0.04 0.02 ± 0.0006 
R41S 0 0.05 ± 0.007  0.029 ± 0.021  
R41K 0.83 ± 0.11     
R41A 0 0.053 ± 0.047 0.016 ± 0.010 0.029 ± 0.055 0.038 ± 0.019  
E75S 0     
R41S + E75S 0     
R41K+ E75S 0     
R41A+ E75A 0 0.11 ± 0.037    
Y76S 0 0.27 ± 0.008  0.011 ± 0.009 0.037 ± 0.009 
Y76F 13.6 ± 1.33 0.03 ± 0.004 0.30 ± 0.003  0.041 ± 0.004 
Y76A 0    0.015 ± 0.003 
Y159F 15.0 ± 5.8 0.03 ± 0.003    0.022 ± 0.002 
Y159A 1.8 ± 0.09 0.003 ± 0.002   0.017 ± 0.002 
R398K 1.3 ± 0.013 - - -  
R41K+R398K 0.41 ± 0.001 - - - 0.017 ± 0.004 
Y76F+R398K 0 - - -  
 
Beside the substrate binding mechanism, the salt bridge between R41 and E75 seems to be very 
important for the functionality of ω-VpTA. The salt-bridge was postulated as a characteristic 
motif for β-amino acid converting ω-TA and the interaction might be important for the 
orientation of R41, which can be underlined by the presented results, because no variant with a 
double mutation at R41 and E75 displayed activity [17]. The only exception is R41A-E75A, 
which is showing activity towards the aromatic amino-donor PEA. This position seems also to 
be important for β-keto ester activity. A short non-polar residue, at position 41, like L-alanine 
might be beneficial for binding molecules absent of a free carboxylic-group (i.e. amines and 
amino esters). In addition also a hydrophobic interaction as well as aromatic π-π stacking of the 
substrate might be necessary for β-amino acid substrates, because 3-amino butyric acid shows 
only low activity and Crismaru et al. reported that the small β-amino acids, like β-alanine cannot 
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be converted, but the more hydrophobic amino acid β-leucine can be transaminated using 
ω-VpTA [17].  
Substrate coordinating Y76 
The amino acid residue Y76 seems to fulfill two functions. The first function might be the 
binding of aromatic substrates, like β-PA or PEA. The variant Y76F showed activity towards 
all substrates with the exception of L-alanine, which could be expandable by a lower binding 
energy due to the loss of the hydroxyl-moiety. Furthermore the residues Y and F may function 
as important intramolecular interaction point with other residues, which stabilizes the structural 
arrangement of the P-pocket, because Y76A causes a loss in activity towards all substrates with 
the exception of EOPP. The smaller residue might be able to rearrange EOPP within the binding 
pockets and enables more space within the P-pocket. This theory can be supported by the 
finding, that Y76S is able to convert EOPP, PEA and L-alanine but not β-PA.  
 
The flipping arginine R398 
Concluding R398 might inhibit the binding of EOPP (lacking of a free β-carboxyl moiety) as 
flexible binding residue within 4AOA [17]. Consequently R398 was mutated to the amino acids 
K, L and S. It was therefore investigated whether R398 is indispensable for the turnover of β-
PA with α-ketoglutarate. It was found that R398L was no longer able to convert the standard 
substrates, whereas the variants R398S and R398K showed a low residual activity 
(Figure  5.11). It can therefore be assumed that the binding of α-ketoglutarate takes place via 
R398, since no interaction with R398 has been reported for the binding of β-PA [17]. 
Furthermore all R398 variants showed low activities towards PEA and EOPP (0.006 to 
0.018 U mg-1).  
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Figure 5.11 Influence of R398-variants on β-PA conversion. The conversion of the substrate β-PA was 
observed and L-glutamic acid detected on TLC plates. The reaction samples were analyzed after 5 min 
of reaction time. Therefore the activity was tested with 0.1 mg mL-1 of enzyme at 40°C. Reaction 
mixture: 15 mM rac β-PA, 15 mM α-ketoglutaric acid, 0.2 mM PLP in 50 mM NaPP (pH 7.2).     
This finding supports also the assumption, that α-ketoglutaric acid is differently bound by 
ω-VpTA. More precisely it was reported that R398 enables an alternative binding mechanism 
for example for the mentioned α-ketoglutaric acid [32]. The PLP-binding residue 159 can be 
successfully exchanged to phenylalanine, which was shown for the ω-TA from Ruegeria sp. 
TM1040 by Pavlidis et al. [21]. The exchange of Y159A shows also, that the activity decreases 
drastically, when no π-π stacking stabilizes the PLP-substrate-intermediate. At all the created 
variants showed that non-β-PA activity is very low compared to the wild type, which suggests 
that the binding mechanism is highly optimized for β-PA, α-ketoglutaric acid and pyruvate. A 
further binding amino acid residue might inhibit the binding of non-charged β-ketones.      
False positive activity?  
Amino acid exchanges R41A, Y76S and Y76F showed the largest effect in the reaction system 
with PEA and with the β-keto ester as acceptor molecule. It can be assumed that the change in 
PEA concentration is not an immediate indication of activity, since the wild-type also shows a 
background activity of at least 0.02 U per mg. The decrease in PEA concentration could be due 
to the first half transamination reaction of the PLP-PMP reaction cycle (see chapter 1) in which 
the amino donor reacts together with PLP to PMP. However, if PMP cannot transfer its amino 
group to an acceptor, PMP9 remains in the reaction batch. Since the concentration of PLP was 
                                                 
9 PMP shows lower adsorption at 395 nm and therefore reaction solution is less yellow than PLP [59] 
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0.2 mM, very small activities could be attributed to this reaction, which would not be evidence 
of real activity. This theory is supported, by the observation that the yellow reaction solution 
(yellow indicates PLP) was converted into a colorless solution by precipitation of the enzyme 
at the same time, because PMP is colorless [35].  
Alternative activity determination 
As an alternative to the determination of the amino donor, the product, β-amino ester, was 
quantified. However, the disadvantage is that the expected amount of product produced by the 
engineered enzyme can be very small and therefore the quantification might be challenging. 
Therefore gas chromatography (GC) method was performed. But even with GC it could not be 
determined clearly whether a product was created since the quantification limit was ~ 0.25 mM 
(The estimated concentration was approx. 0.15 mM.). 
Nonetheless, the variant R41K-R398K may have shown product formation, when using the 
amino donor o-xylylenediamine (OXD) (Figure 5.12). The resulting product concentration, is 
nearby, but lower than the quantification limit of 0.25 mM. The variant R41K-R398K showed 
a possible product peak during the analysis by GC, which however was slightly shifted in time 
but was not present in comparable chromatograms of negative controls.  
 
Figure 5.12 Putative product formation of ω-VpTA variants using OXD as amino donor. The 
experiments were performed at 40°C. a) Y76F-R398K b) R41K-R398S c) R41K-R398K.   
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The Y76F-R398K and R41K-R398K variants also showed smaller measurement signals at the 
edge of the detection limit. However, it is unclear for Y76F-R398K and for R41K-R398K, 
whether they aminate the β-keto ester substrate, because of the small signal intensity, but the 
retention times are comparable to the standard. Thin layer chromatography was also performed, 
but no product formation could be observed with this method. More certainty could result from 
a TLC or GC-MS analysis. However, it is also clear that the possible enzymatic activity is very 
low and further mutagenesis experiments have to be carried out to increase the product yield.  
 
Influence of amino acid exchange on protein stability 
Mutations that could be useful for the conversion of a new substrate could have a negative effect 
on protein stability. Especially the position R398 was therefore examined in detail, as mutations 
at this position have a strong influence on the activity. First experiments using R398 variants 
showed, that precipitations were obtained after incubation at 40°C during 24 h of incubation in 
15 % DMSO containing solutions. Therefore, all tested and expressed variants of R398X are 
displayed in table 5.7. In contrast the wild type enzyme showed stability over 24 h of incubation 
time and retained as yellow (PLP binding) ω-TA in solution. Especially the variant R398L 
showed a reduced stability in the reaction mixture and it is therefore difficult to determine 
whether the functionality was destroyed as well as the stability was negatively affected, since 
no activity was observed in relation to β-PA (Figure 5.12). This was also indicated by FoldX 
calculations using 4AOA. In contrast, the variants R398K and S showed an increase in stability 
according to FoldX. However, calculations by HoTMuSiC showed that all R398 variants were 
destabilizing.   
Table 5.7 Stability calculations of R398 variants. Firstly the 4AOA structure was energy minimized 
using the FoldX repair function. For calculations the Yasara plugin of 4.0 FoldX was utilized [36]. ΔTm 
was calculated using the algorithm HoTMuSiC and PoPMuSiCv3.within dezyme online server [37].  
Variant ΔΔG(FoldX) ΔΔG(PoPMuSiC) ΔTm (HoTMuSiC) 
R398K -0.44 kcal mol-1 0.88 kcal mol-1 -0.4  °C 
R398L 0.02 kcal mol-1 - 0.04 kcal mol-1 -1.16 °C 
R398S -0.11 kcal mol-1 0.67 kcal mol-1 -0.85 °C 
Furthermore, the PoPMuSiC algorithm also predicted that lysine and serine will increase the 
energy content of the protein, but leucine seems to be an energy neutral exchange according to 
FoldX and PoPMuSkiC. On the other hand HoTMuSiC predicts a destabilization for R398L of 
1.2 °C (Tm), which is confirmed by the weak but positive ΔΔG(FoldX) value. This example shows 
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once again that the prediction accuracy is too low (compare to chapter 4). The energy 
calculation shows at least that this residue is not involved e.g. in an important salt bridge(s).  
5.1.4) Conclusion 
In this study a promising variant was found, R41K-R398K, but it has to be demonstrated 
whether the enzyme variant has improved properties. In addition, more extensive experiments 
should be conducted to determine whether the enzyme is active or not, by varying the reaction 
conditions and by using more sensitive analytical techniques. Therefore, this part of the work 
can be understood as an initial basis which has shown that the chosen amino acid residues have 
an influence on the activity, but also on the stability. In particular, it was shown that R398 could 
indeed be the suspected flipping arginine residue, as all three mutations at this position resulted 
in a drastic decrease in activity compared to the original substrate. Furthermore, the elemental 
importance for the binding of the carboxyl moiety of β-PA could also be shown by mutations 
at position R41. Both arginine positions seem to be very important for the recognition of 
substrates.  
Challenges and Outlook 
ω-VpTA mutants that may show activity could be used for further random mutagenesis 
experiments. However, random mutagenesis requires a large number of variants, therefore it is 
also a challenge to perform larger screenings in high-throughput scale without any positive 
control. A second challenge is the stability of the β-keto ester substrate, as it has proved to be 
unstable in experiments with crude cell extracts. Furthermore, the question of chemical 
equilibrium remains. Therefore it would be beneficial to force a shift of the equilibrium by 
using co-product removal systems or special amino donors (e.g. OXD). However, since it could 
not be clearly proven whether OXD is accepted as a substrate by the wild type ω-VpTA, the 
usefulness of screening on this basis is still questionable for the time being. As an alternative 
to a large mutagenesis study, several already engineered and wild-type transaminases of fold 
type I and IV were investigated in a small scale ω-TA screening in (next subchapter, chapter 
5.2). 
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In the following subchapter an ω-TA library, containing engineered and wild type (S) and (R) 
ω-TA from different sources of microorganism (fungi and bacteria), were investigated using 
o-xylylenediamine as screening agent to detect enzymes with activity towards β-keto ester 
substrate. The aim was the enzymatic synthesis of 3-amino-3-phenylpropanoic acid ethyl ester 
 (β-amino acid ester).    
 
 
 
 
 
 
5.2) Screening of an ω-TA library towards β-keto ester converting 
enzymes. 
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5.2.1) Introduction 
Like mentioned before transaminases (TA) are promising enzymes for the synthesis of chiral 
amines, amino acids and amino alcohols. The pyridoxal-5-phosphate (PLP) dependent 
transamination mediates the transfer from an amino donor group onto an acceptor substrate. 
Aldehydes, ketones, keto-acids or keto-esters can serve as acceptor substrate [14,38]. As an 
alternative to complex enzyme engineering (chapter 5.1.) natural resources of wild type ω-TA 
and already available engineered ω-TA were tested towards activity for β-keto ester as donor 
molecules.   
β-amino acid esters as alternative target 
β-PA esters are relevant for the synthesis of nitrogen-containing heterocyclic compounds, e.g. 
for synthesis of β-lactams, aminophenylpropanoic acid-terminated polyoxyethylene esters, 
nicotinamide derivatives for treatment of respiratory and allergic diseases, (S)-dapoxetine 
(reaction with LiAlH4, and for synthesis of putative anti-amnesiant agents) [39–44].  
The first example of an ω-TA mediated transamination of a β-keto ester was reported by 
Midlefort et al.. They demonstrated that the synthesis of Imagabalin, a chiral β-amino acid 
containing drug for diabetes treatment, is possible from the β-keto ester precursor employing 
an engineered variant of the fold type I (S)-selective ω-TA from Vibrio fluvialis [14]. To our 
knowledge, such a synthesis was never reported for aromatic β-amino acid ester, β-PA or rather 
α-hydroxy-β-phenylalanine containing natural substance paclitaxel (Taxol) [45]. Until now, 
different ω-TA based methods for the synthesis of optical pure β-PA, like chiral resolution or 
enzyme cascade reactions were reported (chapter 1.2 ) [5,46,47]. Thereby, the synthesis from 
the stable asymmetric β-keto ester is favored for chiral synthesis of β-PA ester, since the 
corresponding β-keto acid is not stable in water and underlies decarboxylation. An approach to 
circumvent the decarboxylation is the creation of a reaction cascade starting from the β-keto 
ester using a lipase for the hydrolysis of the ester and an ω-TA for the direct conversion of the 
instable β-keto acid intermediate. These alternative enzymatic synthesis methods for the 
preparation of β-PA were already presented in chapter 1 and 5.1 (mostly Mathew et al.) 
[4,33,48].  
To avoid critical cascade intermediates, the direct transamination of the stable aromatic β-keto 
ester would be beneficial and result in the chiral β-PAEE, which can be chemically or 
enzymatically hydrolyzed to β-PA. The only obstacle for this efficient biocatalytic approach is 
the lack of known ω-TA with activity towards β-keto esters. An exception is the engineered 
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ω-TA variant from V. fluvialis with activity towards the aliphatic β-keto ester Imagabalin 
precursor [14]. In general the displayed method could allow the enantioselective synthesis of 
β-PAEE and simplifies the purification using extraction methods. Furthermore, the strategy 
could also improve the atom efficiency (amino donor/acceptor ratio) compared to existing β-
PA asymmetric strategies. 
 
 
Figure 5.13 Synthesis strategies to chiral β-PA or β-PAEE  starting with the β-keto ester substrate EOPP 
(β-KE). β-PAEE could be isolated, using solvent extraction or used in a second enzymatic step using 
lipase. This step would increase the optical purity and will additionally improve the product purification.  
To enable the proposed direct synthesis of β-PAEE by amination of the stable β-keto ester, a 
screening of an ω-TA library (Group of U. Bornscheuer) was performed to identify variants 
converting ethyl-3-oxo-3-phenylpropanoate. The selected library contained ω-TA from Fold 
type I and IV of PLP-dependent enzymes to identify variants with (R)- and (S)-selectivity. 
Several wild type transaminases were analyzed as well as engineered variants from Silicibacter 
pomeroyi (PDB ID: 3HMU), Rhodobacter sphaeroides (PDB ID: 3I5T), Ruegeria sp.TM1040 
(PDB ID: 3FCR) and V. fluvialis (PDB ID: 4E3Q). Also, the engineered ω-TA from Codexis 
(ATA117 11Rd; PDB ID 3WWJ) was included in the screening (see Table S2). For the 
screening the amino donor o-xylylenediamine (OXD) was utilized, because it showed 
promising acceptance by several ω-TA and serves as smart amino donor, since OXD shifts the 
equilibrium towards the products by polymerization of the formed isoindole co-product [49]. 
The formed polymer results in clearly visible precipitate, indicating conversion in the screening 
[49]. After a screening of ω-TA variants was performed, the hits were analyzed in respect of 
yield and optical purity. It was also examined whether a synthesis on a larger scale is possible. 
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5.2.2) Material and Methods  
Materials 
All chemicals were purchased from Sigma-Aldrich or Carl Roth in highest purity grade (>99%), 
otherwise the compounds are indicated.  
Protein-expression and purification 
All ω-TA for large scale expression were included in pET vector systems. The enzymes were 
expressed in the Escherichia coli (E. coli) BL21 strain using auto-induction-medium LB-broth 
with trace elements (Formedium, UK) and purified using Ni-affinity chromatography according 
to Buß et al. 2017 [50].  
High throughput screening  
For screening the ω-TA library E. coli BL21 strains were used containing pET and pGASTON 
plasmids with resistance genes against kanamycin and ampicillin. The concentration of 
kanamycin was 50 µg mL-1 and for ampicillin 100 µg mL-1 in the medium for growing and 
expression. The cells were precultured in 0.2 mL LB-medium overnight at 30 °C, 700 rpm in 
96-microtiter plates (MTP). From this preculture 20 µL were transferred to inoculate 96-
deepwell plates filled with 960 µL TB-medium and appropriate antibiotics. The plates were 
sealed with oxygen permeable membranes (Rotilabo-cling film, Carl-Roth, Germany). The 
cells were incubated at 37 °C for 6 h at 700 rpm and the expression was induced by the addition 
of 0.5 mM IPTG or 0.2 % rhamnose. The cultures were incubated at 26 °C for 20 h at 700 rpm. 
For harvesting, the cells were settled at 5.000 g for 20 min at 4 °C in a robotic centrifuge 
(Rotanta 460-Robotic, Hettich GmbH, Germany). The cell pellets were resuspended in 50 mM 
HEPES buffer pH 7.5 with 0.1 mM PLP for washing the pellets. After centrifuging the pellets 
at 4.500 rpm for 20 min at 4 °C, the pellets were resuspended for lysis in 50 mM HEPES buffer 
pH 7.5 with 0.1 mM PLP and 1 mg/mL lysozyme and incubated at 30 °C for 90 min at 700 rpm. 
The cell debris was sedimented at 4 °C and 5,000 g for 20 min. The supernatant was carefully 
transferred in a clean 96-well plate. 50 µL of cell free supernatant was transferred to 150 µL of 
reaction mixture. The final mixture contained 50 mM HEPES buffer pH 7.5, 5 mM of o-
xylylenediamine, 7.5 mM of ethyl-3-oxo-3-phenylpropanoate (>95% purity, Sigma-Aldrich), 1 
mM PLP and 10 % (v/v) dimethyl sulfoxide (DMSO). The reactions were performed in 96-well 
MTPs at 30 °C and 120 rpm overnight.   
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TLC-(MS) analysis 
For the thin layer chromatography, 100 µL samples were taken from enzymatic synthesis 
mixture and extracted with 200 µL of ethyl acetate (EtOAc). The extraction was performed at 
shaking rate of 2.000 rpm for 5 minutes in a ThermoMixer (Germany, Eppendorf) and phases 
were separated by centrifugation at 13.000 rpm in benchtop centrifuge (Germany, Eppendorf). 
To analyze the synthesis mixture, a mobile phase consisting of acetone: tert-butyl ether, acetate 
and water (45:25:20:10) was used. For observation of reaction process samples of 10 µL were 
spotted on standard silica TLC plates (Sigma-Aldrich) and stained with 0.5% ninhydrin-
solution. For determination of product mass, a synthesis sample was spotted 15-times on TLC 
the plate, separated and analyzed using a thin-layer-chromatography mass spectrometer with 
electron spray ionization (expression CMS, Advion). Samples were taken directly from TLC-
plate using Plate Express-TLC-plate reader and methanol for solubilization. The samples were 
compared to a β-phenylalanine methyl ester as reference substance. For blanking the MS-signal 
a TLC spot without substrate/product were taken and subtracted from sample measurements.  
HPLC analysis  
For HPLC analysis see chapter 4 methods section.   
Enzymatic synthesis  
Enzymatic synthesis of the β-phenylalanine ethyl ester (β-PAEE) was performed in a 1 mL 
scale consisting of 50 mM HEPES buffer (pH 7.5), containing 10 to 30% (v/v) of DMSO, 1 mM 
of pyridoxal-5-phosphate, 10 mM of ethyl-3-oxo-3-phenylpropanoate and different amounts of 
different amino donors. The concentration of the amino donors and support systems are 
mentioned in results section. In general, 0.2 mg mL-1 of purified ω-TA were used in the reaction 
mixture. The temperature was set to 30 °C at 500 rpm shaking rate. 75 µL from samples were 
taken at different times and directly stopped using heat (99 °C), 1 M NaOH and subsequently 
neutralized with 1 M HCl for further analysis using HPLC. A second sample was taken of 75 
µL and extracted using 100 µL EtOAc to isolate the β-PAEE. For extraction, the sample were 
shaken at 2,000 rpm for 5 min and analyzed using TLC-(MS).  
Design of experiments  
For investigation of the influence of solvent content of DMSO in the reaction medium and for 
optimization of substrate concentration a design of experiments was performed using 
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Design-Expert 8 with 11 experiments for each selected ω-TA. Three center points were chosen 
for the experiment setup. At the same time the concentration of β-KE were varied from 10 to 
50 mM, the concentration of OXD from 10 to 100 mM and the content of DMSO (v/v) was 
tested in the range from 10 to 30% (v/v). The response was defined as yield of β-PAEE using 
GC analysis.  
Gas chromatography (GC)-analysis  
GC-analysis was performed in order to monitor the β-PAEE concentration. Therefore, β-PAEE-
standard (Sigma-Aldrich) was first solved in 50 mM HEPES-buffer (pH 7.5 according to 
enzyme synthesis) and a dilution series was mixed. The samples were extracted with 1:1 (v/v) 
of EtOAc. The two-phases were mixed according to the extraction for TLC experiments. GC-
analysis was performed using a 6850N Network GC system from Agilent employing a DB-wax 
column (30 m (length), 0.25 mm (diameter), 0.25 µm (film)) and flame ionization detection. 2 
µL of sample were injected (split ratio 10:1) at a temperature of 250 °C (injector temperature). 
The separation was achieved using an oven temperature gradient of 40 to 250 °C (8 °C/min). 
The flow rate was set to 0.6 mL min-1. β-PAEE was detected at a retention time of 28 min. 
Determination of water activity  
Water activity aw was tested using an AquaLab 4TE devise (METER, USA) with a chilled 
mirror dew point sensor. The measurements were performed at room temperature and buffer 
solutions with different DMSO content were compared.     
Large scale synthesis of (S)-phenylalanine ethyl ester and product purification 
For production on a larger scale (200 mL), 30 mM OXD (0.82 g) and 30 mM β-KE (1.15 g) 
were solved in an aqueous 30% (v/v) DMSO solution. The pH was adjusted to 7.5 with a 
100 mM HEPES buffer and 1 mM PLP was added. The reaction was started by adding 20 mg 
of purified 3FCR_4M. The reaction process was monitored by thin layer chromatography 
(solvent: 40% n-hexane, 40% EtOAc, 10% acetic acid, 10% MeOH). The pH value was 
monitored by pH measuring strips. The reaction was performed in a 500 mL round bottom flask 
at a rotary evaporator at 150 rpm and 30 °C under standard pressure. After 48 h, the reaction 
was stopped by EtOAc extraction using 3 times 150 mL of solvent. The solvent was filtrated to 
remove dark precipitate and the filtrate was dried using anhydrous MgSO4. The extraction 
solvent was subsequently evaporated at the rotary evaporator and the product was solved in 
5 mL EtOAc containing 5% MeOH and 10% acetic acid. The purification was performed using 
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MPLC (Reveleris Prep., BÜCHI Labortechnik AG, Switzerland). For separation, a Reverleris 
PureFlash 4g column and a flow rate of 15 mL min-1 was used. As method, the liquid injection 
was selected and a gradient of n-hexane and EtOAc (5% MeOH and 10% acetic acid) was used 
as follows: 50% for 3.1 min, 50 to 100% EtOAc in 3.1 min, 100% holding for 3.1 min. To elute 
β-PAEE a gradient starting with EtOAc and MeOH was performed starting with 95% of EtOAc. 
Within 6.3 min the concentration of methanol was increased to 100%. Peaks were observed 
using an evaporative light scattering detector and fractions collected. The fractions containing 
β-PAEE were again evaporated and freeze dried to remove acetic acid. The product was 
analyzed using TLC, HPLC (optical purity) and by NMR. 
Analytical NMR data of (S)-phenylalanine ethyl ester 
(S)-ethyl 3-amino-3-phenylpropanoate (2) acetate salt as brown solution.   
1H NMR (Methanol-d4, 300 MHz) δ(ppm): 1.17 (3H, t, 3J = 9 Hz, CH2CH3), 4.57 (1H, dd, 3J = 
9 Hz, 2J = 15 Hz, CHCH2CO), 4.72 (1H, dd, 3J = 6 Hz, 2J = 15 Hz, CHCH2CO), 5.68 (2H, q, 
3J = 9 Hz, CH2CH3), 6.27 (1H, t, 3J = 6 Hz, CHNH2), 8.97-9.06 (5H, m, C6H5), 9.53 (2H, br s, 
NH2).  
13C NMR (Methanol-d4, 300 MHz) δ(ppm): 14.36 (CH2CH3), 39.61 (CHCH2CO), 52.94 
(CHNH2), 62.24 (CH2CH3), 128.42, 130.25, 130.40, 130.86 (C6H5), 171.23 (CO). 
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5.2.3) Results and discussion 
5.2.3.1) Screening of ω-TA library  
The ω-TA containing library was screened towards the β-keto ester substrate EOPP in the 
colorimetric o-xylylenediamine (OXD) assay. The screening was performed in 96-well MTP 
format, enabling the simultaneous analysis of various ω-TA variants. E. coli BL21 strains 
containing the expression plasmids pET and pGASTON were used for this purpose. The 
plasmids contained ω-TA fold type I and IV genes. The analyzed ω-TA variants are summarized 
in appendix (Table S2), including the 29 different ω-TAs. The concentration of the amino donor 
OXD was 5 mM in the screening assay. The plates were in total 24 h incubated and the cell 
lysate was utilized for activity tests. After starting the reaction by addition of ω-TA lysate 
solution, a strong staining was observed within the first hours for variants from Ruegeria sp. 
TM1040 ω-TA (3FCR). The staining was clearly visible after and resulted in dark precipitations 
after 24 h of incubation. In addition, the engineered Fold type IV ω-TA ATA117 11Rd from 
Codexis showed a slight staining. Beside those two variants, also ω-TA from Silicibacter 
pomeroyi (3HMU) showed a slightly change in color. However, it is known that only strong 
changes and precipitations are an indicator for enzymatic activity and therefore 3FCR variants 
and ATA117 11Rd were selected for further characterizations (Figure 5.14) [51,52].  
 
Figure 5.14 Screening for β-PAEE producing ω-TA. A) OXD was used as screening agent in 96-well 
plate screening. High activities resulting in dark precipitates. Yellow indicates that no or low activity is 
present. Brown and orange color are unclear, whether activity is present. Cell-extract mixed with assay 
ingredients are displayed as negative control. B) Result of 1 mL scale experiments after 24 h at 30 °C.  
 
The variant of 3FCR contains four mutations and were chosen as promising enzyme for the 
synthesis of (S)-enantiomer of β-phenylalanine ethyl ester (β-PAEE) and for the synthesis of 
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(R)-enantiomer the engineered ATA117 with 27 mutations was selected. The 3FCR was firstly 
engineered by Pavlidis et al. towards the conversion of bulky chiral amines and afterwards by 
Weiß et al. for the conversion of bicyclic amines, which widen the small binding pocket of the 
enzyme [18,21]. The engineered aminotransferase ATA117 11Rd, harboring 27 mutations, 
from a homolog of an enzyme from Arthrobacter sp. KNK168 was designed by Savile et al. 
towards the conversion of the bulky substrate prositagliptin [53]. Furthermore, ATA117 
belongs to the (R)-selective Fold type IV of PLP-dependent enzymes in contrast to the (S)-
selective fold type I enzyme 3FCR.  
 
5.2.3.2) Asymmetric synthesis of β-PAEE   
The selected ω-TA variants were expressed in larger scale and purified using Ni-NTA 
chromatography. To find the best possible amino donor for this reaction, o-xylylenediamine 
(OXD), phenylethylamine (PEA), alanine and isopropylamine (IPA) tested. PEA shows a wide 
spread acceptance for all ω-TAs as amino donor and the corresponding acetophenone is less 
favorable by ω-TAs as amino acceptor. The corresponding acetophenone of PEA is not well 
accepted as ketone substrate and inhibits the reverse reaction, but on the other hand a clear 
disadvantage is the inhibition of the ω-TA by higher acetophenone concentrations [54]. Beside 
those three widespread amino donors, o-xylylenediamine (OXD) is a promising substrate, 
because it is able to polymerize after deamination and precipitates [51]. For that reason, the 
reaction is naturally shifted towards the products. Furthermore, L-alanine was utilized in an 
enzyme cascade reaction system consisting of glucose-dehydrogenase (GDH) and lactate 
dehydrogenase (LDH) to shift the equilibrium towards products [55]. 
 
Beside those amino donors also the asymmetric IPA was tested. The solubility of the β-keto 
ester substrate is only 2 mM in aqueous solutions, for that reason the DMSO concentration was 
increased to 30 % (v/v) to solubilize 10 mM of β-keto ester and to reduce slightly the water 
activity aw to protect the β-keto ester [56]. The aw-value of DMSO-HEPES solution was 
determined to be 0.966 (30% v/v), 0.980 (20% v/v) and 0.998 for pure HEPES-buffer. The pH 
of 7.5 in reaction mixture is a compromise between ester stability and ω-TA activity. The most 
ω-TA performing best at slightly alkaline conditions between pH 7.5 and 9, but in contrast the 
stability of ester substrate is under slightly acidic conditions higher. An equimolar ratio of OXD 
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was chosen, because by the law of mass action the equilibrium constant is very high caused by 
polymerization and precipitation of the resulting co-product of OXD. The reactions were 
performed in 1 mL scale at 30 °C with 1 mM of pyridoxal-5-phosphate and samples were taken 
after 1 h and 24 h. For (R)-selective ATA117 11Rd D/L-alanine instead of L-alanine were used. 
The reaction process was observed using TLC due to monitor β-PAEE formation (Figure 5.15).  
 
Figure 5.15 β-PAEE synthesis using alanine—GDH-LDH-NADH-regeneration system (a) and OXD 
(b). a) The reaction mixture conducted of 90 U ml-1 of lactate dehydrogenase, 0.3 mg ml-1 of D-glucose 
dehydrogenase and 250 mM of L-alanine respectively rac alanine for ATA117 11Rd. For both enzymes 
a slightly yellow spot is observed. b) 10 mM OXD were utilized as amino donor and a fast change in 
color was be observed.(PAME = β-phenylalanine methyl ester) 
 
For identification of the product spot TLC-MS was used, as reference product the 
β-phenylalanine methyl ester β-PAME (Rf 0.83) was tested, which can be clearly identified on 
TLC-plates as slightly yellow spot after development using ninhydrin solution. The product 
spot β-PAEE showed an Rf value of 0.87 and running on the high of PEA and β-PA in TLC. 
However, PEA and β-PA are showing a purple colored spot after staining and additionally the 
mass is unique for β-PAME or β-PAEE. The β-keto ester substrate showing a quite similar 
mass, but showing a different running performance in TLC. Furthermore the variant 
3FCR_4M_59L was tested, which was active but showed no improvement in comparison to 
3FCR_4M and was therefore also excluded from further experiments. However, according to 
TLC analysis 3FCR_4M produced the expected product using L-alanine as amino donor and 
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pyruvate removal system (GDH-LDH). After 24 h samples were analyzed using EtOAc as 
extraction agent and analyzed the sample by TLC-MS. The product spot was determined to 
have a mass of 194.2 g mol-1, which is in positive mode of the MS exactly the molecular weight 
plus one proton (Figure 5.16). 
 
Figure 5.16 TLC-MS analysis of β-PAEE. β-PAEE was synthesized using 3FCR 4M. The resulting MS 
signals 194.2 (plus proton) and 216.2 (plus sodium) were identified as expected molecular weight signals 
for β-PAEE. TLC-MS measurements were verified using β-PAME standard. 
For validation of the results pure β-PAME standard was used for TLC-MS analysis. The mass 
of β-PAME was determined as 180.1 g mol-1, which is also the molecular mass plus one proton. 
On this account it can be concluded, that the yellow spot is a result of the reaction of ninhydrin 
with β-PA esters. Afterwards we performed experiments with PEA, IPA and OXD using TLC 
as mentioned.  
Small scale synthesis  
The end concentrations of 1 mL scale reactions were calculated using HPLC analysis after 24 h 
in respect of β-PA concentration. The enzyme concentration was set to 0.2 mg ml-1 (Table 5.). 
IPA was not converted with β-KE substrate at any time, but surprisingly the amino donor led 
to hydrolysis of the ester resulting in conversion of AP to PEA by ATA11711Rd as well as with 
IPA-concentrations of 200 and 400 mM of IPA. Since IPA acts as a weak base (pKs 10.6), it 
may have supported the hydrolysis of the β-keto ester and led to a shift in the pH value, 
especially at high concentrations. However, PEA showed no shift in the pH of the buffered 
reaction mixture, although the lower concentration of PEA could be the reason for this. The 
concentration of IPA in all reported reaction mixtures is generally high, since the affinity of the 
transaminases is used as low, which could ultimately also pose a problem for pH-sensitive 
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reactions (because it is a weak base). In contrast to IPA, product concentrations could be 
measured with PEA, alanine and OXD (Table 5.3).  
Using the amino donor PEA, the product concentrations showed to be relative low. After 
HPLC-analysis the reaction resulted in a relative product concentration of 0.8 % for 3FCR_4M. 
In contrast only a slight increase was determined for ATA11711Rd, but the resulting product 
amount was below quantification limit. However, OXD led to a relative product concentration 
of 31.8% with an optical purity of >99%ee using 3FCR_4M. Furthermore, ATA11711Rd was 
able to convert also the β-KE using OXD to produce. The widespread pyruvate removing 
system, containing LDH-GDH-NAD and D-glucose with alanine as amino donor leaded to 
relative product concentrations of 5.8% for 3FCR_4M and no detectable product amounts for 
ATA117 11Rd . 
Table 5.2 Analysis of optical purity and β-PA concentration after hydrolysis with NaOH. Different 
amino donors were tested. The reactions mixture contained 1 mM PLP, 10 mM β-KE and variable 
concentrations of amino donors in 30% (v/v) DMSO solution and 50 mM HEPES (pH 7.5). The 
conversion was determined after 24 h. n.d. = no detectable conversion. 
Amino donor 3FCR -4M ATA11711Rd 
 %ee (S) Relative product 
concentration 
%ee (R) Relative product 
concentration 
α-PEA (50 mM) 99 % 0.8 % n.d. < 0.5 % 
Alanine (250 mM)* 99 % 5.8 % n.d. 0 % 
OXD (10 mM) 99 % 31.8 % 92 % 12.5 % 
                                        *GDL-LDH pyruvate removal system (see also Figure 5.15) 
 
Nevertheless, a very small product spot could be identified by TLC analysis but could not be 
quantified by HPLC (see also Figure 5.15). Hereinafter, different concentrations of OXD were 
tested to increase the maximal yield of β-PAEE.  
Up-scaling for (S)-β-PAEE production 
The substrate and solvent concentration was varied for statistical test design (design of 
experiments). Therefor the reactions were performed in 200 µL scale and samples taken after 
24 h using both ω-TAs. The samples were quantified using GC (non-chiral) to detect the 
resulted ester-product, but the variation of DMSO, OXD and β-KE (substrate) did not increased 
the yield. However, it could be at least demonstrated that β-PAEE was extractable by EtOAc 
using GC for detection. The highest yield, for EtOAc extracted β-PAEE, was achieved for 
3FCR_4M with 2.9 mM using 55 mM of OXD, 25 mM of β-KE and 20 % (v/v) of DMSO. 
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Using the ATA117 11Rd the highest yield was only 0.8 mM of β-PAEE. ATA117 11Rd was 
therefore not used for a larger 200 mL (30 mM) approach, since the yield of β-PAEE was 
generally many times lower than for 3FCR_4M. The reaction was followed by TLC 
measurements and after no increase in product concentration was observed, the synthesis was 
stopped after 48 hours. β-PAEE was subsequently purified using flash chromatography. For 
this purpose, a preparative chromatography method was developed on an ordinary silica column 
to separate the substrate from the product. However, the reaction product first had to be filtered 
because the by-product isoindole polymerizes further and forms larger amounts of 
precipitations (Figure 5.17).  
 
Figure 5.17 Synthesis of β-PAEE on a 200 mL scale. The reaction was performed with 3FCR_4M at 
30°C for 48 h in a constantly rotated round flask. a) TLC-analysis of reaction samples (pink 
β-ketoester/yellow β-PAEE). b) Filtration of the reaction mixture after 48 h. c) Chromatogram of the 
processing of the reaction product using a solvent gradient mixed out of hexane, EtOAc, methanol and 
acetic acid. The product was detected by an evaporative light scattering detector (ELSD). 
HPLC analysis showed that the enantiomeric purity was above 99%ee of the (S)-β-PAEE. In 
summary this is the first example of aromatic β-keto ester reduction using engineered ω-TA. 
However the product yield of (S)-β-PAEE was only about 104 mg, which are only 10 percent 
by mass of the substrate originally used. But this quantity was sufficient at least for the analysis 
5) Towards biocatalytic β-keto ester transamination approaches 
206 
by 13C and 1H-NMR (see section Materials and Methods). In addition to the reaction 
equilibrium itself, the reason for the low turnover may be that the substrates (or intermediates) 
bind poorly to the active center of the enzymes. 
Docking analysis ATA117 
Albeit the turnover seems to be generally low, especially ATA11711Rd showed a relative low 
product formation, which is not only due to the reaction equilibrium. For a more detailed 
analysis, the binding energies of the substrate/product in ATA11711Rd were analyzed and 
compared with the binding energy of a known inhibitor molecule (Figure 5.18). 
 
Figure 5.18 Binding energy plot of intermediate compared to inhibitor in ATA11711Rd (PDB ID 5FR9). 
At the top binding of the inhibitor from the crystal structure 5FR9. Bottom binding of the β-amino acid 
intermediate in 5FR9. At least 200 rotamers were calculated. The total score is an indicator of whether 
the calculated bond is reasonable. The calculations were performed using ROSIE-ligand docking and 
PDB-structure 5FR9. Relatively low REU values are an indicator for the binding of the intermediate (in 
relation to the binding energy of the inhibitor). 
An explanation would be that the binding energy within ATA117 11Rd seems to be lower for the 
substrate(intermediate). For this purpose, the binding energy for the substrate was calculated, 
using crystal structure (PDB ID 5FR9) using Rosetta-Energy calculation algorithms (In-silico 
tool ROSIE). The inhibitor showed a binding energy of nearly19 REU (Rosetta Energy Unit). 
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Typically the binding energies are between-3 and -10 kcal mol-1 [58], but Rosetta is only able 
to calculate energies on an arbitrary scale. For this reason, it is essential to evaluate the binding 
energy on the basis of a reference substrate or inhibitor, which was done. 
In difference the binding energy ΔGbinding is 5.4 REU compared to β-keto ester intermediate. 
This means that the bond of substrate is may be less strong. Furthermore, also the position of 
the inhibitor compared to the substrate-intermediate is slightly shifted. To conclude that it was 
only a calculation error of the algorithm, the calculated position of the inhibitor was compared 
with the crystal structure data. The calculated inhibitor-position superimposed nearly perfect 
with the position in the crystal-structure. In contrast the β-phenylalanine-PLP-intermediate is 
shifted within the substrate binding pocket, compared to the inhibitor (Figure 5.19).   
 
Figure 5.19 Substrate-intermediate docking in ATA117 11Rd. A) Comparison of ROSIE-calculation and 
crystal-structure inhibitor position. The inhibitor binds with 18.8 REU at the congruent position 
compared to the experimental determined position (thin blue and brown lines). Therefor the calculation 
was used as validation for substrate docking. B) The β-phenylalanine-PLP intermediate resulted in 
weaker binding (13.5 REU, thick brown) and is turned and shifted compared to the inhibitor position. 
The Phenyl-moiety is oriented between Y61, Y67 and W192. For calculations the substrate docking tool 
ROSIE-Ligand was utilized. (Homology structure of ATA11711Rd was created by IV. Pavlidis)  
However the lower activity of ATA11711Rd for the β-keto ester might be reasoned by lower 
binding energies compared to 3FCR_4M. Within ATA117 the ethyl-residue of β-keto ester 
intermediate is oriented in a large pocket. However, the phenyl-moiety of the intermediate lies 
between three aromatic amino acid residues (Y61, Y67 and W192). Compared to inhibitor 
orientation (with an aryl-group), the position is occupied by the ethyl residue, thus placing the 
aromatic ring in a pocket full of tyrosine and tryptophan residues, which allows π-π interactions, 
where the hydroxyl groups of Y61/67 may be too polar for the aromatic ring of the 
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substrate/product. In addition, W192 can be protonated and thus carry a positive charge. In 
addition, the mentioned amino acid residues limit the space within the binding pocket. The 
pocket could be expanded by replacing it with phenylalanine or other hydrophobic residues 
(e.g. leucine or alanine). In contrast, the binding energy in 3FCR_4M was also calculated and 
compared with ATA11711Rd . 
 
Docking analysis 3FCR_4M 
The calculated binding energy of the substrate intermediate in 3FCR_4M was slightly lower 
(- 16.3 REU) than in the binding of the intermediate and ATA117. The orientation also matches 
the expected position of the reference bulky substrate ketone (diaryl-ketone intermediate) 
within 3FCR_4M (Figure 5.20).  
 
 
Figure 5.20 Hydrophobic-aromatic substrate pocket allows binding of β-phenylalanine-ester. The 
substrate-intermediate was docked into a calculated 3FCR_4M structure. The structure was calculated 
by Pavlidis et al. and shows binding of a diaryl-ketone. The β-phenylalanine-ethylester-intermediate 
showed to be located in the same manner and was docked into the substrate binding pocket using ROSIE-
ligand. The engineered amino residues are shown within the figure.  
However, like mentioned before the 3FCR_4M variant was engineered for bulky ketones 
without polar or hydrophilic side groups, which is why the substrate binding pocket might not 
be optimally suited for the polar β-keto esters. The enhanced 3FCR variant, 3FCR_4M, contains 
the mutations Y59W, Y87F, Y152F and T231A, which are beneficial for binding the cofactor-
substrate intermediate and expansion the small binding pocket (also known as P-pocket). The 
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residue Y87F belongs to the small binding pocket and increases the hydrophobicity and expand 
the space. Y59F and T213A in combination increasing the activity towards amines and bulky 
substrates [21]. In addition, it has been shown that bulky diaryl ketones can be converted with 
3FCR_4M, so that it is likely that the position of the ethyl ester intermediate appears reasonable. 
A reason for the better binding, compared to ATA11711Rd , might be the high hydrophobicity 
of the 3FCR_4M substrate pocket, which is a result of exchanges of tyrosine-residues against 
non-polar aromatic phenylalanine-residues. Furthermore, the space-consuming threonine 
residue was replaced by a small hydrophobic alanine residue [21]. Moreover it is also possible 
that a tyrosine at position F87 could have a positive effect, as this amino acid residue could 
form a hydrogen bond to the carboxyl group of β-keto ester/intermediate. 
Comparison to another β-keto ester converting ω-TA 
These amino acid positions were also investigated in another transaminase engineering 
experiment. An important amino acid position can be also relocated, using the numbering 
scheme oTAED [58], in the engineered V. fluvialis ω-TA from Midelfort et al. at W57F, which 
showed to be elementary important for the conversion of the ester substrate ethyl 3-
aminohexanoate [14]. Therefore W59 seems to be unbeneficial for conversion of the β-
keto/amino esters within 3FCR_4M. Moreover, it might be beneficial to mutate the flipping 
arginine of 3FCR towards phenylalanine as shown for the engineered V. fluvialis ω-TA. This 
mutation alone increased the activity of the enzyme towards the aliphatic β-keto ester substrate 
about 20-fold.   
5.2.4) Outlook and conclusion 
In summary, ω-TAs have never been engineered towards aromatic β-KE, so this work should 
be considered as proof of concepts. However some amino acid residues within Fold type I ω-TA 
can be remarked as putative important for β-KE activity. It is therefore also clear that the 
enzyme- and reaction properties must first be improved before further reaction scale up is 
sought. 
However, the synthesis of β-keto acids or esters can be conducted using asymmetrical substrates 
and the engineered 3FCR_4M and ATA117 11Rd. Since these enzymes have not been 
particularly designed for the conversion of ester substrates further engineering could increase 
yields and avoid expensive amino donors, like OXD or expensive co-product removal systems 
(e.g. LDH-GDH-pyruvate removal system). In this context, the immobilization of these 
enzymes could also be important. 
5) Towards biocatalytic β-keto ester transamination approaches 
210 
5.3) Conclusion chapter 5  
The targeted mutagenesis of the ω-TA from Variovorax paradoxus could not be realized. 
Further targeted mutations as well as directed evolution should be carried out in order to enable 
the conversion of aromatic β-keto esters. However, the mutations of the arginine residues seem 
to be important for the change in substrate specificity and showed also a large change in activity. 
Nevertheless, this also shows that enzyme engineering can be both time and resource intensive, 
in particular to introduce targeted mutations into the protein by PCR, and to perform enzymatic 
tests or large-scale screenings of random mutagenesis enzyme libraries. Therefore, it is 
recommended to test already characterized and existing ω-TAs as described in chapter 5.2 in 
order to reduce costs and shorten the enzyme engineering process. A combination of enzyme 
engineering and enzyme screening could therefore be an efficient method to obtain ω-TAs with 
the desired properties as quickly as possible. The two ω-TAs identified by the screening could 
be found quickly, but both enzymes do not appear to be adapted for the reaction. Therefore, 
these two enzymes provide a starting point for further enzyme engineering. This demonstrates 
that enzyme engineering is an iterative process until the properties are adapted to the process 
conditions and parameters.
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In addition to the targeted design of enzymes, as well as guided evolution and database mining 
new enzymes can be found using screening of microorganism. The strain Paraburkholderia sp. 
BS115 was discovered by J. Rudat in potting soil in respect of β-amino acid converting 
enzymes . In the following part the degradation of the newly isolated and the already 
discovered strain is compared with regard to the degradation of β-amino acids.   
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6.1) Introduction 
The catabolism of proteinogenic L-alpha-amino acids (L-α-AA) is in-depth understood and part 
of undergraduates’ biochemical education [1]. All other amino acids have long been rendered 
“unnatural”, which at least began to change for D-configurated α-AA.  
D-α-amino acids 
Bacteria have long been known to be a rich source of D-α-aa which are therefore abundant in 
soil and fermented food [2]. The role of these special amino acids and their metabolism in 
mammals has also been elucidated [3]. The bacterial synthesis mechanisms of D-α-AA and their 
incorporation in non-ribosomal peptides are now well-understood [4]. Degradation preferably 
happens via oxidation to the corresponding α-keto acid (α-KA) and is carried out by D-amino 
acid oxidases, the first of which being discovered as early as 1935 [5]. D-α-AA are part of the 
peptidoglycan layer of microorganism and the most important amino acids are D-glutamate and 
D-alanine [4]. These D -α-AAs are synthesized by racemases and D -AA aminotransferases [6] 
[7][8]. Besides this both enzymes, also epimerases and dehydratase/dehydrogenase can catalyze 
reactions towards D-AA [9][10]. However, in some cases the enzymes for these reactions are 
still unknown.  
Role of β-, γ-, ε-amino acids in organism  
Furthermore not only L-α and D-α-AA are present in nature and reactions towards amino acids 
with amino groups in other positions than α-position are possible, leading to β-, γ-, ε- and other 
constitutional isomers of amino acids. ε-amino acids have e.g. a special significance in the 
biosynthesis pathway of β-lactams in actinomycetes and are converted by lysine γ-
aminotransferases [11]. The most popular γ-AA is γ-aminobutyric acid (GABA), an important 
neurotransmitter which is degraded by aminobutyric acid (ω-)transaminase to succinic 
semialdehyde [12]. The γ-AAs are even in the focus of research for artificial bioactive 
molecules and occurring as parts of many natural compounds. The polypeptide Dolastatin is a 
prominent example of a γ-AA containing drug in cancer research [13,14]. A known drug is for 
example the muscle relaxant (-)baclofen, which is a derivative of γ -aminobutyric acid [15].  
The synthesis of non-natural γ-AA from γ-keto acids using an ω-transaminase (ω-TA) has been 
reported recently [14].  
By contrast, only minor insight is gained into the degradation of β-amino acids (β-AA). With 
the exception of β-alanine and β-aminoisobutyric acid which constitute key intermediates in 
several metabolic pathways, β-AA are not as abundant in nature as their α-configured 
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counterparts. β-alanine can be metabolized by mammalian organism [16] and is involved in 
pantothenate metabolism [17], finally becoming a component of the key metabolite 
coenzyme A (CoA). β-alanine is also linked with histidine by carnosine synthase to the 
dipeptide carnosine which is abundant in skeletal muscles as well as the central nervous system 
of most vertebrates [18]. Since β-alanine appears as the rate-limiting precursor, this β-AA has 
become a popular supplement in athlete diet with a documented increase in exercise 
performance like high intensity cycling [19]. Using the KEGG-pathway tool for analyzing the 
degradation of β-alanine, it can be shown that a transaminase reaction is forming malonate-
semialdehyde which is further converted to malonate and finally enters the fatty acid 
biosynthesis as malonyl-CoA [20]. The synthesis of β-AA and their incorporation into natural 
compounds has been extensively reviewed by Kudo [21]. Microorganisms appear to be quite 
routinely affected with β-AA. Thus a deeper understanding of degradation mechanisms 
promises (A) an insight into defense mechanisms of microorganisms affected with these natural 
compounds (B) environmental aspects referring to the persistence of β-AA in soil and water 
(C) pharmacokinetics of these natural compounds when used as a drug, e.g. cytostatics 
containing aromatic β-AA. Focused on the mentioned β-phenylalanine (β-PA) as an example 
for chiral β-AA synthesis an approach might be the synthesis of the racemic β-PA using 
classical chemistry, i.e. by reaction of benzaldehyde with malonic acid and ammonium acetate, 
the produced racemate can be optical purified by kinetic resolution using a enantioselective 
transaminases and fermentation processes might be an alternative to isolated enzymes [22–24]. 
Such deracemization approaches are showed e.g. for secondary aryl alcohols using whole-cell 
biocatalysts [15]. Furthermore, the investigation of the β-PA degradation process could lead to 
a deeper understanding of the biochemical pathways. This chapter is focused on the isolated 
Paraburkholderia sp as whole cell biocatalyst in respect of enantiomeric resolution of the chiral 
β-phenylalanine. 
In a previous study enrichment cultures with aromatic β-PA as sole nitrogen sources were 
cultivated [25]. From a variety of soil samples different bacteria capable to grow with β-PA as 
sole nitrogen source were investigated. Transamination was found to be the predominant initial 
degradation step, using cell extracts and fractions thereof gained by ammonia phosphate 
precipitation degradation only occurred when a suitable amino acceptor was additionally 
applied (preferably α-ketoglutarate or pyruvate) as well as the well-known transaminase 
cofactor pyridoxal phosphate (PLP). Until today, the microbial degradation of rac-β-PA has 
only once been documented by Mano et al. in 2006 and to the best of our knowledge these 
experiments have never been continued. However, further metabolization of the desaminated 
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(S)-β-PA (and thereby created β-keto acid, β-KA) in the degrading microorganism remained as 
uncertain as the fate of the (R)-β-AA. Here we report the degradation of racemic β-PA by the 
newly isolated Paraburkholderia strain BS115 and the Paraburkholderia type strain P. 
phytofirmans PsJN. The degradation of racemic β-phenylalanine using BS115 as fermentation 
strain was analyzed previously in the doctoral thesis of S.M. Dold [27]. In contrast this chapter 
is focused on the comparison of the results in regard to the β-PA degradation capabilities of the 
P. phytofirmans PsJN strain. In addition, the degradation behavior of both strains was 
investigated with chiral (R) and (S)-β-PA. 
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6.2) Materials and methods 
Chemicals  
All amino acids and chemicals were purchased from Sigma Aldrich (St.Louis, US) and Carl 
Roth (Karlsruhe, Germany) in analytical grade. All enantiopure amino acids were purchased 
from PepTech Corporation (Bedford, US). 
Bacterial strains 
Paraburkholderia BS115 was isolated by enrichment culture from garden soil spiked with soy 
peptone due to its high content of aromatic amino acids [25]. The strain was identified by the 
culture collection DSMZ (Deutsche Stammsammlung für Mikroorganismen und Zellkulturen 
GmbH) as P.  phytofirmans. Cultures of the strain were deposited at the DSMZ designated as 
DSM 103130 P.  phytofirmans (BS115). P. phytofirmans PsJN was also delivered by DSMZ 
(DSM 17436). 
Fermentation process  
The sterile minimal medium M1 contained 100 mM D-glucose and 10 mM of rac-β-PA, 5.8 mM 
KH2PO4, 4.1 mM NaHPO4·  2 H2O , 1 mM MgSO4 ·7 H2O, 0.5 mM CaCl2 ·  2 H2O and 0.01 
mM FeCl2 ·  4 H2O. Additionally the vitamins pyridoxal-5-phosphate (PLP) and cobalamin were 
added to the mixture in concentrations of 1 µM and 1 nM, respectively. The vitamins, β-
phenylalanine and FeCl2 were sterile filtrated separately while all other compounds were 
autoclaved. The sterile compounds were then mixed. The fermentation process was optimized 
for maximal growth rate in a small scale bioreactor system without pH regulation. 
The fermentation of PsJN and BS115 was performed in a benchtop reactor (vessel volume 
2.5 L; Minifors, Infors-HT, Switzerland) with a working volume of 1 L in minimal medium 
M1. The system was equipped with a pH probe (Mettler-Toledo, USA) and a Pt-100 
temperature probe. The temperature was set to 30° C and the stirrer speed was adjusted to 120 
rpm at the beginning.  For mixing and disruption of gas bubbles a standard Rushton stirrer 
(diameter 46 mm) was used. The pH-value and pO2 content were not controlled during the 
reaction. The aeration rate was set to 1 L/min. The experiment was conducted in a triplicate. 
The precultures were grown in a 100 mL shake flask in the minimal medium at the same 
temperature and inoculated from a glycerol stock. The precultures were cultivated in a rotary 
shaker (Infors-HT, Switzerland) at 120 rpm. The bioreactors were inoculated with the 
precultures to an optical density at OD600nm of at least 0.1.  
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Dry cell mass measurement  
10 mL of the cultures were centrifuged at 6.000 g for at least 10 min at 4°C. The pellets were 
washed with HPH2O (high-purity water, type I ISO 3696). After this, the cell pellets were dried 
overnight at 60°C in a drying oven.  
Glucose assay 
The concentration of d-glucose was measured by an enzymatic glucose-assay from R-Biopharm 
AG (Darmstadt, Germany). According to the manufacturer’s assay protocol volumes were 
down-scaled to 96-well microtiter plates (scale 1:20). 5 µL of the sample was mixed with 
100 µL HPH2O and 50 µL of solution 1. 10 µL of 1 to 10 diluted suspension 2 was pipetted to 
the mixture. The adsorption at 340 nm of the incomplete mixture was measured in an epoch 
plate reader system before and after suspension 2 was added to the mixture. Also after 5 and 10 
min the adsorption was measured. The measurement was calibrated by a D-glucose dilution 
series from 0.01 to 1 g/L.       
Enzyme activity assay  
Both strains were cultivated for at least 3 days at 120 rpm and 30°C in 100 mL minimal medium 
in shake flasks, the final OD600 was 3.4 for BS115 and 3.1 for PsJN. The cells were harvested 
by centrifugation at 8.000 rpm in Beckman Coulter (Brea, USA) centrifuge (JA-10 rotor) and 
lysed by incubation with 1 mg mL-1 lysozyme (Fluka) for 15 min at room temperature. Pellets 
were resuspended in 5 mL 40 mM ice cold sodium phosphate buffer (pH 7.2) and sonicated for 
5 min with 30 sec pulsations at 50% amplitude. The cell lysate was clearified by centrifugation 
at 50.000 g for 30 min at 4°C (Beckman Coulter). The cell free supernatants were used for 
testing the enzyme activity of both strains: 100 µL of lysate were added to 100 µL of reaction 
solution. The consumption rate was normalized by the protein concentration (standard Bradford 
test) of both lysates [28]. The activity test solution contained 15 mM of rac-β-PA and 15 mM 
α-ketoglutaric acid (amino acceptor). Additionally, 0.1 mM of the cofactor PLP was added to 
the solution. The solution was buffered by 40 mM sodium phosphate and adjusted at 7.2 with 
HCl. The reaction temperature was set to 30°C and samples were taken at various points. The 
samples were diluted with preheated sodium phosphate buffer (40 mM, 1 mM L-leucin, pH 7.2) 
and incubated at 99°C for 5 min to stop the reaction. L-leucin was used as internal standard for 
HPLC analysis.   
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Quantification of β-PA by HPLC 
The samples of the fermentation process were centrifuged for at least 5 min at 13.000 rpm in a 
bench top centrifuge (Eppendorf, Germany) and used for quantification of β-PA and AP. The 
so collected supernatant was used for HPLC analysis (Agilent 1200 Series) by automated 
precolumn derivatization with ortho-phtaldialdehyde and IBLC [29]. A reversed phase C18 
column (150 x 4.6 mm HyperClone 5 µm. Phenomenex Inc., Aschaffenburg, Germany) was 
used. The mobile phase was a mixture of 55% methanol and 45% of 40 mM sodium phosphate 
buffer (pH 6.5). The flow rate was set to 1 ml/min and the column temperature to 40°C. 
Detection was carried out by light absorption at 337 nm. The injection volume of the samples 
for the derivatization mixture was set to 0.5 µL. The total injection volume of the derivatization 
mixture was 10 µL. Calibration was performed using rac-β-PA (0 to 15 mM). To determine 
(R)- and (S)-enantiomers we used optically pure β-PA standards from Peptech (Burlington, 
USA).  
Quantification of Acetophenone (AP) by HPLC 
For analysis of AP the same HPLC method as mentioned before, but without derivatization. 
According to β-PA quantification, samples were centrifuged for at least 5 min at 13.000 rpm in 
a bench top centrifuge.  AP was measured at 245 nm and 5 µL sample was injected. Also a 
different C18 column was used (Kinetex 5 µm EVO C18 150 x 4.6 mm).  
Quantification of D-glucose by HPLC 
For quantification of D-glucose in PsJN samples, HPLC was used. This was necessary, because 
samples showed an interaction with the enzymatic assay. Glucose concentration was measured 
using HPLC-system with RI-detector system (Agilent 1100 series) adapted from Buchholz et 
al., 2014 [30]. Briefly, samples (S) were precipitated by 4 M NH3 in combination with 1.2 M 
MgSO4 in ratio of 0.87 (S): 0.039 (NH3): 0.087 (MgSO4), incubated for a few minutes at RT 
and centrifuged at 17.000 g in benchtop centrifuge. The supernatant was mixed 1:1 with 0.1 M 
H2SO4 and was again incubated at RT for at least 20 min and centrifuged at 17.000 g for 15 min. 
10 µL of the supernatant were injected on a Rezex ROA-organic acid H+ column (300 x 7.8 
mm, Phenomenex). The mobile phase consisted of 5 mM H2SO4 solution with a flow rate of 
0.4 ml/min. The temperature was set to 50°C for the column and 32°C for RI-detector. For 
calculation of the d-glucose concentration, a calibration curve was measured from 0.01 g/L to 
0.5 g/L. 
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Data analysis  
The maximal growth rate µ and substrate-consumption were fitted using a sigmoidal equation 
with three variable parameters to the optical density/dry-cell mass of the cell cultures and to the 
concentration of β-PA during the fermentation with data analysis software Sigma Plot (San 
Jose,  USA) adapted to Dörsam et al. [31]. The parameters a and b were defined as variables 
for the sigmoidal equation fit using Sigma Plot. x0 can be interpreted as half maximum of 
biomass production or as the half amount of the consumed β-PA and is the inflection point of 
the function. The variables are x and f(x). The cultivation time was defined as x in hours. The 
corresponding f(x) was defined as optical density, dry cell mass or the concentration of β-PA 
[mM]. 𝑓(𝑥) = 𝑎1 + 𝑒−𝑥−𝑥𝑜𝑏  
After fitting of the function against the measured values, the maximal rates were determined by 
calculating the slope using numeric differentiation with Excel (Microsoft, USA).   
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6.3) Results 
Both strains BS115 and PsJN were able to grow in minimal medium containing β-PA as sole 
nitrogen source in 1 L scale experiment. The fermentation process was started by inoculation 
of β-PA induced precultures.  
6.3.1) Fermentation of Paraburkholderia  
The main fermentation process of BS115 is illustrated in figure 6.1 a. The lag phase of the 
culture was observed between 0 h and 12 h. After this incubation period the culture was growing 
with maximal growth rate (12 h -21 h) until (S)-β-PA was almost completely consumed. After 
the preferred enantiomer was depleted, growth continued at a considerably slower rate. The 
stationary phase was reached 48 h after inoculation. The total consumed amount of (R)-β-PA 
was 2.5 mmol after 50 h of fermentation. In contrast the AP concentration increased with 
progressing fermentation and peaked at 4.5 mmol, when (S)-β-PA was almost fully consumed 
thereby nearly matching the consumed concentration of (S)-PA. Thereafter the AP 
concentration substantially decreased until the stationary growth phase was reached (Appendix 
S. Figure X).  
 
Figure 6.1 Degradation of rac-β-phenylalanine by Paraburkholderia sp. in a 2.5 L bioreactor. The 
fermentation was conducted in triplicate at 30°C in 1L minimal medium M1. a) BS115 b) PsJN. The red 
line indicates > 1% (S)-β-PA.. The experiments of BS115 were performed by Sarah Dold [27]. 
Growth resulted in a maximal optical density of 7.0, resembling a dry cell mass (DCM) 
concentration of 1.8 g/L at the end of the fermentation. The oxygen concentration before 
inoculation was set to 100 % and dropped during the process to a minimum of 80 %. While 
centrifuging fermentation samples for analytical purposes, the formation of a slime layer was 
observed when (S)-β-PA was fully consumed, which reproducibly happened at each 
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fermentation. The extracellular capsule built by BS115 was visualized by negative contrasting 
with Chinese ink (Figure S11). 
After 24 h the pH-level dropped from pH 7.0 to pH 6.0, then remained constant for 20 hours, 
but decreased in the last 10 h to a final pH of 3.5 (Figure S13). The remaining concentration of 
D-glucose inside the reactor was 27 ± 1.6 mM and total amount of consumed d-glucose was 
73 mM. The ratio between consumed carbon to consumed nitrogen (C: N) was calculated as 
14.6 mM per 1 mM of (S)-β-PA.  
The fermentation process of PsJN to characterize β-PA degradation was also investigated. 
Furthermore PsJN was used as control strain, to exclude that the degradation of (R)-β-PA is 
only an unspecific effect during the fermentation process e.g. by adsorption of the amino acid 
to bacterial cell envelopes or due to other reasons.  
The fermentation parameters were maintained according to the BS115 fermentation. The 
degradation of the (S)-enantiomer was almost complete after 38 h, which is in total 5 mM of β-
PA (Figure 6.1). During the whole fermentation no degradation of (R)-β-PA was observed. The 
AP concentration increased during the process to a maximum of 1.6 mM after 35 h (Figure 6.2). 
After 50 hours a slow decrease of the AP concentration in the medium to 0.8 mM was 
determined. In addition, we also observed only a slight capsulation of the microorganism with 
increasing fermentation time, which was not observed in shake flask experiments.  
Figure 6.2 Acetophenone content during fermentation process in comparison to (S)-β-PA concentration. 
AP concentration rises inversely proportional to (S)-β-PA degradation and decreases after (S)-β-PA 
depletion. A) BS115 fermentation B) PsJN fermentation. 
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The total amount of consumed (S)-β-PA was three times higher than the maximal concentration 
of AP in the medium. The OD600nm reached a maximum of 3.3 which is half the OD600 reached 
in the BS115 fermentation. The oxygen concentration decreased to a minimum of 70 %. In 
contrast to BS115, the pH-value dropped from neutral (pH 7) to pH 5, instead of pH 3.5. The 
d-glucose concentration could not be determined by glucose assay, caused by an inhibition or 
unknown interaction of the enzymatic assay with the supernatant of the fermentation medium. 
Therefore, we determined the concentration of d-glucose by HPLC. The remaining 
concentration of glucose inside the fermentation medium was 21.9 mM ± 2.5 mM after 50 h, 
which is 5 mM less than for BS115. The molar ratio of consumed carbon to nitrogen source 
was 15.6 per 1 mM (S)-β-PA. The DCM peaked after 50 h of cultivation at the concentration 
of 0.9 g/L, which is only half as much as for BS115. 
Table 6.1 Characterization of Paraburkholderia sp. fermentation process. The calculations are 
based on the mean values of three independent fermentations 
 Max. growth 
rate µmax [1/h] 
Max. 
volumetric 
growth rate 
rx [g/(L h)] 
Max. (S)-β-PA 
volumetric 
consumption 
rate Q(s)-PA 
[mM/h] 
Max. specific 
(S)-β-PA 
consumption 
rate q(S)-PA 
[mmol/(g h)] 
td [h]  
Paraburkholderia 
phytofirmans PsJN 
0.14 0.036 0.21 -2.1 4.95 
Paraburkholderia sp. 
BS115  
0.23 0.063 0.26 -1.3 3.0 
 
Within the two day fermentation using BS115 the DCM level of 2 g/L is clearly higher 
compared to PsJN, but in respect of the produced biomass in ratio to the depleted glucose 
amount the Yx/s-value of 0.15 is rather low.  Surprisingly a consumption of the (R)-enantiomer 
of β-PA was shown for BS115 but the growth was limited although neither (R)-β-PA nor 
glucose was fully depleted. The remaining concentration of glucose was 27 ± 1.6 mM and the 
oxygen concentration of 80% can be ruled out as limiting factor for further growth. The 
conversion rates of β-PA and the growth rate µ and volumetric growth rate rx were compared 
in Table 1. The µmax was determined for PsJN after 17.9 h of cultivation with 0.14 h-1, which is 
equate to a doubling time (td) of 4.95 h. Strain BS115 reached its maximum at 27.0 h of 
cultivation time with 0.23 h-1.  
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Figure 6.3 Dry cell mass building rate of a) BS115 and b) PsJN. The dry cell mass data points were 
fitted with a 3 parameter sigmoid function with an R2 of 0.99. This function was used to calculate the 
slope (ΔDCM/Δt). 
During fermentation BS115 grew 1.6 times faster than PsJN on β-PA. (Figure 6.3). The Q(s)-PA 
rate was calculated to be 0.26 mM h-1 for BS115 after 14.2 h (Figure 6.4). The Q(s)-PA rate of 
PsJN was slightly lower with 0.21 mM h-1 after 16.2 h of cultivation time. In addition the q(s)-PA 
was determined for both strains, which is correlated to the biomass concentration.  On the other 
hand BS115 had a specific q(s)-PA rate which is slightly lower with 0.74  mmol g-1 h-1 compared 
to PsJN with 0.88 mmol g-1 h-1  (Figure 6.4). 
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Figure 6.4 Decrease rate of (S)-β-PA. Bold line – q(s)-PA. Points with line – concentration of (S)-β-PA in 
bioreactor. a). BS115 b) PsJN. 
 
PsJN produced less biomass but the cells converted (S)-β-PA more efficiently. PsJN started to 
convert with maximal specific consumption rate, whereas BS115 reached its maximal 
consumption rate after 8 h of cultivation time. In contrast to (S)-β-PA, the consumption rate of 
(R)-β-PA could not be fitted for BS115, caused by the high variances and inconstant decreasing 
rate between 25 and 50 h of cultivation. The volumetric production rate QAP of AP reached a 
maximum of 0.07 mM h-1 for PsJN after 10.8 h of fermentation. After several hours the AP 
concentration decreased with a much slower with a QAP rate of 0.01 mM h-1. Initially, the BS115 
QAP rate was faster than calculated for PsJN, with 0.34 mM h-1. 
6.3.2) ω-TA activity test 
The β-PA degrading activity of both strains were tested with cell free lysate from BS115 and 
compared to PsJN lysate. The temperature was set to 30°C according to the cultivation 
temperature of BS115 and PsJN. For the transamination reaction  0.1 mM of the ω-TA cofactor 
molecule PLP and selected α-ketoglutarate as acceptor molecule was added due to the 
compatibility towards well characterized β-phenylalanine transaminases [24,31]. The final 
concentration of applied protein in the reaction mixture was 0.47 mg/mL for PsJN and 
0.95 mg/mL for BS115. The concentration of rac-β-PA in the lysate-reaction mixture was 
determined at different times, to recognize slow and fast conversions as well as long-term 
effects (Figure S12). After 24 h both lysates showed only activity for (S)-β-PA and a complete 
conversion of the (S)-enantiomer. The transaminase activity at the beginning of the reaction 
was considerably higher for PsJN lysate than for BS115. The specific activities of both 
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preparations were calculated between samples of 15 s and 1 h and varied between 35 ± 5 mU/mg 
for PsJN and 8 ± 4 mU/mg for BS115. In total, the amounts of the obtained lysate activity was 
1.25 U and 0.32 U in 100 mL cell culture at an OD600 of 3.1.  
 
6.4) Discussion  
6.4.1) Degradation of (S)-β-PA by BS115 and PsJN 
Both Paraburkholderia strains BS115 and PsJN were able to grow with (S)-β-PA as sole source 
of nitrogen. The metabolization of the N-source most likely occurs via a transaminase reaction 
in which the amino group of (S)-β-PA is transferred to an α-keto acid. Although α-ketoglutarate 
has been shown to be the most suitable in vitro amino acceptor, the in vivo application of other 
molecules like pyruvate is also possible. 
Deracemization of β-PA has only once been reported so far: The only comparable fermentation 
example from Mano et al. showed that the soil bacterium Variovorax sp. JH2 is able to convert 
(S)-selective 61 mM of β-PA within 8 days [26]. They achieved a maximal degradation rate of 
0.26 mM h-1 towards (S)-β-PA, which is comparable to the uptake rates of PsJN and BS115. 
The opportunity to utilize bacterial strains for chiral resolution of rac-β-PA should be tested in 
further experiments in larger scales and at higher concentration levels, to prove whether a 
microbial process might be able to compete with established industrial deracemization 
processes as known from Evonik-Degussa using lipases [32]. Yeast cells have successfully been 
used for the chiral resolution of alcohols and more recent examples document the microbial 
resolution e.g. of  DL-glyceric acid [33–35].   
The rapid degradation of the (S)-enantiomer, in contrast to the (R)-enantiomer, resulted in a 
reduction of the pH-value by metabolizing almost half of the D-glucose. According to this, the 
final pH value of 3.5 is most likely to be limiting. In addition it could be seen that during BS115 
fermentation the pH-value stagnated at a constant value of five for several hours before it 
dropped to 3.5. A total consumption of the (R)-enantiomer might be possible, if the fermentation 
process was pH regulated. The fermentation parameters quantified are valuable for using the 
strains as whole cell biocatalyst for chiral resolution of rac-β-PA for lab scale chiral resolution 
experiments and lead the assumption, that BS115 is able to convert (R)-β-PA by a mechanism 
unknown so far.  The lowering of the pH value indicates that either an organic acid is formed 
or a previously buffering substance has been absorbed by BS115. A possible explanation for 
this could also be that when switching from (S) to (R)-enantiomer degradation, the resulting β-
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keto acid production stops for a while, and its restart ultimately lowers the pH-value. The 
decomposing β-keto acid also forms CO2, which could acidify the medium but is likely to be 
driven out over time by the supply of fresh air. 
By-product analysis     
The proposed transamination of (S)-β-PA leads to the corresponding β-keto acid 3-oxo-3-
phenylpropanoic acid. However, this molecule has never been detected in medium as it 
spontaneously decarboxylates to AP as has been shown in previous studies [24,36]. AP on the 
other hand was shown to emerge in parallel to the degradation of (S)-β-PA, peaking for both 
strains after about 30h when (S)-β-PA is depleted. Progress of AP formation rate and (S)-β-PA 
degradation rate are nearly identical for both strains which is strong evidence for the proposed 
transamination mechanism (Figure 6.5). In BS115, even the molar concentrations of emerging 
AP and metabolized (S)-β-PA are close to identical. So it is most likely that after transamination 
the corresponding β-keto acid decarboxylates and the emerging AP is excreted. 
 
Figure 6.5 Putative degradation mechanisms for conversion of β-PA. In grey: putative degradation 
mechanisms of (R)-β-PA and (S)-β-PA. In black: identified degradation pathways of (S)-β-PA. 
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After depletion of (S)-β-PA, AP concentration in the medium notably decreases. Substantial 
evaporation of the volatile AP can be excluded from control experiments (data not shown). A 
reuptake of AP is possible, but from the data at hand it cannot be stated whether AP serves as 
additional carbon source or as amino acceptor without further metabolization which would also 
lead to the observed depletion. Rehdorf et al. showed in Pseudomonas putida strain JD1, that a 
Baeyer-Villiger monooxygenase converts 4-hydroxy AP to phenyl-acetate. Finally, phenyl-
acetate is further degraded via a β-ketoadipate metabolic pathway. At the same time, the enzyme 
is also able to convert AP [37]. This metabolic pathway releases acetic acid, which should lower 
the pH value of the fermentation medium. This is supported by the fact that at the very time 
when acetophenone decreases drastically (after 40 h), also the pH value of BS115 fermentation 
decreases from 6 to 4 (Figure S13).  
Further experiments with a different Paraburkholderia strain demonstrated that AP can be 
reduced by a carbonyl reductase [38], which might serve as an evidence for further 
metabolization inside the cells. It is also known that Burkholderia sp. expresses a reductase 
which is able to reduce 2-aminoacetophenone to 2-amino-1-phenylethanol [39]. The same 
reductase might also be able to convert AP. Furthermore PsJN is known to degrade even more 
complex aromatic biomolecules like the plant hormone indole-3-acetic acid by a rather complex 
degradation pathway to catechol [40]. So a bacterial metabolization of AP as a reason for its 
decrease is most likely. 
 
Superior growth of BS115  
Although both strains clearly metabolize (S)-β-PA via the same mechanism, BS115 reaches a 
final OD600 twice as high as that of PsJN under identical growth conditions. According to 16S-
rDNA sequencing, both strains show >99% identity, so the basic metabolism might not differ 
too much and maybe only one additional enzyme makes up the severe difference in growth. 
However, it is also possible that different enzymes from other microbial sources are integrated 
in BS115 genome via horizontal gene transfer, especially when the strain was exposed to 
extraordinary amino sources in soil. Since the PsJN cultures obviously reaches the stationary 
phase when (S)-β-PA is depleted although sufficient amounts of d-glucose are still at hand, a 
growth stop can be explained by the inability of this strain to use the (R)-enantiomer as nitrogen 
source; (R)-β-PA remains completely unconsumed during the whole fermentation. A growth 
inhibition by other factors like toxic metabolites is unlikely since the closely related strain 
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BS115 very probably faces similar but even stronger stress conditions (e.g. ongoing 
acidification, depletion of other nutrients than N-source). 
Moreover, BS115 shows a quite similar cell dry mass per depleted (S)-β-PA minus depleted 
(R)-β-PA. In total BS115 built 1.82 g of biomass per liter and consumed 7.72 mM of rac- β-
PA, that is a ratio of 4.3 g/(mM(β-PA)). In contrast PsJN built only 0.82 g L-1 (ratio 
5.9 g/(mM(β-PA)) and was at the same time more efficient in using only (S)-PA. So we 
postulate at least one additional enzyme in BS115 which allows the metabolization or (R)-β-
PA as additional N-source and potentially also as additional C-source, leading to a better growth 
and to the formation of considerably more cell dry mass from the same medium. 
Degradation of (R)-β-PA by BS115 
Several options of amino acid metabolization are identified and well investigated (see also 
introduction section), and most of these also seem conceivable for the degradation of (R)-β-PA. 
Since activity has only been observed in growing cells, a cofactor-dependent mechanism is 
likely. Moreover, an additional transaminase would have been detected under the given 
conditions, and also a side activity of the identified (S)-β-PA can be excluded: (R) and (S)-ω-
TAs show only low sequence identities and can clearly be differentiated by protein fold types 
[41,42]. A transamination of (R)-β-PA would have led to the formation of AP, but on the 
contrary the concentration of AP decreased. Several (R)-selective ω-TAs have been described 
for the ability to convert and synthesize (R)-configurated amines. However, activity towards 
aromatic or bulky β-AAs were only observed for (S)-selective ω-TAs [36,43,44] and no (R)-PA 
converting transaminase has been reported until now [45–48]. Only Mano et al. investigated an 
(R)-selective strain, Arthrobacter sp. AKU 638, which is suitable for chiral resolution to gain 
the optical pure (S)-β-PA.  However, this degradation process is very slow and took 13 days of 
fermentation and in contrast to BS115 they did not recognize any depletion of the (S)-
enantiomer at the same time [26]. Oxidative deamination has been suggested, but until now, the 
mechanism for the degradation of (R)-β-PA in Arthrobacter sp. AKU 638 is uncovered. .  
In fact, the metabolism of (R)-β-PA has only been reported for microorganism with assured 
aminomutases or ammonia lyases genes [48–50]. The activity of aminomutases is described as 
quite low which might explain the rather slow degradation of (R)-β-PA using BS115 [51] . Also 
several amino acid oxidases exist with high activity towards several amines [52,53], but as yet 
amino acid oxidases with activity towards β-PA have not been published. Analogously no 
wildtype β-amino acid dehydrogenase is known; the only example of a dehydrogenase with 
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activity towards β-PA is an engineered enzyme from the amino acid fermenting bacterium 
Candidatus cloacamonas [54].  
However, PA-racemases have been described for the racemization between l and d-α-PA in 
bacteria [55] and for plants the Taxus (yew) PA aminomutase is known to use α-phenylalanine 
as substrate to produce (R)-β-PA [56]. Wu et al. showed that a PA mutase from Taxus chinensis 
can be utilized for chiral separation of rac-β-PA. The corresponding α-PA is then degraded to 
cinnamic acid using an α-PA ammonia lyase from Rhodosporidium toruloides. The reported 
reaction time for chiral resolution was quite long with more than 48 h using 2 mM of substrate 
[57]. Apart from this also β-tyrosine aminomutase is known from Oryzae sativa with high 
enantioselectivity towards (R)-β-PA [58]. So a slow enzymatic racemization of (R)-PA to 
(S)-PA and further metabolization of the latter by BS115 appears at least possible; but no 
bacterial racemase with such an activity is known until now.  
 
Hypothetical degradation pathway for (R)-β-PA 
Recently Csuka et al. reported that Pseudomonas fluorescens R124 encodes three different class 
I lyase like enzymes, namely an ammonia-lyase, an aromatic 2,3 aminomutase and a histidine 
ammonia-lyase [59]. The authors describe, that under nitrogen limitation, P. fluorescens is able 
to integrate new genes by horizontal gene transfer to overcome limitations. Therefore BS115 
might be adapted towards special nitrogen limitations, even when the genome is quite similar 
to PsJN. For this reason it might be possible that BS115, in the presence of (S)-β-PA, expresses 
an ammonia-lyase which could convert (R)-β-PA to cinnamic acid which could further 
metabolized in catabolism and might be additionally a reason for lowering the pH-value. 
Pseudomonas strains can metabolize cinnamic acid to o-hydroxyphenylpropionic acid and to 
2,3-dihydroxyphenylpropionic acid [60]. BS115 might be able to regenerate NAD(P)+ by this 
way using an NADP oxidoreductase. In high concentrations cinnamic can also be reduced by 
NADH using fumarate reductase or by an oxygen-sensitive 2-enoate reductase [61,62]. An 
oxygen-sensitive enzyme would also give an explanation why the activity is hard to detect in 
crude extracts without further protective measures.  
This assumption is supported by growth experiments on enantiopure (R) and (S)-β-PA as 
nitrogen sources, as BS115 is only able to degrade (R)-β-PA in the presence of (S)-β-PA and 
not when added as sole N-source (Figure 6.6). The experiments showed that (S)-β-PA was 
completely converted, whereas the (R)-enantiomer as sole nitrogen source remained untouched 
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even after a cultivation duration of 70 h (Figure 5a). On the other hand, the (R)-enantiomer was 
substantially degraded in the presence of (S)-β-PA (Figure 6.6 b). Only 40 % of 10 mM (R)-
enantiomer retained within the cultivation medium after 70 h. Therefore (S)-β-PA serves as 
nitrogen source and (R) might only serve as additional carbon source or as electron acceptor, if 
cinnamic acid as intermediate is produced.      
 
Figure 6.6 Conversion of (R)-β-PA in presence of the (S)-enantiomer (b) and no conversion as sole 
nitrogen source (a). The experiment was performed using optically pure β-PA in minimal medium. 
BS115 was pre-cultivated on (R/S)-β-PA for three days in shaking-flaks. 
All of the above discussed potential pathways and metabolization steps using the addressed 
different enzymes are also summarized in figure 6.5.These results also confirm the report from 
Mano et al., that no activity can be detected in cell-free lysate of an Arthrobacter sp. AKU 638 
strain for (R)-β-PA consumption. Furthermore, the reported very slow degradation, might hint 
to a similar mechanism using the same enzyme as in BS115.  
6.5) Conclusion 
We characterized the degradation of racemic β-PA by a three days fermentation of two 
Paraburkholderia strains PsJN and BS115 in a 2.5 L-benchtop fermenter in 1 L medium. PsJN 
exhibited strict (S)-selectivity and therefore can be utilized as whole cell biocatalyst to obtain 
(R)-β-PA in high optical purity by chiral resolution. The spontaneous decarboxylation of the 
emerging β-keto acid to acetophenone, for the first time documented over the whole degradation 
process, shifts the equilibrium irreversibly towards the desired direction. To gain industrial 
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relevance a high cell density fermentation has to be developed with medium conditions 
allowing much higher substrate concentrations, maybe using fed batch approaches. 
By contrast, BS115 also metabolizes (R)-β-PA by a so far unknown mechanism. Today, the 
possibilities to synthesize (R)-configurated aromatic amines and amino acids are limited by the 
availability of (R)-selective enzymes; so far, only few plant enzymes are known for the 
synthesis of (R)-β-PA [63]. So the investigation of the (R)-β-PA degradation process in BS115 
might not only lead to a deeper understanding of the biochemical pathways of β-AA but to 
novel approaches for the chemoenzymatic synthesis of this highly relevant substance class.  
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7) Concluding remarks  
The family of ω-TA could be the next important group of enzymes (within the enzyme class of 
transferases) that are important for industrial applications after hydrolases and oxidoreductases, 
which is also reflected as a global trend in the field of industrial biocatalysis [1]. The enzyme 
classes of isomerases, ligases and lyases have not been sufficiently investigated and too less 
enzyme engineering was performed in the past to achieve an equivalent importance of this 
classes compared to transferases, oxidoreductases and hydrolases. However, it is also clear that 
hydrolases remain the most important industrial enzyme class, as they are independent of 
cofactors and have already been thoroughly analyzed [2].   
Transaminases have the potential to improve pharmaceutical synthesis processes and thus gain 
the research interest of industry and academia. This doctoral thesis therefore shows the potential 
of ω-transaminases as demonstrated by the exemplary synthesis of β-phenylalanine. 
Furthermore β-phenylalanine, and β-amino acids (esters)  in general, are of particular interest 
for the development of new active ingredients, peptidomimetics and flavors (chapter 1) as well 
as drug delivering co-polymers [3,4].  
Green and efficient synthesis methods have rarely been shown so far, since chiral β-amino acids 
are often produced using metallic-ligand based catalysts or just the racemate is synthesized. The 
synthesis of β-phenylalanine ester via ω-TA seems to be a green and efficient strategy, but the 
scientific basis for the development of processes is currently still too small. Therefore, ω-TA 
must first be specifically adapted for processes, as their natural variants are often not 
sufficiently optimized for production on a larger scale. To solve this problem, the literature data 
of ω-TA were analyzed in chapter 1 and 3 and functional important amino acid residues were 
underlined. Furthermore the diversity of the ω-transaminases family was demonstrated.  
On this basis, the β-amino acid converting enzyme from V. paradoxus was selected as starting 
point. In addition, this enzyme has been thermostabilized (chapter 4) to fulfill the requirements 
of enzymatic processes and for enzyme engineering procedures. The improvement allowed the 
expansion of the long-term activity of the ω-transaminase in solution, but still the synthesis of 
β-phenylalanine was not possible by a one-step reaction. It could be shown that a reaction 
cascade consisting of lipase plus ω-TA is feasible, but neither the product yield was sufficient 
nor the possibility of up-scaling was given. Therefore enzyme engineering was performed 
(chapter 5), but it was shown that more experiments have to be performed to gain a functional 
V. paradoxus ω-transaminase. The screening of already existing engineered transaminases 
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showed, that it is possible to convert aromatic β-keto ester substrates into β-amino acid esters. 
Also it was highlighted, that no wildtype transaminase showed activity towards the substrate of 
interest. However, this is an example for modern protein engineering and underlines, how 
important the transformation of mutagenesis studies can be. Overall, the knowledge base of a 
certain enzyme class is the most important factor for successful enzyme engineering. Within 
this thesis, it was also shown, that this knowledge base is still not enough for engineering ω-TA 
into β-keto ester converting enzymes. Conversion is possible by 3FCR_4M and by 
ATA11711Rd, but the results also suggest that both enzymes are not optimized for β-keto ester 
conversion and therefore more engineering has to be performed to result in an industrial 
enzyme. The fact that β-amino acids, although rarely free occurring in nature, can be consumed 
by microorganisms (Chapter 6), suggests that several β-amino acid converting enzymes 
(including transaminases) are still to be discovered, which might also be applicable for the 
synthesis of β-amino acids. The two Proteobacteria strains Paraburkholderia PsJN and BS115 
could therefore be used as sources for new ω-TAs and other enzymes with activity against β-
phenylalanine. Albeit, in silico mining of transaminases in databases, such as oTAED 
(chapter 3), is also an alternative to microbial tests, as artificial gene synthesis becomes cheaper. 
This represents an alternative to protein engineering. 
7.1) Reaction conditions 
Besides the question of identifying or generating ω-TA that can be used for the synthesis of β-
amino acids (esters), the question arises how the reaction conditions can be optimized. The 
reaction equilibrium can be successfully shifted to the product side by removing the co-product 
of the transaminase reaction. This has been shown in particular for the reaction approaches with 
ortho-xylylenediamine as amino donor. Ortho-xylylenediamine, however, leads to 
polymerization products that precipitate during the reaction, but also remain partly in solution, 
and therefore make reaction processes more difficult. Alternative and cheaper amino donors 
such as 1-phenylethyl amine and isopropylamine, both of which are able to shift the chemical 
equilibrium in transaminase reactions, were much less equilibrium shifting than ortho-
xylylenediamine in the reactions shown or did not even enable turnovers. But on the other hand 
not all ω-TA are able to accept ortho-xylylyenediamine as amino donor (e.g. from V. 
paradoxus). Reactions with isopropyl amine as donor would be most favorable, but this amino 
donor is also not accepted by the most of ω-transaminases and must also be used in high molar 
excess. 
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7.2) Outlook 
The industrial application of ω-TA remains demanding, but in recent years many promising 
examples have already been shown that underline the possibilities. Accordingly, optimizing 
ω-TAs for reactions is only the first step towards an enzymatic process. It is therefore necessary 
to investigate how ω-transaminases can be used in a technical context, since the production of 
the enzymes can be associated with high costs.  
Immobilization 
Immobilization processes such as the LentiKats® system (encapsulation) or immobilization by 
magnetic beads, presented in Chapter 1, already show that this processes are realizable in 
smaller scales. Other immobilization methods, such as 3D-printed enzymatic flow cell reactors 
are also conceivable. Within the scope of this thesis and the research project Molecular 
Interaction Engineering (MIE), preliminary tests for 3D-printed and functionalized reaction 
systems were therefore performed (see appendix Figure S14). First tests showed that 3D 
functionalization of 3D-printed materials is possible to bind specifically ω-TA on the surface, 
but the enzymatic activity and the amount of bound transaminase remained low (data not 
shown). In contrast, commercially available Ni-NTA-columns proved to be significantly better 
transaminase reactors. Further tests and redesign of the printed 3D flow reactors must therefore 
be carried out.  
Nevertheless, further work could show that ω-TA could be used for the synthesis of β-amino 
acid (esters) on a larger scale, in flow cell reactors, membrane reactors or batch reactors. Finally, 
after solving the mentioned challenges, ω-TA could be established as catalysts in 
pharmaceutical chemistry and in particular for the synthesis of β-amino acids. We will see 
whether ω-TA in particular and whether enzymes in general can contribute to a more efficient 
and greener chemical industry in the near future.  
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 Abbreviations and Symbols 
µmax   Max growth rate   
Å Ångstrom  
AB 3-Amino butyric acid 
ADCL 4-Amino-4-deoxychorismate lyase  
AP    Acetophenone 
aw Water activity  
BCAT l-branched-chain aminotransferase 
CRL Candida rugosa lipase 
DAPP 4'-Deoxy-4'-acetylyamino-pyridoxal-5'-phosphate 
DATA (R)-selective d-α-transaminases  
DKR Dynamic Kinetic Resolution 
E. coli Escherichia coli 
EOPP Ethyl-3-oxo-phenylpropanoate  
EtOAc Ethyl acetate 
FoldX Empirical force field algorithm  
FPLC Fast protein liquid chromatography 
GC Gas chromatography  
Hfams Homologous families 
HPLC High performance liquid chromatography 
IBLC N-isobutyryl- L-cysteine 
IPA Isopropylamine 
KG α-Keto glutarate  
KR Kinetic resolution 
L Liter 
mM Milli-molar  
MD Molecular dnymaic simulation 
mg Milli gram 
ms Milli second 
ns Nano second 
oTAED ω-Transaminase engineering database  
OXD O-xylylenediamine 
OPA Ortho-phthalaldehyde 
PCR Polymerase chain reaction 
PEA 1-Phenylethylamine 
PEEP β-Phenylalanine ethyl ester-PLP intermediate  
PLP Pyridoxal-5-phosphate 
PMP Pyridoxamine phosphate 
P-pocket  5'phosphate oriented binding pocket of PLP in ω-TA 
PT Paclitaxel 
q
 (s)-PA      Specific consumption rate 
Q(s)-PA  Volumetric consumption rate (S)-β-PA   
Q-AP Volumetric production rate AP  
qPCR Quantitative Polymerase chain reaction 
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REU Rosetta Energy Units 
rx    Volumetric growth rate    
s Second 
td  Doubling time (microorganism) 
TLC Thin layer chromatography  
Tm Protein melting point 
OD Spectral absorbance 
V. paradoxus Variovorax paradoxus 
Y
 x/s   Biomass yield per substrate amount    
β-AA  β-Amino acid   
β-KE  β-Keto ester 
β-PA β-Phenylalanine  
β-PAEE β-Phenylalanine ethyl ester 
β-PAME  β-Phenylalanine methyl ester 
ΔG Change in free energy  
ΔH Enthalpy 
ΔΔG Difference in folding-energy between wild type and 
mutant 
ω-TA ω-Transaminase(s) 
ω-VpTA  ω-TA from Variovorax paradoxus 
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Codon optimized gene-sequence of ω-VpTA for E. coli BL21-expression. 
ATGACCCATGCAGCAATTGATCAGGCACTGGCAGATGCATATCGTCGTTTTACCG
ATGCAAATCCGGCAAGCCAGCGTCAGTTTGAAGCACAGGCACGTTATATGCCTGG
TGCAAATAGCCGTAGCGTTCTGTTTTATGCACCGTTTCCGCTGACCATTGCACGTG
GTGAAGGTGCAGCACTGTGGGATGCAGATGGTCATCGTTATGCAGATTTTATTGC
AGAGTATACCGCAGGCGTTTATGGTCATAGCGCACCGGAAATTCGTGATGCAGTT
ATTGAAGCAATGCAGGGTGGTATTAATCTGACAGGTCATAATCTGCTGGAAGGTC
GTCTGGCACGTCTGATTTGTGAACGTTTTCCGCAGATTGAACAGCTGCGTTTTACC
AATAGCGGCACCGAAGCAAATCTGATGGCACTGACCGCAGCACTGCATTTTACCG
GTCGTCGTAAAATTGTTGTTTTTAGCGGTGGTTATCATGGTGGTGTTCTGGGTTTT
GGTGCACGTCCGAGCCCGACCACCGTTCCGTTTGATTTTCTGGTTCTGCCGTATAA
TGATGCACAGACCGCACGTGCACAGATCGAACGTCATGGTCCGGAAATTGCAGTT
GTTCTGGTTGAACCTATGCAAGGTGCAAGCGGTTGTATTCCGGGTCAGCCGGATT
TTCTGCAGGCACTGCGTGAAAGCGCAACCCAGGTTGGTGCACTGCTGGTTTTTGA
TGAAGTTATGACCAGTCGCCTGGCACCGCATGGTCTGGCAAATAAACTGGGTATT
CGTAGCGATCTGACCACCCTGGGCAAATATATCGGTGGTGGTATGAGCTTTGGTG
CATTTGGTGGTCGTGCAGATGTTATGGCACTGTTTGATCCGCGTACCGGTCCGCTG
GCACATAGCGGTACATTTAACAATAATGTGATGACCATGGCAGCCGGTTATGCAG
GTCTGACCAAACTGTTTACACCGGAAGCAGCCGGTGCACTGGCCGAACGCGGTG
AAGCTCTGCGTGCCCGTCTGAATGCACTGTGTGCAAATGAAGGTGTTGCAATGCA
GTTTACCGGCATTGGTAGCCTGATGAATGCACATTTTGTTCAGGGTGATGTTCGTA
GCAGCGAAGATCTGGCAGCAGTTGATGGTCGTCTGCGTCAGCTGCTGTTTTTTCAT
CTGCTGAATGAAGATATCTATAGCAGTCCGCGTGGTTTTGTTGTTCTGAGCCTGCC
GCTGACCGATGCCGATATTGATCGTTATGTGGCAGCGATTGGTAGCTTTATTGGT
GGTCATGGTGCCCTGCTGCCTCGTGCCAATTAA 
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Figure S1 SDS-PAGE analysis of the purification of the wild type ω-VpTA and mutant enzyme variants 
by Ni-NTA affinity chromatography. Comparison of whole cells expressing the variants ω-VpTA 
G98M, E391K, G98M+E345F, G98M+392K, G165M, E345F, D392K along with the corresponding 
purified enzymes. 
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Figure S2 Thermal-shift assay for determination of exemplary melting curves and melting points of the 
wild type ω-VpTA (a) and of variant G98M+D392K (b). The inflection point of the melting curve 
function marks the Tm (protein melting point). The melting point was determined by triple measurement. 
Protein expression was performed twice for the final determination of the protein melting point. For 
each determination 5 µM of Ni-NTA purified ω-VpTA were utilized.  
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Figure S3 Influence of the G98M mutation on the protein flexibility. The amino acid position of dimer 
A and B is numbered consecutively. The MD-Simulation was performed over a time period of 100 ns 
in 40 mM sodium phosphate buffer at 300 K and 333 K. (Left) MD-Simulation data for the wild type is 
shown in blue, G98M is shown in red. The backbone flexibility is indicated by RMSF-value. (Right) 
The ΔRMSF-values of every position of the wildtype in relation to G98M highlighting the differences 
in flexibility. Note that at 333 K the behavior of the G98M mutant remains largely unchanged (compare 
the red curves in the left images) in comparison to the simulation at 300 K, whereas the wild type clearly 
shows less thermostability (compare the blue curves in the left images). 
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Figure S4 Melting curve of disulfide variants of ω-VpTA. a) Variant 125C showed a melting point of 
only 53.5°C, this is 2°C less than known for wild type. b) Variant 5C+429C showed no significant 
difference compared to the wild type. The variants were expressed using E. coli SHuffle and purified 
using Ni-NTA.  
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Figure S5 Alanine conversion by ω-VpTA using α-ketoglutarate as acceptor. For reaction 4 µM of ω-
TA were utilized in 100 mM sodium phosphate buffer at pH 7.2 with 0.2 mM of PLP, 50 mM  α-
ketoglutarate and 250 mM of rac-alanine. For removal of pyruvate 1 U mL-1 lactate dehydrogenase was 
utilized, which oxidizes NADH to NAD+. The reaction was observed at 340 nm in Tecan-plate reader 
in a scale of 200 µL. The temperature was set to 35°C. The control was performed without α-
ketoglutarate. The reaction was performed in threefold determination. The standard deviation is shown 
as grey bars. 
 
Figure S6 ω-VpTA showing activity towards (S)-PEA. 0.5 µM of ω-TA was utilized in 400 µL of 
reaction buffer at 45°C. The reaction mixture consisted of: 100 mM α-MBA, 15 mM α-ketoglutarate, 
0.1 mM PLP and 40 mM of sodium phosphate buffer (pH 7.2). The reaction was started by addition of 
enzyme solution. The control was performed without α-ketoglutarate. 
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Figure S7. Calibration of (S)-β-phenylalanine concentration with peak area for quantitative HPLC 
analysis of the transaminase reaction. The standard solutions were diluted and treated identically to the 
reaction samples.  
 
Figure S8 Analysis of different amino acids (amines) by reversed phase chromatography and IBLC-
OPA derivatization. Concentrations were used which typically represent the initial situations of 
enzymatic reactions. The method is described in Chapter 4. 
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Table S1 Standard numbering of VpTA (PDB ID 4AOA). The standard numbering (S.N.) was created 
using the oTAED standard numbering tool.   
S.N. AA S.N. AA S.N. AA S.N. A
A 
S.N. A
A 
S.
N. 
A
A 
S.N
. 
A
A 
S.N. A
A 
S.N. A
A 
0.1 M 0.5
1 
L 50 N 100 K 150 I 20
0 
G 25
1 
F 301 F 346.6 V 
0.2 T 0.5
2 
T 51 L 101 I 151 A 20
1 
L 25
2 
N 302 T 346.7 V 
0.3 H 2 I 52 T 102 V 152 V 20
2 
A 25
3 
N 303 G 346.8 L 
0.4 A 3 A 53 G 103 V 153 V 20
3 
N 25
4 
N 304 I 346.9 S 
0.5 A 4 R 54 H 104 F 154 L 20
4 
K 25
5 
V 305 G 346.1 L 
0.6 I 5 G 55 N 105 S 155 V 20
5 
L 25
6 
M 306 S 346.1
1 
P 
0.7 D 6 E 56 L 106 G 156 E 20
6 
G 25
7 
T 307 L 346.1
2 
L 
0.8 Q 7 G 57 L 107 G 157 P 20
7 
I 25
8 
M 308 M 346.1
3 
T 
0.9 A 8 A 58 E 108 Y 158 M 20
8 
R 25
9 
A 309 N 346.1
4 
D 
0.1 L 9 A 59 G 109 H 159 Q 20
9 
S 26
0 
A 310 A 346.1
5 
A 
0.1
1 
A 10 L 60 R 110 G 160 G 21
0 
D 26
1 
G 311 H 346.1
6 
D 
0.1
2 
D 11 W 61 L 111 G 161 A 21
1 
L 26
2 
Y 312 F 346.1
7 
I 
0.1
3 
A 12 D 62 A 112 V 162 S 21
2 
T 26
3 
A 313 V 346.1
8 
D 
0.1
4 
Y 13 A 63 R 113 L 163 G 21
3 
T 26
4 
G 314 Q 346.1
9 
R 
0.1
5 
R 14 D 64 L 114 G 164 C 21
4 
L 26
5 
L 315 G 346.2 Y 
0.1
6 
R 15 G 65 I 115 F 165 I 21
5 
G 26
6 
T 316 D 346.2
1 
V 
0.1
7 
F 16 H 66 C 118.
4 
G 166 P 21
6 
K 26
7 
K 317 V 346.2
2 
A 
0.1
8 
T 17 R 67 E 118.
5 
A 167 G 21
7 
Y 26
8 
L 318 R 346.2
3 
A 
0.1
9 
D 18 Y 68 R 118.
6 
R 168 Q 21
8 
I 26
9 
F 319 S 346.2
4 
I 
0.2 A 19 A 69 F 119 P 169 P 21
9 
G 27
0 
T 320 S 346.2
5 
G 
0.2
1 
N 20 D 70 P 120 S 170 D 22
0 
G 27
1 
P 321 E 346.2
6 
S 
0.2
2 
P 21 F 71 Q 121 P 171 F 22
1 
G 27
2 
E 322 D 346.2
7 
F 
0.2
3 
A 22 I 72 I 122 T 172 L 22
2 
M 27
3 
A 323 L 346.2
8 
I 
0.2
4 
S 23 A 73 E 123 T 173 Q 22
3 
S 27
4 
A 324 A 346.2
9 
G 
0.2
5 
Q 24 E 74 Q 124 V 174 A 22
4 
F 27
5 
G 325 A 346.3 G 
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0.2
6 
R 25 Y 75 L 125 P 175 L 22
5 
G 27
6 
A 326 V 346.3
1 
H 
0.2
7 
Q 26 T 76 R 126 F 176 R 22
6 
A 27
7 
L 327 D 346.3
2 
G 
0.2
8 
F 27 A 77 F 127 D 177 E 22
7 
F 27
8 
A 328 G 346.3
3 
A 
0.2
9 
E 28 G 78 T 128 F 178 S 22
8 
G 27
9 
E 329 R 346.3
4 
L 
0.3 A 29 V 79 N 129 L 179 A 22
9 
G 28
0 
R 330 L 346.3
5 
L 
0.3
1 
Q 30 Y 80 S 130 V 180 T 23
0 
R 28
1 
G 331 R 346.3
6 
P 
0.3
2 
A 31 G 81 G 131 L 181 Q 23
1 
A 28
2 
E 332 Q 346.3
7 
R 
0.3
3 
R 32 H 82 T 132 P 182 V 23
2 
D 28
3 
A 333 L 346.3
8 
A 
0.3
4 
Y 33 S 83 E 133 Y 183 G 23
3 
V 28
4 
L 334 L 346.3
9 
N 
0.3
5 
M 34 A 84 A 134 N 184 A 23
4 
M 28
5 
R 335 F   
0.3
6 
P 35 P 85 N 135 D 185 L 23
5 
A 28
6 
A 336 F   
0.3
7 
G 36 E 86 L 136 A 186 L 23
6 
L 28
7 
R 337 H   
0.3
8 
A 37 I 87 M 137 Q 187 V 23
7 
F 28
8 
L 338 L   
0.3
9 
N 38 R 88 A 138 T 188 F 23
8 
D 28
9 
N 339 L   
0.4 S 39 D 89 L 139 A 189 D 23
9 
P 29
0 
A 340 N   
0.4
1 
R 40 A 90 T 140 R 190 E 24
1 
R 29
1 
L 341 E   
0.4
2 
S 41 V 91 A 141 A 191 V 24
2 
T 29
2 
C 342 D   
0.4
3 
V 42 I 92 A 142 Q 192 M 24
3 
G 29
3 
A 343 I   
0.4
4 
L 43 E 93 L 143 I 193 T 24
4 
P 29
4 
N 344 Y   
0.4
5 
F 44 A 94 H 144 E 194 S 24
5 
L 29
5 
E 345 S   
0.4
6 
Y 45 M 95 F 145 R 195 R 24
6 
A 29
6 
G 346.
1 
S   
0.4
7 
A 46 Q 96 T 146 H 196 L 24
7 
H 29
7 
V 346.
2 
P   
0.4
8 
P 47 G 97 G 147 G 197 A 24
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Figure S9 Gas chromatography for detection of β-PAEE. The calibration solution were mixed in EtOAc. 
The resulting peak area under the curve (AUC) at 28.9 min, detected by FID, was utilized for linear 
calibration. 
 
 
Table S2 ω-TA gene-sources for β-PAEE screening. Therefore different Fold type I and IV 
ω-TA were expressed in E. coli BL21 and tested in OXD-screening.  
Source Abbr. Vector Resistance Induction 
Fold 
type 
PDB code or 
protein ID 
(NCBI) 
Ruegeria 
pomeroyi  3HMU pET22b Amp IPTG I 3HMU 
)Ruegeria sp. 
TM1040  3FCR pET22b Amp IPTG I 3FCR 
Mesorhizobium 
loti 3GJU pET22b Amp IPTG I 3GJU 
Rhodobacter 
sphaeroides 
KD131 3I5T pET22b Amp IPTG I 3I5T 
Vibrio fluvialis  VibFlu pET24b Kan IPTG I 3NUI 
Mesorhizobium 
sp. LUK  2YKY pET28b Kan IPTG I 2YKY 
Chromobacterium 
violaceum Cvi pET28a Kan IPTG I 4BA5 
Aspergillus 
oryzae AspOry pGASTON Amp Rhamnose IV (16976819) 
Aspergillus 
terreus AspTer pGASTON Amp Rhamnose IV 4CE5 
Mycobacterium 
vanbaalenii MycVan pGASTON Amp Rhamnose IV (120405468) 
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Penicillium 
chrysogenum PenChr pGASTON Amp Rhamnose IV (211591081) 
Burkholderia sp. BurSp pGASTON Amp Rhamnose IV (78059900) 
Rhizobium etli RhiEtl pGASTON Amp Rhamnose IV (190895112) 
Hyphomonas 
neptumium HypNep pGASTON Amp Rhamnose IV (114797240) 
Gamma 
proteobacterium GamPro pGASTON Amp Rhamnose IV (219677744) 
Labrenzia 
alexandrii LabAle pGASTON Amp Rhamnose IV (EEE43073) 
Marimonas sp. MarSp pGASTON Amp Rhamnose IV (8712265) 
Nocardia 
farcinica NocFar pGASTON Amp Rhamnose IV (unpublished)  
Rhodoferax 
ferrireducens RhoFer pGASTON Amp Rhamnose IV (89899273) 
Bacillus sp. D-AlaTA pGASTON Amp Rhamnose IV (ecDATA) 
Aspergillus 
fumigatus AspFum pET22b Amp IPTG IV (70986662) 
Gibberella zeae GibZea pET22b Amp IPTG IV (4610976) 
Neosartorya 
fischeri NeoFis pET22b Amp IPTG IV (119483224) 
Rhodobacter 
sphaeroides RhoSph pET22b Amp IPTG I 3I5T 
Jannaschia sp. JanSp pET22b Amp IPTG IV 8905361 
Mesorhizobium 
loti MesLoti pET22b Amp IPTG IV 1347158 
Roseobacter sp. RosSp pET22b Amp IPTG IV 8613754 
Arthrobacter sp. 
KNK168 ATA117 pET22b Amp IPTG IV 3WWH 
Arthrobacter sp. 
KNK168 (mut) ATA117 27rd pET22b Amp IPTG IV 5FR9 
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Figure S10 1H (a) and 13C (b) – NMR-spectra of the purified β-PAEE product. Besides the product, 
acetic acid could also be determined. H/C-NMR was determined at 500 MHz.    
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Chapter 6)  
 
Figure S11 Negative contrasting of Paraburkholderia BS115 cells after growing on β-phenylalanine 
using Chinese ink. Figures were captured by J. Rudat.  
 
Figure S12 Activity of cell free lysate of BS115 and PsJN. In red triangles: (R)- β-PA; in green triangles 
(S)- β-PA. The reaction was performed at 30°C in reaction mixture. 
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Figure S13. Change in pH during fermentation of Paraburkholderia BS115 and PsJN in 2.5 L 
bioreactor systems using minimal medium.  
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Figure S14 3D-printed flow cell reactor for immobilization of ω-TAs via metal affinity binding. The 
3D-printed material was functionalized with IDA (c) to ensure the coordination of a two-valued metal 
atom, like cobalt (produced by group of Prof. Franzreb). To test the flow-cell device, IDA-cylinder (b) 
were incubated with protein solution contain 3FCR_4M (with Hexa-his-Tag). For enzymatic reactions, 
the substrate solution (10 mM PEA, 10 mM pyruvate, 50 mM HEPES (pH 7.5) was preheated to 40°C, 
passed via a persistaltic pump (flow rate approx. 100 µL min) into the 40°C tempered enzyme reactor. 
Samples were collected in an auto sampler and analyzed by TLC and HPLC. The system was compared 
with a Ni-NTA-column (Thermofischer) as a reference for a functional flow cell system. It turned out 
that only small amounts of enzyme could be bound specifically. Therefore, both the IDA 
functionalization and the nature of the enzyme carrier have to be improved.         
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